##GENOME_BUILD=GRCh38
##CREATION_DATE=2021-07-15
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.2-660-g1c2b0c04
##SAMPLE=<ID=NA12878_03,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=affected>
##DESCRIPTION=NA12878_03=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=MMsplice delta Logit PSI score: variant's effect on the exon inclusion - positive score shows higher exon inclusion, negative higher exclusion rate. A score greater than 2 or less than -2 can be considered strong.
##DESCRIPTION=MMSplice_pathogenicity=MMsplice pathogenicity score: probability of pathogenic effect of the variant on splicing
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	SpliceAI	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	27355990	27355990	G	A	het	off-target	QUAL=2185;DP=168;AF=0.51;MQM=60;SAP=15;ABP=3	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::,MAP3K6:XM_017002771.1:intron_variant:MODIFIER:intron25/26:c.2454+36C>T::,MAP3K6:XR_946795.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/28:n.5158+36C>T::						rs12569127	0.1903	0.2714	5878,.	0.2161,0.2029,0.1156,0.3237,0.1645	-0.4890			0.35				COSV58872155	0.002	0.1439	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27359572	27359572	G	C	hom	off-target	QUAL=6130;DP=198;AF=1.00;MQM=60;SAP=5;ABP=0	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::,MAP3K6:XM_017002771.1:intron_variant:MODIFIER:intron15/26:c.1063-50C>G::,MAP3K6:XM_017002772.1:intron_variant:MODIFIER:intron17/17:c.2320-13C>G::,MAP3K6:XR_946794.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/24:n.3751-50C>G::,MAP3K6:XR_946795.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/28:n.3750-50C>G::						rs7521552		0.9943	74221,.	0.9655,0.9966,1.0000,0.9953,0.9965	-0.1950			3.40					-0.0295	0.1433	0.79	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27360975	27360975	G	T	het		QUAL=9721;DP=729;AF=0.52;MQM=60;SAP=4;ABP=5	MAP3K6	missense	MAP3K6:ENST00000357582.3:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:ENST00000374040.7:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:	MAP3K6:NM_001297609.2:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:,MAP3K6:NM_004672.5:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:XM_017002771.1:missense_variant:MODERATE:exon12/27:c.609C>A:p.Asn203Lys:,MAP3K6:XM_017002772.1:missense_variant:MODERATE:exon14/18:c.1866C>A:p.Asn622Lys:,MAP3K6:XR_946794.3:non_coding_transcript_exon_variant:MODIFIER:exon14/25:n.3297C>A::,MAP3K6:XR_946795.3:non_coding_transcript_exon_variant:MODIFIER:exon14/29:n.3296C>A::	regulatory_region_variant:promoter		403071 [benign DISEASE=not specified];			rs35659744	0.1220	0.2260	4303,.	0.0497,0.1399,0.0936,0.3028,0.1508	0.1830	T(0.18),T(0.20)	B(0.00),B(0.00)	13.87	0.04			COSV62887042,COSV62889375	0.1192	0.1097	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363868	27363868	T	C	het	off-target	QUAL=1451;DP=111;AF=0.53;MQM=60;SAP=4;ABP=4	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron5/28:c.864+49A>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron4/27:c.840+49A>G::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron4/27:c.840+49A>G::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron5/28:c.864+49A>G::,MAP3K6:XM_017002771.1:intron_variant:MODIFIER:intron3/26:c.-406+49A>G::,MAP3K6:XM_017002772.1:intron_variant:MODIFIER:intron5/17:c.864+49A>G::,MAP3K6:XR_946794.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/24:n.2295+49A>G::,MAP3K6:XR_946795.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/28:n.2294+49A>G::					MIRb (SINE/MIR)	rs4307592	0.2196	0.3044	7286,.	0.3199,0.2199,0.1139,0.3232,0.1662	-0.0450			5.97				COSV62890059	0.0319	0.2915	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27364153	27364153	A	G	het	off-target	QUAL=639;DP=88;AF=0.35;MQM=60;SAP=4;ABP=20	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron4/28:c.695+51T>C::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron3/27:c.671+51T>C::	MAP3K6:NM_001297609.2:intron_variant:MODIFIER:intron3/27:c.671+51T>C::,MAP3K6:NM_004672.5:intron_variant:MODIFIER:intron4/28:c.695+51T>C::,MAP3K6:XM_017002771.1:intron_variant:MODIFIER:intron2/26:c.-575+51T>C::,MAP3K6:XM_017002772.1:intron_variant:MODIFIER:intron4/17:c.695+51T>C::,MAP3K6:XR_946794.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/24:n.2126+51T>C::,MAP3K6:XR_946795.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/28:n.2125+51T>C::		604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]				rs12727507	0.3548	0.4246	15760,.	0.6804,0.2466,0.1147,0.3568,0.1999	0.0210			3.13				COSV54641801	-0.0365	0.3088	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	45330597	45330597	G	C	hom	off-target	QUAL=264;DP=10;AF=1.00;MQM=60;SAP=25;ABP=0	MUTYH,	intron,intron&NMD_transcript	MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-1160C>G::,:ENST00000671898.1:intron_variant&NMD_transcript_variant:MODIFIER:intron18/20:c.1981-40C>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::	MUTYH:NM_001048171.2:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:NM_001048172.2:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:NM_001048173.2:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:NM_001048174.2:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:NM_001128425.2:intron_variant:MODIFIER:intron14/15:c.1477-40C>G::,MUTYH:NM_001293190.2:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:NM_001293191.2:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:NM_001293192.2:intron_variant:MODIFIER:intron14/15:c.1117-40C>G::,MUTYH:NM_001293195.2:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:NM_001293196.2:intron_variant:MODIFIER:intron14/15:c.1117-40C>G::,MUTYH:NM_001350650.2:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:NM_001350651.2:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:NM_012222.3:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:NR_146882.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/16:n.1621-40C>G::,MUTYH:NR_146883.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/15:n.1470-40C>G::,MUTYH:XM_011541497.3:intron_variant:MODIFIER:intron14/15:c.1453-40C>G::,MUTYH:XM_011541498.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_011541499.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_011541500.3:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_011541501.2:intron_variant:MODIFIER:intron15/16:c.1435-40C>G::,MUTYH:XM_011541502.2:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_011541503.2:intron_variant:MODIFIER:intron13/14:c.1435-40C>G::,MUTYH:XM_011541504.2:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:XM_011541505.2:intron_variant:MODIFIER:intron10/11:c.1015-40C>G::,MUTYH:XM_011541506.2:intron_variant:MODIFIER:intron10/11:c.1015-40C>G::,MUTYH:XM_017001331.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_017001332.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_017001333.1:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:XM_017001334.1:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:XM_017001335.1:intron_variant:MODIFIER:intron14/15:c.1117-40C>G::,MUTYH:XM_017001336.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:XM_017001337.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:XM_024447244.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:XM_024447245.1:intron_variant:MODIFIER:intron13/14:c.1048-40C>G::,MUTYH:XM_024447248.1:intron_variant:MODIFIER:intron12/13:c.1006-40C>G::,MUTYH:XM_024447249.1:intron_variant:MODIFIER:intron12/13:c.877-40C>G::,MUTYH:XM_024447250.1:intron_variant:MODIFIER:intron12/13:c.877-40C>G::,MUTYH:XM_024447251.1:intron_variant:MODIFIER:intron12/13:c.877-40C>G::,MUTYH:XR_001737190.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/16:n.1438-40C>G::,MUTYH:XR_001737192.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/14:n.1250-40C>G::,MUTYH:XR_002956643.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/14:n.1430-40C>G::,MUTYH:XR_002956644.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/13:n.1965-40C>G::,MUTYH:XR_946658.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/16:n.1538-40C>G::		618994_[GENE=HPDL_PHENOS=Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive; Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Gastric cancer, somatic, 613659 (3); Adenomas, multiple colorectal, 608456 (3), Autosomal recessive]	439920 [benign DISEASE=none provided];			rs3219493		0.9295	65830,.	0.9591,0.9512,0.8911,0.9120,0.9177	0.2630			4.74					0.0398	0.0368	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45331833	45331833	C	G	het		QUAL=3110;DP=231;AF=0.51;MQM=60;SAP=5;ABP=3	MUTYH,	missense,intron,missense&NMD_transcript	MUTYH:ENST00000354383.10:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:ENST00000355498.6:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000372098.7:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372104.5:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:ENST00000372110.7:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:ENST00000372115.7:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000448481.5:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000456914.7:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000528013.6:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-2396G>C::,:ENST00000671898.1:missense_variant&NMD_transcript_variant:MODERATE:exon16/21:c.1518G>C:p.Gln506His:,MUTYH:ENST00000672818.3:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:	MUTYH:NM_001048171.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001048172.2:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:NM_001048173.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001048174.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:NM_001128425.2:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His:,MUTYH:NM_001293190.2:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:NM_001293191.2:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:NM_001293192.2:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:NM_001293195.2:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:NM_001293196.2:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:NM_001350650.2:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:NM_001350651.2:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:NM_012222.3:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:NR_146882.2:non_coding_transcript_exon_variant:MODIFIER:exon12/17:n.1158G>C::,MUTYH:NR_146883.2:non_coding_transcript_exon_variant:MODIFIER:exon11/16:n.1007G>C::,MUTYH:XM_011541497.3:missense_variant:MODERATE:exon12/16:c.990G>C:p.Gln330His:,MUTYH:XM_011541498.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_011541499.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_011541500.3:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_011541501.2:missense_variant:MODERATE:exon13/17:c.972G>C:p.Gln324His:,MUTYH:XM_011541502.2:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_011541503.2:missense_variant:MODERATE:exon11/15:c.972G>C:p.Gln324His:,MUTYH:XM_011541504.2:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:XM_011541505.2:missense_variant:MODERATE:exon8/12:c.552G>C:p.Gln184His:,MUTYH:XM_011541506.2:missense_variant:MODERATE:exon8/12:c.552G>C:p.Gln184His:,MUTYH:XM_017001331.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_017001332.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_017001333.1:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:XM_017001334.1:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:XM_017001335.1:missense_variant:MODERATE:exon12/16:c.654G>C:p.Gln218His:,MUTYH:XM_017001336.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:XM_017001337.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:XM_024447244.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:XM_024447245.1:missense_variant:MODERATE:exon11/15:c.585G>C:p.Gln195His:,MUTYH:XM_024447248.1:missense_variant:MODERATE:exon10/14:c.543G>C:p.Gln181His:,MUTYH:XM_024447249.1:missense_variant:MODERATE:exon10/14:c.414G>C:p.Gln138His:,MUTYH:XM_024447250.1:missense_variant:MODERATE:exon10/14:c.414G>C:p.Gln138His:,MUTYH:XM_024447251.1:missense_variant:MODERATE:exon10/14:c.414G>C:p.Gln138His:,MUTYH:XR_001737190.1:non_coding_transcript_exon_variant:MODIFIER:exon12/17:n.975G>C::,MUTYH:XR_001737192.1:non_coding_transcript_exon_variant:MODIFIER:exon10/15:n.787G>C::,MUTYH:XR_002956643.1:non_coding_transcript_exon_variant:MODIFIER:exon10/15:n.967G>C::,MUTYH:XR_002956644.1:non_coding_transcript_exon_variant:MODIFIER:exon9/14:n.1502G>C::,MUTYH:XR_946658.2:non_coding_transcript_exon_variant:MODIFIER:exon12/17:n.1075G>C::		618994_[GENE=HPDL_PHENOS=Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive; Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Gastric cancer, somatic, 613659 (3); Adenomas, multiple colorectal, 608456 (3), Autosomal recessive]	41767 [benign DISEASE=Carcinoma of colon,MYH-associated polyposis,Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,not specified,none provided,not provided];	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH];		rs3219489	0.3135	0.2900	5824,.	0.2630,0.4881,0.3974,0.2444,0.2371	-0.2650	T(0.10),T(0.10),T(0.08),T(0.10),T(0.09),T(0.08),T(0.09),T(0.10), ,T(0.08), , ,T(0.09),T(0.08)	B(0.15),B(0.21),B(0.29),B(0.21),B(0.38),B(0.21),B(0.29),B(0.21), ,B(0.21), , ,P(0.90),B(0.29)	8.88	0.04			COSV58343790	0.0714	0.9516	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45332883	45332883	T	C	hom	off-target	QUAL=5838;DP=189;AF=1.00;MQM=60;SAP=3;ABP=0	MUTYH,	intron,intron&NMD_transcript	MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.115+1508A>G::,:ENST00000671898.1:intron_variant&NMD_transcript_variant:MODIFIER:intron10/20:c.1008+35A>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron6/15:c.495+35A>G::	MUTYH:NM_001048171.2:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:NM_001048172.2:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:NM_001048173.2:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:NM_001048174.2:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:NM_001128425.2:intron_variant:MODIFIER:intron6/15:c.504+35A>G::,MUTYH:NM_001293190.2:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:NM_001293191.2:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:NM_001293192.2:intron_variant:MODIFIER:intron6/15:c.144+35A>G::,MUTYH:NM_001293195.2:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:NM_001293196.2:intron_variant:MODIFIER:intron6/15:c.144+35A>G::,MUTYH:NM_001350650.2:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:NM_001350651.2:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:NM_012222.3:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:NR_146882.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/16:n.648+35A>G::,MUTYH:NR_146883.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/15:n.497+35A>G::,MUTYH:XM_011541497.3:intron_variant:MODIFIER:intron6/15:c.480+35A>G::,MUTYH:XM_011541498.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_011541499.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_011541500.3:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_011541501.2:intron_variant:MODIFIER:intron7/16:c.462+35A>G::,MUTYH:XM_011541502.2:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_011541503.2:intron_variant:MODIFIER:intron5/14:c.463-49A>G::,MUTYH:XM_011541504.2:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:XM_011541505.2:intron_variant:MODIFIER:intron2/11:c.43-49A>G::,MUTYH:XM_011541506.2:intron_variant:MODIFIER:intron2/11:c.43-49A>G::,MUTYH:XM_017001331.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_017001332.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_017001333.1:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:XM_017001334.1:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:XM_017001335.1:intron_variant:MODIFIER:intron6/15:c.144+35A>G::,MUTYH:XM_017001336.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:XM_017001337.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:XM_024447244.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:XM_024447245.1:intron_variant:MODIFIER:intron5/14:c.75+35A>G::,MUTYH:XM_024447248.1:intron_variant:MODIFIER:intron4/13:c.34-49A>G::,MUTYH:XM_024447249.1:intron_variant:MODIFIER:intron4/13:c.-97+35A>G::,MUTYH:XM_024447250.1:intron_variant:MODIFIER:intron4/13:c.-97+35A>G::,MUTYH:XM_024447251.1:5_prime_UTR_variant:MODIFIER:exon5/14:c.-145A>G::,MUTYH:XR_001737190.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/16:n.465+35A>G::,MUTYH:XR_001737192.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/14:n.278-49A>G::,MUTYH:XR_002956643.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/14:n.458-49A>G::,MUTYH:XR_002956644.1:non_coding_transcript_exon_variant:MODIFIER:exon4/14:n.944A>G::,MUTYH:XR_946658.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/16:n.565+35A>G::		618994_[GENE=HPDL_PHENOS=Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive; Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Gastric cancer, somatic, 613659 (3); Adenomas, multiple colorectal, 608456 (3), Autosomal recessive]	257529 [benign DISEASE=not specified,none provided];			rs3219487		0.9326	66268,.	0.9677,0.9530,0.8902,0.9134,0.9190	-1.2610			0.66				COSV58343750	0.1949	0.943	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	62247552	62247552	C	G	hom		QUAL=1165;DP=37;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	missense	KANK4:ENST00000317477.8:missense_variant:MODERATE:exon3/4:c.217G>C:p.Val73Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon8/9:c.919G>C:p.Val307Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000371150.5:missense_variant:MODERATE:exon6/7:c.871G>C:p.Val291Leu:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000371153.9:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:PF13857 [Ankyrin repeats (many copies)]	KANK4:NM_001320269.2:missense_variant:MODERATE:exon8/9:c.919G>C:p.Val307Leu:,KANK4:NM_181712.5:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:,KANK4:XM_011540843.3:missense_variant:MODERATE:exon9/10:c.2803G>C:p.Val935Leu:,KANK4:XM_011540845.3:missense_variant:MODERATE:exon9/10:c.2731G>C:p.Val911Leu:,KANK4:XM_017000483.2:intron_variant:MODIFIER:intron8/8:c.2682+5515G>C::,KANK4:XM_017000484.2:missense_variant:MODERATE:exon9/10:c.919G>C:p.Val307Leu:,KANK4:XM_017000485.2:missense_variant:MODERATE:exon7/8:c.871G>C:p.Val291Leu:	regulatory_region_variant:open_chromatin_region					rs2941679		0.9767	72601,.	0.9936,0.9872,0.9993,0.9639,0.9725	0.7870	T(0.37),T(0.28),T(0.31),T(0.94)	B(0.00),B(0.00),B(0.00),B(0.00)	14.11	0.04				-0.0002	0.1727	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247574	62247574	G	A	het		QUAL=1311;DP=117;AF=0.44;MQM=60;SAP=3;ABP=7	KANK4	synonymous	KANK4:ENST00000317477.8:synonymous_variant:LOW:exon3/4:c.195C>T:p.His65=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000354381.3:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000371150.5:synonymous_variant:LOW:exon6/7:c.849C>T:p.His283=:PF13857 [Ankyrin repeats (many copies)],KANK4:ENST00000371153.9:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:PF13857 [Ankyrin repeats (many copies)]	KANK4:NM_001320269.2:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon9/10:c.2709C>T:p.His903=:,KANK4:XM_017000483.2:intron_variant:MODIFIER:intron8/8:c.2682+5493C>T::,KANK4:XM_017000484.2:synonymous_variant:LOW:exon9/10:c.897C>T:p.His299=:,KANK4:XM_017000485.2:synonymous_variant:LOW:exon7/8:c.849C>T:p.His283=:	regulatory_region_variant:open_chromatin_region					rs10889315	0.3189	0.3893	11539,.	0.3207,0.3324,0.1573,0.4246,0.4067	-0.0850			0.70				COSV58092010	-0.0649	0.1708	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263112	62263112	A	G	hom		QUAL=38141;DP=1196;AF=1.00;MQM=60;SAP=5;ABP=0	KANK4	5'UTR,missense	KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-68T>C::,KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150.5:missense_variant:MODERATE:exon4/7:c.587T>C:p.Val196Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153.9:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:PF00023 [Ankyrin repeat]	KANK4:NM_001320269.2:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:,KANK4:NM_181712.5:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:,KANK4:XM_011540843.3:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:,KANK4:XM_011540845.3:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:,KANK4:XM_017000483.2:missense_variant:MODERATE:exon7/9:c.2519T>C:p.Val840Ala:,KANK4:XM_017000484.2:missense_variant:MODERATE:exon7/10:c.635T>C:p.Val212Ala:,KANK4:XM_017000485.2:missense_variant:MODERATE:exon5/8:c.587T>C:p.Val196Ala:	regulatory_region_variant:promoter_flanking_region					rs2666472		0.7540	38394,.	0.5500,0.8594,0.8461,0.7369,0.7029	2.8390	 ,T(0.32),T(0.35),T(0.93)	 ,B(0.04),B(0.06),B(0.06)	9.67	0.16			COSV58093169	-0.0205	0.46	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263166	62263166	T	C	hom		QUAL=35318;DP=1135;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	5'UTR,missense	KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-122A>G::,KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150.5:missense_variant:MODERATE:exon4/7:c.533A>G:p.His178Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153.9:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:	KANK4:NM_001320269.2:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:,KANK4:NM_181712.5:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:,KANK4:XM_011540843.3:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:,KANK4:XM_011540845.3:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:,KANK4:XM_017000483.2:missense_variant:MODERATE:exon7/9:c.2465A>G:p.His822Arg:,KANK4:XM_017000484.2:missense_variant:MODERATE:exon7/10:c.581A>G:p.His194Arg:,KANK4:XM_017000485.2:missense_variant:MODERATE:exon5/8:c.533A>G:p.His178Arg:	regulatory_region_variant:promoter_flanking_region					rs2258470		0.7541	38311,.	0.5508,0.8597,0.8459,0.7369,0.7029	2.7470	 ,T(0.41),T(0.43),T(0.22)	 ,B(0.00),B(0.00),B(0.00)	18.45	0.10				0.0359	0.4629	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263189	62263189	T	C	hom		QUAL=35829;DP=1143;AF=1.00;MQM=60;SAP=5;ABP=0	KANK4	5'UTR,synonymous	KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-145A>G::,KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150.5:synonymous_variant:LOW:exon4/7:c.510A>G:p.Lys170=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371153.9:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:	KANK4:NM_001320269.2:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon7/9:c.2442A>G:p.Lys814=:,KANK4:XM_017000484.2:synonymous_variant:LOW:exon7/10:c.558A>G:p.Lys186=:,KANK4:XM_017000485.2:synonymous_variant:LOW:exon5/8:c.510A>G:p.Lys170=:	regulatory_region_variant:promoter_flanking_region					rs2260581		0.7543	38296,.	0.5516,0.8598,0.8461,0.7373,0.7029	0.5990			11.06					0.1288	0.4678	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263246	62263246	G	A	hom		QUAL=5604;DP=187;AF=1.00;MQM=60;SAP=31;ABP=0	KANK4	5'UTR,synonymous	KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-202C>T::,KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:,KANK4:ENST00000371150.5:synonymous_variant:LOW:exon4/7:c.453C>T:p.Pro151=:,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:	KANK4:NM_001320269.2:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:,KANK4:NM_181712.5:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon7/9:c.2385C>T:p.Pro795=:,KANK4:XM_017000484.2:synonymous_variant:LOW:exon7/10:c.501C>T:p.Pro167=:,KANK4:XM_017000485.2:synonymous_variant:LOW:exon5/8:c.453C>T:p.Pro151=:	regulatory_region_variant:promoter_flanking_region					rs2262110		0.7545	38368,.	0.5517,0.8595,0.8467,0.7377,0.7028	-1.7700			0.77				COSV58094416	-0.0241	0.4598	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263343	62263343	G	A	hom	off-target	QUAL=7385;DP=225;AF=1.00;MQM=60;SAP=11;ABP=0	KANK4	5'UTR,intron	KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-299C>T::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron5/8:c.436-32C>T::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron3/6:c.388-32C>T::,KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron5/8:c.436-32C>T::,KANK4:NM_181712.5:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::,KANK4:XM_011540843.3:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::,KANK4:XM_011540845.3:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::,KANK4:XM_017000483.2:intron_variant:MODIFIER:intron6/8:c.2320-32C>T::,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron6/9:c.436-32C>T::,KANK4:XM_017000485.2:intron_variant:MODIFIER:intron4/7:c.388-32C>T::	regulatory_region_variant:promoter_flanking_region					rs2262106		0.7556	37689,.	0.5279,0.8585,0.8486,0.7400,0.7037	0.5880			13.85				COSV58091893	-0.1656	0.4523	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62266749	62266749	T	C	het		QUAL=11398;DP=885;AF=0.52;MQM=60;SAP=3;ABP=5	KANK4	missense	KANK4:ENST00000354381.3:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon3/7:c.370A>G:p.Thr124Ala:,KANK4:ENST00000371153.9:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:	KANK4:NM_001320269.2:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:,KANK4:NM_181712.5:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:,KANK4:XM_011540843.3:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:,KANK4:XM_011540845.3:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:,KANK4:XM_017000483.2:missense_variant:MODERATE:exon6/9:c.2302A>G:p.Thr768Ala:,KANK4:XM_017000484.2:missense_variant:MODERATE:exon6/10:c.418A>G:p.Thr140Ala:,KANK4:XM_017000485.2:missense_variant:MODERATE:exon4/8:c.370A>G:p.Thr124Ala:						rs11207949	0.3055	0.2967	5876,.	0.2153,0.4784,0.5863,0.2438,0.1437	2.3690	T(0.55),T(0.54),T(0.12)	B(0.01),B(0.01),B(0.01)	17.77	0.02				0.1201	0.7193	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62268267	62268267	G	A	het	off-target	QUAL=1679;DP=151;AF=0.46;MQM=60;SAP=3;ABP=5	KANK4	intron	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron4/8:c.347+20C>T::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron2/6:c.299+20C>T::,KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron5/9:c.2231+20C>T::	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron4/8:c.347+20C>T::,KANK4:NM_181712.5:intron_variant:MODIFIER:intron5/9:c.2231+20C>T::,KANK4:XM_011540843.3:intron_variant:MODIFIER:intron5/9:c.2231+20C>T::,KANK4:XM_011540845.3:intron_variant:MODIFIER:intron5/9:c.2231+20C>T::,KANK4:XM_017000483.2:intron_variant:MODIFIER:intron5/8:c.2231+20C>T::,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron5/9:c.347+20C>T::,KANK4:XM_017000485.2:intron_variant:MODIFIER:intron3/7:c.299+20C>T::						rs11207950	0.4669	0.4519	16100,.	0.5722,0.3458,0.2627,0.4150,0.5666	-0.4840			0.35				COSV58092900	0.028	0.1733	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273232	62273232	T	C	hom		QUAL=1844;DP=63;AF=1.00;MQM=60;SAP=9;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.1872A>G:p.Pro624=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-1643A>G::	regulatory_region_variant:promoter_flanking_region					rs7516290		0.7556	43916,.	0.8562,0.8321,0.8485,0.6898,0.7526	-0.8210			1.88					0.0065	0.5269	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273526	62273526	G	A	het		QUAL=1755;DP=140;AF=0.49;MQM=60;SAP=10;ABP=3	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.1578C>T:p.Ser526=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-1937C>T::	regulatory_region_variant:promoter_flanking_region					rs17855078	0.2506	0.3037	6374,.	0.1791,0.2220,0.1264,0.3399,0.4044	-1.1030			0.19				COSV62990033	-0.0137	0.5258	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274393	62274393	A	G	het		QUAL=1454;DP=128;AF=0.48;MQM=60;SAP=3;ABP=4	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.711T>C:p.Gly237=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-2804T>C::						rs12127930	0.4822	0.4810	18375,.	0.6174,0.3608,0.2619,0.4397,0.5676	-1.1560			0.28				COSV62986848	0.0154	0.5273	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274774	62274774	T	C	hom		QUAL=7500;DP=239;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.330A>G:p.Pro110=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-3185A>G::						rs2666506	0.8045	0.7557	43743,.	0.8578,0.8402,0.8658,0.6865,0.7418	-0.6950			3.59				COSV62988812	0.0056	0.5268	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274777	62274777	T	C	hom		QUAL=7500;DP=239;AF=1.00;MQM=60;SAP=4;ABP=0	KANK4	intron,synonymous	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:NM_181712.5:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:XM_011540843.3:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:XM_011540845.3:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:XM_017000483.2:synonymous_variant:LOW:exon3/9:c.327A>G:p.Ser109=:,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-3188A>G::						rs2666507	0.7809	0.7418	40797,.	0.7750,0.8364,0.8658,0.6862,0.7416	-2.2680			0.25				COSV62988817	0.0049	0.5268	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62275109	62275109	A	-	het	off-target	QUAL=270;DP=116;AF=0.20;MQM=60;SAP=3;ABP=95	KANK4	intron	KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron2/9:c.17-22del::	KANK4:NM_001320269.2:intron_variant:MODIFIER:intron2/8:c.17-3520del::,KANK4:NM_181712.5:intron_variant:MODIFIER:intron2/9:c.17-22del::,KANK4:XM_011540843.3:intron_variant:MODIFIER:intron2/9:c.17-22del::,KANK4:XM_011540845.3:intron_variant:MODIFIER:intron2/9:c.17-22del::,KANK4:XM_017000483.2:intron_variant:MODIFIER:intron2/8:c.17-22del::,KANK4:XM_017000484.2:intron_variant:MODIFIER:intron3/9:c.17-3520del::	regulatory_region_variant:open_chromatin_region					rs761923018		0.1206	0,.	0.0807,0.1653,0.1052,0.1096,0.1776	0.0400			2.59								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	78112493	78112493	T	C	het		QUAL=4981;DP=413;AF=0.46;MQM=60;SAP=4;ABP=10	GIPC2	intron	GIPC2:ENST00000370759.4:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	GIPC2:NM_001304725.2:intron_variant:MODIFIER:intron3/5:c.386-6900T>C::,GIPC2:NM_017655.6:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	regulatory_region_variant:open_chromatin_region					rs6666954	0.4489	0.3776	12754,.	0.6112,0.2545,0.6166,0.2758,0.2698	-1.1960			0.35				COSV66129252			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a oe_syn=1.00 oe_mis=1.06 oe_lof=1.01)
chr1	119915381	119915381	A	T	het		QUAL=1766;DP=130;AF=0.55;MQM=60;SAP=3;ABP=6	NOTCH2	synonymous	NOTCH2:ENST00000256646.7:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:	NOTCH2:NM_024408.4:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]	261705 [benign DISEASE=not specified];			rs6685892	0.1925	0.1680	2968,.	0.3365,0.0881,0.0295,0.1028,0.1890	-0.7840			5.31				COSV56683182	0.0062	0.8881	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119922762	119922762	C	T	het		QUAL=272;DP=562;AF=0.33;MQM=60;SAP=403;ABP=148	NOTCH2	missense	NOTCH2:ENST00000256646.7:missense_variant:MODERATE:exon27/34:c.4876G>A:p.Glu1626Lys:PF07684 [NOTCH protein]	NOTCH2:NM_024408.4:missense_variant:MODERATE:exon27/34:c.4876G>A:p.Glu1626Lys:		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs1447900658		0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	6.1530	D(0.00)	D(1.00)	31.00	0.48				-0.1306	0.9313	0.01	0	0	0 / 0					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119929234	119929234	C	T	het	off-target	QUAL=525;DP=29;AF=0.69;MQM=60;SAP=5;ABP=12	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::	NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs2493392	0.1925	0.1677	2962,.	0.3357,0.0880,0.0295,0.1022,0.1892	0.4450			5.44				COSV56687338	-0.1364	0.187	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119935375	119935375	C	A	het	off-target	QUAL=286;DP=19;AF=0.63;MQM=60;SAP=3;ABP=6	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3655+97G>T::	NOTCH2:NM_001200001.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*44G>T::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron22/33:c.3655+97G>T::		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs2453056	0.3013	0.2442	6810,.	0.5311,0.1816,0.1008,0.1229,0.3007	-0.0250			2.76				COSV104375007	-0.2149	0.9591	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119935662	119935662	T	C	het	off-target	QUAL=11655;DP=891;AF=0.51;MQM=60;SAP=3;ABP=4	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron21/33:c.3523-58A>G::	NOTCH2:NM_001200001.2:intron_variant:MODIFIER:intron21/21:c.3523-58A>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron21/33:c.3523-58A>G::		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs5025718		0.6698	40976,.		-1.1160			5.22					-0.056	0.9652	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119941798	119941798	G	A	het	off-target	QUAL=762;DP=65;AF=0.49;MQM=60;SAP=3;ABP=3	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron17/33:c.2753-44C>T::	NOTCH2:NM_001200001.2:intron_variant:MODIFIER:intron17/21:c.2753-44C>T::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron17/33:c.2753-44C>T::		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs2493420	0.2714	0.2186	5056,.	0.4422,0.1784,0.1021,0.1236,0.3014	-0.0270			5.76				COSV99862942	-0.004	0.1312	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119953496	119953496	A	T	het	off-target	QUAL=7157;DP=638;AF=0.45;MQM=60;SAP=3;ABP=17	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron14/33:c.2365+47T>A::,NOTCH2:ENST00000579475.7:intron_variant:MODIFIER:intron14/14:c.2248+47T>A::	NOTCH2:NM_001200001.2:intron_variant:MODIFIER:intron14/21:c.2365+47T>A::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron14/33:c.2365+47T>A::		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs7534585	0.1923	0.1669	2891,.	0.3358,0.0882,0.0296,0.1022,0.1879	0.4620			3.55				COSV56685993	-0.0409	0.5435	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119953504	119953504	A	C	het	off-target	QUAL=7123;DP=638;AF=0.45;MQM=60;SAP=3;ABP=17	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron14/33:c.2365+39T>G::,NOTCH2:ENST00000579475.7:intron_variant:MODIFIER:intron14/14:c.2248+39T>G::	NOTCH2:NM_001200001.2:intron_variant:MODIFIER:intron14/21:c.2365+39T>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron14/33:c.2365+39T>G::		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs7534586	0.1923	0.1668	2888,.	0.3358,0.0882,0.0296,0.1022,0.1879	0.5980			5.95				COSV56686003	-0.0756	0.5439	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119969481	119969481	T	C	hom	off-target	QUAL=18002;DP=571;AF=1.00;MQM=60;SAP=4;ABP=0	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron6/33:c.1108+30A>G::,NOTCH2:ENST00000579475.7:intron_variant:MODIFIER:intron6/14:c.991+30A>G::	NOTCH2:NM_001200001.2:intron_variant:MODIFIER:intron6/21:c.1108+30A>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron6/33:c.1108+30A>G::		600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs2493409		0.9942	72873,.	0.9220,0.9966,1.0000,0.9995,0.9997	-2.8650			0.02				COSV99862551	0.0392	0.3482	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119987127	119987127	A	C	het	off-target	QUAL=11312;DP=921;AF=0.48;MQM=60;SAP=4;ABP=6	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron4/33:c.752-45T>G::,NOTCH2:ENST00000579475.7:intron_variant:MODIFIER:intron4/14:c.635-45T>G::	NOTCH2:NM_001200001.2:intron_variant:MODIFIER:intron4/21:c.752-45T>G::,NOTCH2:NM_024408.4:intron_variant:MODIFIER:intron4/33:c.752-45T>G::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	600275_[GENE=NOTCH2_PHENOS=Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant; Alagille syndrome 2, 610205 (3), Autosomal dominant]				rs2453040	0.1907	0.1652	2870,.	0.3302,0.0871,0.0299,0.1014,0.1877	-0.0060			3.93				COSV56686013	-0.0313	0.0716	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr2	17760156	17760156	T	G	hom	off-target	QUAL=1007;DP=33;AF=1.00;MQM=60;SAP=38;ABP=0	GEN1,SMC6	intron	GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-14205A>C::	GEN1:NM_001130009.3:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:NM_182625.5:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_005262613.4:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_006712005.3:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_011532820.2:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_011532821.2:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:XM_011532822.2:intron_variant:MODIFIER:intron2/13:c.161+52T>G::						rs2555072		0.6825	29355,.	0.4720,0.8154,0.9574,0.6213,0.8616	-0.5730			0.32					-0.042	0.5316	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17761508	17761508	T	A	hom		QUAL=3038;DP=92;AF=1.00;MQM=60;SAP=14;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.11:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],GEN1:ENST00000381254.7:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-15557A>T::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:NM_182625.5:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_005262613.4:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_006712005.3:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_011532820.2:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_011532821.2:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:,GEN1:XM_011532822.2:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:						rs1812152		0.7177	37688,.	0.7654,0.8383,0.9844,0.6243,0.8734	0.6630	T(0.36),T(0.36), 	B(0.00),B(0.00), 	9.80	0.03				0.0628	0.9187	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17772760	17772760	G	A	hom		QUAL=972;DP=30;AF=1.00;MQM=60;SAP=22;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.11:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+15055C>T::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:NM_182625.5:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_005262613.4:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_006712005.3:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_011532820.2:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_011532821.2:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:XM_011532822.2:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,LOC105373449:XR_939762.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1418-8113C>T::						rs300175		0.9944	74046,.	0.9515,0.9973,0.9998,0.9999,0.9842	-2.3000	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.00	0.02				0.0986	0.3022	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17773154	17773154	C	G	hom	off-target	QUAL=3002;DP=93;AF=1.00;MQM=60;SAP=4;ABP=0	GEN1,SMC6	intron	GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14661G>C::	GEN1:NM_001130009.3:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:NM_182625.5:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_005262613.4:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_006712005.3:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_011532820.2:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_011532821.2:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:XM_011532822.2:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,LOC105373449:XR_939762.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1418-8507G>C::						rs300177		0.7167	37402,.	0.7561,0.8376,0.9847,0.6241,0.8732	-2.1750			0.06					-0.0804	0.3192	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781183	17781183	A	G	hom		QUAL=3083;DP=96;AF=1.00;MQM=60;SAP=84;ABP=0	GEN1,SMC6	synonymous,intron	GEN1:ENST00000317402.11:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:ENST00000381254.7:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6632T>C::	GEN1:NM_001130009.3:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:NM_182625.5:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_005262613.4:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_006712005.3:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_011532820.2:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_011532821.2:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:XM_011532822.2:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,LOC105373449:XR_939762.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1418-16536T>C::						rs300168		0.5891	19073,.	0.2165,0.7466,0.9232,0.5153,0.7680	0.7070			6.44				COSV58057416	-0.0013	0.8753	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781251	17781251	C	T	hom		QUAL=3598;DP=112;AF=1.00;MQM=60;SAP=3;ABP=0	GEN1,SMC6	missense,intron	GEN1:ENST00000317402.11:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6564G>A::	GEN1:NM_001130009.3:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:NM_182625.5:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_005262613.4:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_006712005.3:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_011532820.2:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_011532821.2:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:XM_011532822.2:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,LOC105373449:XR_939762.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1418-16604G>A::						rs300169		0.7049	32838,.	0.5958,0.8273,0.9846,0.6234,0.8730	0.1650	T(1.00),T(1.00), 	B(0.00),B(0.00), 	4.92	0.05				-0.0058	0.8752	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	47373967	47373967	T	C	het		QUAL=747;DP=42;AF=0.71;MQM=60;SAP=3;ABP=20	EPCAM	missense	EPCAM:ENST00000263735.9:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:PF00086 [Thyroglobulin type-1 repeat],EPCAM:ENST00000405271.5:missense_variant:MODERATE:exon4/10:c.428T>C:p.Met143Thr:PF00086 [Thyroglobulin type-1 repeat]	EPCAM:NM_002354.3:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	185535_[GENE=EPCAM_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3); Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive]	183700 [benign DISEASE=Lynch syndrome I,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified];			rs1126497	0.6661	0.5769	27689,.	0.8418,0.4720,0.8320,0.4359,0.4807	0.0500	T(1.00),T(1.00)	B(0.00),B(0.00)	11.74	0.18			COSV55392922	0.0873	0.9348	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47408397	47408397	-	T	het	off-target	QUAL=53;DP=18;AF=0.33;MQM=60;SAP=16;ABP=7	MSH2	intron	MSH2:ENST00000233146.7:intron_variant:MODIFIER:intron1/15:c.212-4dup::,MSH2:ENST00000406134.5:intron_variant:MODIFIER:intron1/15:c.212-4dup::,MSH2:ENST00000543555.6:intron_variant:MODIFIER:intron2/16:c.14-4dup::,MSH2:ENST00000645506.1:intron_variant:MODIFIER:intron1/16:c.212-4dup::	MSH2:NM_000251.3:intron_variant:MODIFIER:intron1/15:c.212-4dup::,MSH2:NM_001258281.1:intron_variant:MODIFIER:intron2/16:c.14-4dup::,MSH2:XM_005264332.4:intron_variant:MODIFIER:intron1/16:c.212-4dup::,MSH2:XM_011532867.2:intron_variant:MODIFIER:intron1/16:c.212-4dup::,MSH2:XR_001738747.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/17:n.274-4dup::,MSH2:XR_939685.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/17:n.274-4dup::		609309_[GENE=MSH2_PHENOS=Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive; Muir-Torre syndrome, 158320 (3), Autosomal dominant; Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominant]	491795 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs746333570		0.2036	1,.	0.1599,0.2545,0.2199,0.1769,0.2580				5.55								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	47783349	47783349	G	A	het		QUAL=143;DP=14;AF=0.50;MQM=60;SAP=3;ABP=3	MSH6	missense,5'UTR,synonymous,intron	MSH6:ENST00000234420.11:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000540021.6:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:,MSH6:ENST00000614496.4:5_prime_UTR_variant:MODIFIER:exon1/9:c.-621G>A::,MSH6:ENST00000616033.4:synonymous_variant:LOW:exon2/6:c.114G>A:p.Arg38=:,MSH6:ENST00000622629.4:5_prime_UTR_variant:MODIFIER:exon1/13:c.-2981G>A::,MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron3/11:c.-37-7578G>A::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron1/9:c.-38+118G>A::	MSH6:NM_000179.3:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:NM_001281492.2:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:,MSH6:NM_001281493.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-621G>A::,MSH6:XM_024452819.1:missense_variant:MODERATE:exon1/9:c.116G>A:p.Gly39Glu:,MSH6:XM_024452822.1:5_prime_UTR_variant:MODIFIER:exon1/8:c.-621G>A::	regulatory_region_variant:promoter	600678_[GENE=MSH6_PHENOS={Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant]	36581 [benign DISEASE=Breast carcinoma,Carcinoma of colon,Lynch syndrome,Lynch syndrome I,Hereditary nonpolyposis colorectal cancer type 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,none provided,not provided];	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6];		rs1042821	0.2009	0.1888	2796,.	0.2215,0.1042,0.2531,0.1809,0.2120	1.7840	T(1.00),T(0.62), , , , , 	B(0.00),B(0.00), , , , , 	16.79	0.16			COSV52274018	0.0502	0.6269	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34)
chr2	47790891	47790891	A	G	het	off-target	QUAL=10791;DP=927;AF=0.46;MQM=60;SAP=3;ABP=14	MSH6,FBXO11	intron	MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-1451T>C::,MSH6:ENST00000538136.1:intron_variant:MODIFIER:intron1/9:c.-642-36A>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.237+7421A>G::,MSH6:ENST00000614496.4:intron_variant:MODIFIER:intron1/8:c.-476-36A>G::,MSH6:ENST00000616033.4:intron_variant:MODIFIER:intron3/5:c.258-36A>G::,MSH6:ENST00000622629.4:intron_variant:MODIFIER:intron1/12:c.-2836-36A>G::,MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron3/11:c.-37-36A>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron1/9:c.-37-36A>G::	MSH6:NM_000179.3:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:NM_001281492.2:intron_variant:MODIFIER:intron1/7:c.237+7421A>G::,MSH6:NM_001281493.2:intron_variant:MODIFIER:intron1/8:c.-476-36A>G::,MSH6:NM_001281494.2:intron_variant:MODIFIER:intron1/9:c.-642-36A>G::,MSH6:XM_024452819.1:intron_variant:MODIFIER:intron1/8:c.261-36A>G::,MSH6:XM_024452820.1:intron_variant:MODIFIER:intron1/8:c.78-36A>G::,MSH6:XM_024452821.1:intron_variant:MODIFIER:intron1/8:c.-37-36A>G::,MSH6:XM_024452822.1:intron_variant:MODIFIER:intron1/7:c.-476-36A>G::		600678_[GENE=MSH6_PHENOS={Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89301 [benign DISEASE=Lynch syndrome,not specified];			rs1800931	0.0220	0.0373	131,.	0.0091,0.0338,0.0190,0.0542,0.0167	0.4140			13.73				COSV104579250	0.0151	0.7414	0	0	89	0 / 2					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47795842	47795842	G	T	het	off-target	QUAL=281;DP=26;AF=0.46;MQM=60;SAP=15;ABP=3	MSH6,FBXO11	intron	MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-6402C>A::,MSH6:ENST00000538136.1:intron_variant:MODIFIER:intron2/9:c.-445-52G>T::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.238-2769G>T::,MSH6:ENST00000614496.4:intron_variant:MODIFIER:intron2/8:c.-279-2769G>T::,MSH6:ENST00000616033.4:intron_variant:MODIFIER:intron4/5:c.455-52G>T::,MSH6:ENST00000622629.4:intron_variant:MODIFIER:intron2/12:c.-2639-52G>T::,MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron4/11:c.161-52G>T::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron2/9:c.161-52G>T::	MSH6:NM_000179.3:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:NM_001281492.2:intron_variant:MODIFIER:intron1/7:c.238-2769G>T::,MSH6:NM_001281493.2:intron_variant:MODIFIER:intron2/8:c.-279-2769G>T::,MSH6:NM_001281494.2:intron_variant:MODIFIER:intron2/9:c.-445-52G>T::,MSH6:XM_024452819.1:intron_variant:MODIFIER:intron2/8:c.458-52G>T::,MSH6:XM_024452820.1:intron_variant:MODIFIER:intron2/8:c.275-52G>T::,MSH6:XM_024452821.1:intron_variant:MODIFIER:intron2/8:c.161-52G>T::,MSH6:XM_024452822.1:intron_variant:MODIFIER:intron2/7:c.-279-2769G>T::		600678_[GENE=MSH6_PHENOS={Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89532 [benign DISEASE=Lynch syndrome];		FLAM_C (SINE/Alu)	rs1800934	0.2244	0.2084	3539,.		0.3750			2.12				COSV52273967	0.0528	0.8892	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02), RPL36AP15 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47803553	47803553	T	A	het		QUAL=247;DP=17;AF=0.65;MQM=60;SAP=27;ABP=6	MSH6,FBXO11	synonymous,intron	MSH6:ENST00000234420.11:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4642A>T::,MSH6:ENST00000538136.1:synonymous_variant:LOW:exon5/10:c.2400T>A:p.Thr800=:,MSH6:ENST00000540021.6:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:,MSH6:ENST00000614496.4:synonymous_variant:LOW:exon4/9:c.2400T>A:p.Thr800=:,MSH6:ENST00000622629.4:synonymous_variant:LOW:exon5/13:c.210T>A:p.Thr70=:,MSH6:ENST00000652107.1:synonymous_variant:LOW:exon7/12:c.3009T>A:p.Thr1003=:,MSH6:ENST00000673637.1:synonymous_variant:LOW:exon5/10:c.3009T>A:p.Thr1003=:	MSH6:NM_000179.3:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:,MSH6:NM_001281492.2:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:,MSH6:NM_001281493.2:synonymous_variant:LOW:exon4/9:c.2400T>A:p.Thr800=:,MSH6:NM_001281494.2:synonymous_variant:LOW:exon5/10:c.2400T>A:p.Thr800=:,MSH6:XM_024452819.1:synonymous_variant:LOW:exon5/9:c.3306T>A:p.Thr1102=:,MSH6:XM_024452820.1:synonymous_variant:LOW:exon5/9:c.3123T>A:p.Thr1041=:,MSH6:XM_024452821.1:synonymous_variant:LOW:exon5/9:c.3009T>A:p.Thr1003=:,MSH6:XM_024452822.1:synonymous_variant:LOW:exon4/8:c.2400T>A:p.Thr800=:		600678_[GENE=MSH6_PHENOS={Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	36589 [benign DISEASE=Carcinoma of colon,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified];			rs2020910	0.0493	0.0203	112,.	0.0080,0.0137,0.2030,0.0017,0.0080	-2.3440			0.17				COSV52275019	-0.018	0.1869	0.02	0	18	0 / 1					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47803699	47803699	A	T	het	off-target	QUAL=2490;DP=238;AF=0.49;MQM=60;SAP=208;ABP=3	MSH6,FBXO11	intron	MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron5/9:c.3438+14A>T::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4496T>A::,MSH6:ENST00000538136.1:intron_variant:MODIFIER:intron5/9:c.2532+14A>T::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron3/7:c.3048+14A>T::,MSH6:ENST00000614496.4:intron_variant:MODIFIER:intron4/8:c.2532+14A>T::,MSH6:ENST00000622629.4:intron_variant:MODIFIER:intron6/12:c.334+21A>T::,MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron7/11:c.3141+14A>T::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron5/9:c.3141+14A>T::	MSH6:NM_000179.3:intron_variant:MODIFIER:intron5/9:c.3438+14A>T::,MSH6:NM_001281492.2:intron_variant:MODIFIER:intron3/7:c.3048+14A>T::,MSH6:NM_001281493.2:intron_variant:MODIFIER:intron4/8:c.2532+14A>T::,MSH6:NM_001281494.2:intron_variant:MODIFIER:intron5/9:c.2532+14A>T::,MSH6:XM_024452819.1:intron_variant:MODIFIER:intron5/8:c.3438+14A>T::,MSH6:XM_024452820.1:intron_variant:MODIFIER:intron5/8:c.3255+14A>T::,MSH6:XM_024452821.1:intron_variant:MODIFIER:intron5/8:c.3141+14A>T::,MSH6:XM_024452822.1:intron_variant:MODIFIER:intron4/7:c.2532+14A>T::		600678_[GENE=MSH6_PHENOS={Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	42471 [benign DISEASE=Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,Hereditary cancer-predisposing syndrome,not specified,none provided];			rs2020911	0.4010	0.4118	9379,.	0.1685,0.5075,0.6240,0.3819,0.4764	-0.0370			3.84				COSV52273834	0.0415	0.1872	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47805740	47805743	CTAT	-	het	off-target	QUAL=603;DP=44;AF=0.59;MQM=60;SAP=8;ABP=6	MSH6,FBXO11	intron	MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron7/9:c.3646+35_3646+38del::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+2456_169+2459del::,MSH6:ENST00000538136.1:intron_variant:MODIFIER:intron7/9:c.2740+35_2740+38del::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron5/7:c.3256+35_3256+38del::,MSH6:ENST00000614496.4:intron_variant:MODIFIER:intron6/8:c.2740+35_2740+38del::,MSH6:ENST00000622629.4:intron_variant:MODIFIER:intron8/12:c.550+35_550+38del::,MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron9/11:c.3349+35_3349+38del::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron7/9:c.3349+35_3349+38del::	MSH6:NM_000179.3:intron_variant:MODIFIER:intron7/9:c.3646+35_3646+38del::,MSH6:NM_001281492.2:intron_variant:MODIFIER:intron5/7:c.3256+35_3256+38del::,MSH6:NM_001281493.2:intron_variant:MODIFIER:intron6/8:c.2740+35_2740+38del::,MSH6:NM_001281494.2:intron_variant:MODIFIER:intron7/9:c.2740+35_2740+38del::,MSH6:XM_024452819.1:intron_variant:MODIFIER:intron7/8:c.3646+35_3646+38del::,MSH6:XM_024452820.1:intron_variant:MODIFIER:intron7/8:c.3463+35_3463+38del::,MSH6:XM_024452821.1:intron_variant:MODIFIER:intron7/8:c.3349+35_3349+38del::,MSH6:XM_024452822.1:intron_variant:MODIFIER:intron6/7:c.2740+35_2740+38del::		600678_[GENE=MSH6_PHENOS={Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89429 [benign DISEASE=Lynch syndrome,not specified,not provided];			rs1805181		0.7064	38205,.	0.8012,0.5297,0.8703,0.6763,0.7258	1.3380			1.21					-0.0938	0.2606	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47806412	47806412	C	G	hom	off-target	QUAL=1514;DP=48;AF=1.00;MQM=60;SAP=5;ABP=0	MSH6,FBXO11	intron	MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron8/9:c.3802-40C>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+1783G>C::,MSH6:ENST00000538136.1:intron_variant:MODIFIER:intron8/9:c.2896-40C>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron6/7:c.3412-40C>G::,MSH6:ENST00000614496.4:intron_variant:MODIFIER:intron7/8:c.2896-40C>G::,MSH6:ENST00000622629.4:intron_variant:MODIFIER:intron11/12:c.703-40C>G::,MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron10/11:c.3505-40C>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron8/9:c.3505-40C>G::	MSH6:NM_000179.3:intron_variant:MODIFIER:intron8/9:c.3802-40C>G::,MSH6:NM_001281492.2:intron_variant:MODIFIER:intron6/7:c.3412-40C>G::,MSH6:NM_001281493.2:intron_variant:MODIFIER:intron7/8:c.2896-40C>G::,MSH6:NM_001281494.2:intron_variant:MODIFIER:intron8/9:c.2896-40C>G::,MSH6:XM_024452819.1:synonymous_variant:LOW:exon8/9:c.3855C>G:p.Leu1285=:,MSH6:XM_024452820.1:synonymous_variant:LOW:exon8/9:c.3672C>G:p.Leu1224=:,MSH6:XM_024452821.1:synonymous_variant:LOW:exon8/9:c.3558C>G:p.Leu1186=:,MSH6:XM_024452822.1:synonymous_variant:LOW:exon7/8:c.2949C>G:p.Leu983=:		600678_[GENE=MSH6_PHENOS={Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	36594 [benign DISEASE=Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,not specified,not provided];			rs3136367		0.7725	46108,.	0.9186,0.6161,0.8828,0.7298,0.7398	-1.0020			0.34				COSV52273637	-0.0732	0.3885	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47806769	47806769	T	-	het	off-target	QUAL=285;DP=31;AF=0.48;MQM=60;SAP=7;ABP=3	MSH6,FBXO11	intron	MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron9/9:c.4002-10del::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+1443del::,MSH6:ENST00000538136.1:intron_variant:MODIFIER:intron9/9:c.3096-10del::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron7/7:c.3612-10del::,MSH6:ENST00000614496.4:intron_variant:MODIFIER:intron8/8:c.3096-10del::,MSH6:ENST00000622629.4:intron_variant:MODIFIER:intron12/12:c.903-10del::,MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron11/11:c.3705-10del::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron9/9:c.3705-10del::	MSH6:NM_000179.3:intron_variant:MODIFIER:intron9/9:c.4002-10del::,MSH6:NM_001281492.2:intron_variant:MODIFIER:intron7/7:c.3612-10del::,MSH6:NM_001281493.2:intron_variant:MODIFIER:intron8/8:c.3096-10del::,MSH6:NM_001281494.2:intron_variant:MODIFIER:intron9/9:c.3096-10del::,MSH6:XM_024452819.1:intron_variant:MODIFIER:intron8/8:c.4095-10del::,MSH6:XM_024452820.1:intron_variant:MODIFIER:intron8/8:c.3912-10del::,MSH6:XM_024452821.1:intron_variant:MODIFIER:intron8/8:c.3798-10del::,MSH6:XM_024452822.1:intron_variant:MODIFIER:intron7/7:c.3189-10del::		600678_[GENE=MSH6_PHENOS={Endometrial cancer, familial}, 608089 (3), Somatic mutation, Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominant]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89508 [likely benign DISEASE=Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 5,not specified];		(T)n (Simple_repeat)	rs59056100		0.2762	4785,.		-1.0800			0.01					0.0951	0.8859	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	146839405	146839405	A	G	het		QUAL=10818;DP=817;AF=0.51;MQM=60;SAP=3;ABP=4	LINC01911	intron&non_coding_transcript	LINC01911:ENST00000450667.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/10:n.229+1200A>G::,LINC01911:ENST00000656564.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.320+1359A>G::,LINC01911:ENST00000667114.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/9:n.77+1200A>G::,LINC01911:ENST00000669097.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.280+1359A>G::,LINC01911:ENST00000670621.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.291+1359A>G::	LINC01911:XR_001739725.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.438+1200A>G::,LINC01911:XR_001739726.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.438+1200A>G::,LINC01911:XR_001739727.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.279+1359A>G::,LINC01911:XR_001739728.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/4:n.202+1200A>G::						rs4411641	0.5090	0.4814	18524,.	0.6458,0.6144,0.4402,0.3990,0.4075	0.2300			3.78								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LINC01911 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	189805824	189805824	-	A	het	off-target	QUAL=41;DP=44;AF=0.18;MQM=60;SAP=20;ABP=42	PMS1	intron,frameshift	PMS1:ENST00000374826.8:intron_variant:MODIFIER:intron4/4:c.418+70dup::,PMS1:ENST00000409823.7:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:ENST00000409985.5:frameshift_variant:HIGH:exon4/4:c.488dup:p.Leu164ValfsTer4:,PMS1:ENST00000418224.7:intron_variant:MODIFIER:intron4/10:c.418+70dup::,PMS1:ENST00000432292.7:intron_variant:MODIFIER:intron2/10:c.-110-12193dup::,PMS1:ENST00000441310.7:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:ENST00000447232.6:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:ENST00000618056.4:intron_variant:MODIFIER:intron4/5:c.418+70dup::,PMS1:ENST00000624204.3:intron_variant:MODIFIER:intron3/11:c.-111+9873dup::,PMS1:ENST00000639501.1:intron_variant:MODIFIER:intron4/9:c.418+70dup::	PMS1:NM_000534.5:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:NM_001128143.2:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:NM_001128144.2:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:NM_001289408.2:intron_variant:MODIFIER:intron3/11:c.-111+9873dup::,PMS1:NM_001289409.2:intron_variant:MODIFIER:intron2/10:c.-110-12193dup::,PMS1:NM_001321044.2:intron_variant:MODIFIER:intron4/10:c.418+70dup::,PMS1:NM_001321045.2:intron_variant:MODIFIER:intron5/13:c.418+70dup::,PMS1:NM_001321046.2:intron_variant:MODIFIER:intron3/11:c.235+70dup::,PMS1:NM_001321047.2:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:NM_001321048.2:intron_variant:MODIFIER:intron5/13:c.418+70dup::,PMS1:NM_001321049.2:frameshift_variant:HIGH:exon4/4:c.488dup:p.Leu164ValfsTer4:,PMS1:NM_001321051.2:intron_variant:MODIFIER:intron4/4:c.418+70dup::,PMS1:NR_110332.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/12:n.679+70dup::,PMS1:XM_011511356.3:intron_variant:MODIFIER:intron4/13:c.-906+70dup::,PMS1:XM_017004344.1:intron_variant:MODIFIER:intron5/12:c.418+70dup::,PMS1:XM_017004345.1:intron_variant:MODIFIER:intron3/11:c.235+70dup::,PMS1:XM_017004346.2:intron_variant:MODIFIER:intron3/11:c.235+70dup::,PMS1:XM_017004347.1:intron_variant:MODIFIER:intron3/10:c.235+70dup::,PMS1:XM_017004348.1:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:XM_017004349.2:intron_variant:MODIFIER:intron4/12:c.-906+70dup::,PMS1:XM_017004350.1:intron_variant:MODIFIER:intron3/10:c.235+70dup::,PMS1:XM_024452964.1:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:XM_024452965.1:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:XM_024452966.1:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:XM_024452967.1:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:XM_024452968.1:intron_variant:MODIFIER:intron3/11:c.-111+9873dup::,PMS1:XM_024452969.1:intron_variant:MODIFIER:intron3/10:c.-111+9873dup::,PMS1:XR_001738779.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/13:n.673+70dup::,PMS1:XR_002959307.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/13:n.678+70dup::,PMS1:XR_922951.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/12:n.576+70dup::						rs3214425		0.2784	3953,.	0.3364,0.3245,0.3048,0.2639,0.2164				1.27					-0.0378	0.9042	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD oe_syn=0.84 oe_mis=0.92 oe_lof=0.76)
chr2	214730440	214730440	G	A	het		QUAL=261;DP=27;AF=0.44;MQM=60;SAP=4;ABP=4	BARD1	missense,3'UTR	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:ENST00000421162.2:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys:,BARD1:ENST00000613374.5:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys:,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon10/11:c.1564C>T:p.Arg522Cys:,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys:,BARD1:ENST00000619009.5:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys:,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon9/10:c.*638C>T::	BARD1:NM_000465.4:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys:,BARD1:NM_001282545.2:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys:,BARD1:NM_001282548.2:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys:,BARD1:NM_001282549.2:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys:,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon9/10:n.1937C>T::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon8/9:n.1880C>T::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon9/10:n.1136C>T::,BARD1:XM_017004613.1:missense_variant:MODERATE:exon11/12:c.2071C>T:p.Arg691Cys:,BARD1:XR_002959322.1:non_coding_transcript_exon_variant:MODIFIER:exon11/12:n.2162C>T::	regulatory_region_variant:enhancer	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	136500 [likely benign(replaced by megSAP based on classifications:7x1,4x2,1x3) DISEASE=Malignant tumor of breast,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Triple-Negative Breast Cancer Finding,not specified,not provided];	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1];		rs3738888	0.0054	0.0084	15,.	0.0020,0.0125,0.0115,0.0087,0.0041	5.2690	D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00), 	B(0.36),B(0.01),P(0.78),D(0.99),P(0.52),B(0.38), 	24.30	0.10			COSV53616840	-0.1567	0.8792	0.01	0	6	0 / 1					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214745914	214745914	A	G	het	off-target	QUAL=3825;DP=272;AF=0.51;MQM=60;SAP=3;ABP=4	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron7/10:c.1678-60T>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron3/6:c.325-60T>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron2/5:c.268-60T>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron7/10:c.1270-60T>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron6/9:c.1621-60T>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.365-15406T>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron6/9:c.*344-60T>C::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron7/10:c.1678-60T>C::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron6/9:c.1621-60T>C::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron3/6:c.325-60T>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron2/5:c.268-60T>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.365-15406T>C::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1643-60T>C::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.1586-60T>C::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.842-60T>C::,BARD1:XM_017004613.1:intron_variant:MODIFIER:intron8/11:c.1777-60T>C::,BARD1:XM_017004614.1:intron_variant:MODIFIER:intron8/10:c.1777-60T>C::,BARD1:XR_002959322.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/11:n.1868-60T>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	676478 [likely benign DISEASE=not provided];			rs4986842	0.0030	0.0070	15,.		-1.4830			0.34					-0.0329	0.9359	0	0	6	0 / 1					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767431	214767431	T	C	het	off-target	QUAL=1555;DP=109;AF=0.57;MQM=60;SAP=5;ABP=7	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron6/10:c.1568+51A>G::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14876A>G::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14876A>G::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron6/10:c.1160+51A>G::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron5/9:c.1511+51A>G::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24866A>G::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron5/9:c.*234+51A>G::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron6/10:c.1568+51A>G::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron5/9:c.1511+51A>G::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14876A>G::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14876A>G::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24866A>G::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.1533+51A>G::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.1476+51A>G::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.732+51A>G::,BARD1:XM_017004613.1:intron_variant:MODIFIER:intron7/11:c.1667+51A>G::,BARD1:XM_017004614.1:intron_variant:MODIFIER:intron7/10:c.1667+51A>G::,BARD1:XR_002959322.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/11:n.1758+51A>G::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]				rs5031009	0.3662	0.3712	10628,.	0.3713,0.2925,0.3633,0.3675,0.4021	-3.4800			0.07				COSV53611189	-0.0742	0.4383	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767468	214767468	G	A	het	off-target	QUAL=1787;DP=114;AF=0.57;MQM=60;SAP=4;ABP=8	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron6/10:c.1568+14C>T::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14913C>T::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14913C>T::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron6/10:c.1160+14C>T::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron5/9:c.1511+14C>T::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24829C>T::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron5/9:c.*234+14C>T::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron6/10:c.1568+14C>T::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron5/9:c.1511+14C>T::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14913C>T::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14913C>T::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24829C>T::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.1533+14C>T::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.1476+14C>T::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.732+14C>T::,BARD1:XM_017004613.1:intron_variant:MODIFIER:intron7/11:c.1667+14C>T::,BARD1:XM_017004614.1:intron_variant:MODIFIER:intron7/10:c.1667+14C>T::,BARD1:XR_002959322.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/11:n.1758+14C>T::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	256214 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified];			rs5031011	0.3522	0.3569	9506,.	0.3471,0.2866,0.3664,0.3480,0.3938	-0.2950			1.75				COSV53615058	0.144	0.436	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767531	214767531	C	T	het		QUAL=3056;DP=110;AF=0.55;MQM=60;SAP=29;ABP=6	BARD1	missense,intron,3'UTR	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14976G>A::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14976G>A::,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon6/11:c.1111G>A:p.Val371Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000617164.5:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24766G>A::,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon5/10:c.*185G>A::	BARD1:NM_000465.4:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14976G>A::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14976G>A::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24766G>A::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.1484G>A::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon4/9:n.1427G>A::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.683G>A::,BARD1:XM_017004613.1:missense_variant:MODERATE:exon7/12:c.1618G>A:p.Val540Met:,BARD1:XM_017004614.1:missense_variant:MODERATE:exon7/11:c.1618G>A:p.Val540Met:,BARD1:XR_002959322.1:non_coding_transcript_exon_variant:MODIFIER:exon7/12:n.1709G>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	140757 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified];	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1];		rs2070094	0.3662	0.3739	10590,.	0.3752,0.2940,0.3662,0.3707,0.4030	-5.2200	T(0.12), , ,T(0.07),T(0.11), , 	B(0.03), , ,B(0.30),B(0.01), , 	0.01	0.11			COSV53610001	0.0231	0.4387	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767532	214767532	A	G	hom		QUAL=3056;DP=110;AF=0.55;MQM=60;SAP=18;ABP=9	BARD1	synonymous,intron,3'UTR	BARD1:ENST00000260947.9:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14977T>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14977T>C::,BARD1:ENST00000613706.5:synonymous_variant:LOW:exon6/11:c.1110T>C:p.His370=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000617164.5:synonymous_variant:LOW:exon5/10:c.1461T>C:p.His487=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24765T>C::,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon5/10:c.*184T>C::	BARD1:NM_000465.4:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:,BARD1:NM_001282543.2:synonymous_variant:LOW:exon5/10:c.1461T>C:p.His487=:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-14977T>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-14977T>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+24765T>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.1483T>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon4/9:n.1426T>C::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.682T>C::,BARD1:XM_017004613.1:synonymous_variant:LOW:exon7/12:c.1617T>C:p.His539=:,BARD1:XM_017004614.1:synonymous_variant:LOW:exon7/11:c.1617T>C:p.His539=:,BARD1:XR_002959322.1:non_coding_transcript_exon_variant:MODIFIER:exon7/12:n.1708T>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183704 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified];			rs2070093	0.7706	0.8169	44222,.	0.5970,0.8158,0.9535,0.8062,0.8408	-0.2410			4.69				COSV53617490	0.0674	0.4409	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214769331	214769331	C	T	het	off-target;low_conf_region	QUAL=2564;DP=270;AF=0.47;MQM=60;SAP=262;ABP=5	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron4/10:c.1315-19G>A::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-16776G>A::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-16776G>A::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron4/10:c.907-19G>A::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron3/9:c.1258-19G>A::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+22966G>A::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron3/9:c.365-19G>A::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron4/10:c.1315-19G>A::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron3/9:c.1258-19G>A::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.216-16776G>A::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-16776G>A::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+22966G>A::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.1280-19G>A::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.1223-19G>A::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.479-19G>A::,BARD1:XM_017004613.1:intron_variant:MODIFIER:intron5/11:c.1414-19G>A::,BARD1:XM_017004614.1:intron_variant:MODIFIER:intron5/10:c.1414-19G>A::,BARD1:XR_002959322.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/11:n.1505-19G>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	256213 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs6704780	0.3652	0.3734	10597,.	0.3747,0.2939,0.3659,0.3702,0.4006	0.1260			0.84		10.09>9.72		COSV53612311	-0.2383	0.7633	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214780740	214780740	C	G	het		QUAL=1090;DP=79;AF=0.53;MQM=60;SAP=8;ABP=4	BARD1	missense,intron	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.215+16321G>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-28185G>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron4/10:c.906+228G>C::,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser:,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+11557G>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron3/9:c.365-11428G>C::	BARD1:NM_000465.4:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser:,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron2/6:c.215+16321G>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.159-28185G>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron3/4:c.364+11557G>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon3/10:n.1099G>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon2/9:n.1042G>C::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/9:n.479-11428G>C::,BARD1:XM_017004613.1:missense_variant:MODERATE:exon5/12:c.1233G>C:p.Arg411Ser:,BARD1:XM_017004614.1:missense_variant:MODERATE:exon5/11:c.1233G>C:p.Arg411Ser:,BARD1:XR_002959322.1:non_coding_transcript_exon_variant:MODIFIER:exon5/12:n.1324G>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	142769 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified];	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs2229571	0.4593	0.5436	22188,.	0.3976,0.4125,0.3645,0.6166,0.4846	-0.3950	T(0.24), , , ,T(0.25), , 	B(0.02), , , ,B(0.10), , 	4.32	0.11			COSV53612030	-0.0023	0.2567	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214809366	214809366	T	G	hom	off-target	QUAL=3869;DP=120;AF=1.00;MQM=60;SAP=3;ABP=0	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron1/6:c.158+46A>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.158+46A>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron1/9:c.158+46A>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron1/4:c.158+46A>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron1/9:c.158+46A>C::	BARD1:NM_000465.4:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:NM_001282543.2:intron_variant:MODIFIER:intron1/9:c.158+46A>C::,BARD1:NM_001282545.2:intron_variant:MODIFIER:intron1/6:c.158+46A>C::,BARD1:NM_001282548.2:intron_variant:MODIFIER:intron1/5:c.158+46A>C::,BARD1:NM_001282549.2:intron_variant:MODIFIER:intron1/4:c.158+46A>C::,BARD1:NR_104212.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/9:n.272+46A>C::,BARD1:NR_104215.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.272+46A>C::,BARD1:NR_104216.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/9:n.272+46A>C::,BARD1:XM_017004613.1:intron_variant:MODIFIER:intron1/11:c.158+46A>C::,BARD1:XM_017004614.1:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:XR_002959322.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/11:n.249+46A>C::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]				rs35933323		0.7395	41393,.	0.7659,0.8196,0.8124,0.7135,0.6646	0.1910			9.02					-0.0009	0.5014	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809500	214809500	G	A	het		QUAL=8447;DP=788;AF=0.48;MQM=60;SAP=3;ABP=5	BARD1	missense	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000421162.2:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser:,BARD1:ENST00000613374.5:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser:,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,BARD1:ENST00000619009.5:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser:,BARD1:ENST00000620057.4:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:	BARD1:NM_000465.4:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:NM_001282543.2:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,BARD1:NM_001282545.2:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser:,BARD1:NM_001282548.2:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser:,BARD1:NM_001282549.2:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser:,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.184C>T::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon1/9:n.184C>T::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.184C>T::,BARD1:XM_017004613.1:missense_variant:MODERATE:exon1/12:c.70C>T:p.Pro24Ser:,BARD1:XM_017004614.1:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:XR_002959322.1:non_coding_transcript_exon_variant:MODIFIER:exon1/12:n.161C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183698 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified];	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs1048108	0.3313	0.3836	8911,.	0.2213,0.4318,0.3576,0.3775,0.4088	0.9900	T(0.13),T(0.09),D(0.00),T(0.27),T(0.13),T(0.18),T(0.13)	B(0.01),D(0.99),P(0.81),P(0.76),B(0.03),B(0.07),B(0.09)	19.26	0.26			COSV53608734	0.0306	0.5029	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809599	214809599	C	G	hom	off-target	QUAL=3244;DP=106;AF=1.00;MQM=60;SAP=13;ABP=0	BARD1	5'UTR	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000613374.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-30G>C::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000617164.5:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::,BARD1:ENST00000620057.4:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::	BARD1:NM_000465.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:NM_001282543.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::,BARD1:NM_001282545.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-30G>C::,BARD1:NM_001282548.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-30G>C::,BARD1:NM_001282549.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-30G>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.85G>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon1/9:n.85G>C::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.85G>C::,BARD1:XM_017004613.1:5_prime_UTR_variant:MODIFIER:exon1/12:c.-30G>C::,BARD1:XM_017004614.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:XR_002959322.1:non_coding_transcript_exon_variant:MODIFIER:exon1/12:n.62G>C::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	334199 [benign DISEASE=Familial cancer of breast];			rs1129804		0.7368	41325,.	0.7644,0.8147,0.8037,0.7082,0.6635	-0.2340			8.10					-0.0084	0.5009	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809617	214809617	A	G	hom	off-target	QUAL=3155;DP=105;AF=1.00;MQM=60;SAP=14;ABP=0	BARD1	5'UTR	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000613374.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-48T>C::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000617164.5:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::,BARD1:ENST00000620057.4:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::	BARD1:NM_000465.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:NM_001282543.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::,BARD1:NM_001282545.2:5_prime_UTR_variant:MODIFIER:exon1/7:c.-48T>C::,BARD1:NM_001282548.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-48T>C::,BARD1:NM_001282549.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-48T>C::,BARD1:NR_104212.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.67T>C::,BARD1:NR_104215.2:non_coding_transcript_exon_variant:MODIFIER:exon1/9:n.67T>C::,BARD1:NR_104216.2:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.67T>C::,BARD1:XM_017004613.1:5_prime_UTR_variant:MODIFIER:exon1/12:c.-48T>C::,BARD1:XM_017004614.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:XR_002959322.1:non_coding_transcript_exon_variant:MODIFIER:exon1/12:n.44T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	334200 [benign DISEASE=Familial cancer of breast];			rs17489363		0.7369	41341,.	0.7646,0.8147,0.8047,0.7071,0.6627	-2.5770			3.11					-0.0202	0.5003	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	219550878	219550879	GA	-	hom	off-target	QUAL=4860;DP=157;AF=0.99;MQM=60;SAP=3;ABP=0	OBSL1	intron	OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5408-33_5408-32del::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5684-33_5684-32del::	OBSL1:NM_015311.3:intron_variant:MODIFIER:intron20/20:c.5684-33_5684-32del::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron20/20:c.5683+654_5683+655del::,OBSL1:XM_017003696.2:3_prime_UTR_variant:MODIFIER:exon21/21:c.*367_*368del::,OBSL1:XM_017003697.2:splice_region_variant&intron_variant:LOW:intron20/20:c.5684-7_5684-6del::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron19/19:c.5407+654_5407+655del::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron19/19:c.5407+654_5407+655del::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron18/18:c.5131+654_5131+655del::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs146790993		0.4377	14809,.	0.3849,0.5338,0.4071,0.4448,0.2437	1.2180			17.26					-0.9072	0.9967	0.22	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551848	219551848	C	T	hom	off-target	QUAL=341;DP=13;AF=1.00;MQM=60;SAP=31;ABP=0	OBSL1	intron	OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5138-50G>A::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::	OBSL1:NM_015311.3:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron18/19:c.5138-50G>A::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron18/19:c.5138-50G>A::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron17/18:c.4862-50G>A::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs4672931		0.9774	66559,.	0.7691,0.9818,0.9999,0.9937,0.9993	-0.4130			6.49					-0.2079	0.9213	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552081	219552081	A	T	hom	off-target	QUAL=37753;DP=1163;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	intron	OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5137+31T>A::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::	OBSL1:NM_015311.3:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron18/19:c.5137+31T>A::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron18/19:c.5137+31T>A::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron17/18:c.4861+31T>A::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs4672933		0.9954	73419,.	0.9350,0.9953,0.9999,0.9996,0.9998	-0.6360			5.23					-0.11	0.1641	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552220	219552220	G	C	hom		QUAL=1045;DP=34;AF=1.00;MQM=60;SAP=34;ABP=0	OBSL1	splice_region&intron	OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron17/19:c.5033-4C>G::,OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::	OBSL1:NM_015311.3:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::,OBSL1:XM_011510857.2:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::,OBSL1:XM_017003696.2:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::,OBSL1:XM_017003697.2:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::,OBSL1:XM_017003698.1:splice_region_variant&intron_variant:LOW:intron17/19:c.5033-4C>G::,OBSL1:XM_017003699.1:splice_region_variant&intron_variant:LOW:intron17/19:c.5033-4C>G::,OBSL1:XM_017003700.1:splice_region_variant&intron_variant:LOW:intron16/18:c.4757-4C>G::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	194972 [benign DISEASE=Three M syndrome 2,not specified];			rs34490902	0.3876	0.4454	15411,.	0.4019,0.5464,0.4234,0.4682,0.2587	-0.2900			10.06		6.86>7.91	0.000/0.104	COSV54703179	0.2739	0.1649	0.24	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552506	219552506	G	T	hom	off-target	QUAL=2373;DP=79;AF=1.00;MQM=60;SAP=166;ABP=0	OBSL1	intron	OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron17/19:c.5032+30C>A::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::	OBSL1:NM_015311.3:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron17/19:c.5032+30C>A::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron17/19:c.5032+30C>A::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron16/18:c.4756+30C>A::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs60549465	0.3391	0.4213	13124,.	0.2341,0.5338,0.4153,0.4572,0.2546	0.1300			10.68					-0.0448	0.4123	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552544	219552544	C	T	hom		QUAL=4420;DP=146;AF=1.00;MQM=60;SAP=93;ABP=0	OBSL1	missense	OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_015311.3:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:,OBSL1:XM_011510857.2:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:,OBSL1:XM_017003696.2:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:,OBSL1:XM_017003697.2:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:,OBSL1:XM_017003698.1:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:,OBSL1:XM_017003699.1:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:,OBSL1:XM_017003700.1:missense_variant:MODERATE:exon16/19:c.4748G>A:p.Arg1583Gln:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	288014 [benign DISEASE=Three M syndrome 2,not specified];			rs59332477	0.3766	0.4319	14500,.	0.3735,0.5443,0.4201,0.4570,0.2527	1.1840	T(0.81),T(0.33)	D(1.00),D(1.00)	25.60	0.24			COSV54703732	-0.0279	0.4104	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554514	219554514	T	C	hom		QUAL=14216;DP=466;AF=1.00;MQM=60;SAP=515;ABP=0	OBSL1	synonymous	OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:	OBSL1:NM_015311.3:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron14/14:c.4610-1490A>G::,OBSL1:XM_011510865.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*230A>G::,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon13/19:c.4284A>G:p.Thr1428=:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334466 [benign DISEASE=Three M syndrome 2];			rs10932813		0.9967	74351,.	0.9595,0.9964,1.0000,0.9997,0.9998	-3.9870			2.14					0.0537	0.9246	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554617	219554617	T	C	hom		QUAL=21571;DP=692;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	missense	OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:	OBSL1:NM_015311.3:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:XM_011510857.2:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron14/14:c.4609+1403A>G::,OBSL1:XM_011510865.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*127A>G::,OBSL1:XM_017003696.2:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:XM_017003697.2:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:XM_017003698.1:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,OBSL1:XM_017003699.1:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,OBSL1:XM_017003700.1:missense_variant:MODERATE:exon13/19:c.4181A>G:p.Gln1394Arg:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334469 [benign DISEASE=Three M syndrome 2];			rs10932814		0.9873	70786,.	0.8802,0.9883,1.0000,0.9941,0.9995	0.1340	T(0.61),T(0.51)	B(0.00),B(0.00)	7.41	0.09				0.0628	0.9247	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556234	219556234	A	G	hom		QUAL=1388;DP=52;AF=1.00;MQM=60;SAP=91;ABP=0	OBSL1	synonymous	OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:,OBSL1:XM_011510863.3:synonymous_variant:LOW:exon14/15:c.4395T>C:p.Asp1465=:,OBSL1:XM_011510864.2:missense_variant:MODERATE:exon14/14:c.4271T>C:p.Met1424Thr:,OBSL1:XM_011510865.2:missense_variant:MODERATE:exon14/15:c.4271T>C:p.Met1424Thr:,OBSL1:XM_011510866.2:missense_variant:MODERATE:exon13/13:c.3995T>C:p.Met1332Thr:,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon12/19:c.3843T>C:p.Asp1281=:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334475 [benign DISEASE=Three M syndrome 2];			rs10932816		0.9917	71824,.	0.8885,0.9929,0.9999,0.9996,0.9996	-3.1400			0.29				COSV54708888	0.0395	0.9393	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556695	219556695	C	G	hom		QUAL=23402;DP=732;AF=1.00;MQM=60;SAP=10;ABP=0	OBSL1	missense	OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510857.2:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510863.3:missense_variant:MODERATE:exon13/15:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510864.2:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510865.2:missense_variant:MODERATE:exon13/15:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_011510866.2:missense_variant:MODERATE:exon12/13:c.3819G>C:p.Glu1273Asp:,OBSL1:XM_017003696.2:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_017003697.2:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:,OBSL1:XM_017003698.1:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:,OBSL1:XM_017003699.1:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:,OBSL1:XM_017003700.1:missense_variant:MODERATE:exon11/19:c.3543G>C:p.Glu1181Asp:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334483 [benign DISEASE=Three M syndrome 2];			rs1983210		0.7384	37847,.	0.6130,0.6707,0.7101,0.7404,0.8941	0.6310	T(0.27),T(0.23),T(0.13)	P(0.77),P(0.76),D(0.95)	22.50	0.17			COSV54706342	-0.0856	0.6619	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556734	219556734	C	A	hom	off-target	QUAL=22586;DP=677;AF=1.00;MQM=60;SAP=40;ABP=0	OBSL1	intron	OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3791-11G>T::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron12/20:c.4067-11G>T::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron12/13:c.4067-11G>T::	OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron12/13:c.4067-11G>T::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron12/20:c.4067-11G>T::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron12/20:c.4067-11G>T::,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron12/14:c.4067-11G>T::,OBSL1:XM_011510864.2:intron_variant:MODIFIER:intron12/13:c.4067-11G>T::,OBSL1:XM_011510865.2:intron_variant:MODIFIER:intron12/14:c.4067-11G>T::,OBSL1:XM_011510866.2:intron_variant:MODIFIER:intron11/12:c.3791-11G>T::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron12/20:c.4067-11G>T::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron12/20:c.4067-11G>T::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron11/19:c.3791-11G>T::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron11/19:c.3791-11G>T::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron10/18:c.3515-11G>T::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334484 [benign DISEASE=Three M syndrome 2];			rs1983211	0.1170	0.1685	1807,.	0.0309,0.2186,0.1316,0.1826,0.1521	-0.6670			0.45		7.34>8.35	0.000/0.040	COSV54703188	0.5591	0.5971	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557307	219557307	G	A	hom	off-target	QUAL=4744;DP=163;AF=1.00;MQM=60;SAP=5;ABP=0	OBSL1	intron	OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3790+516C>T::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron12/13:c.4066+36C>T::	OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron12/13:c.4066+36C>T::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron12/14:c.4066+36C>T::,OBSL1:XM_011510864.2:intron_variant:MODIFIER:intron12/13:c.4066+36C>T::,OBSL1:XM_011510865.2:intron_variant:MODIFIER:intron12/14:c.4066+36C>T::,OBSL1:XM_011510866.2:intron_variant:MODIFIER:intron11/12:c.3790+36C>T::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron11/19:c.3790+516C>T::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron11/19:c.3790+36C>T::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron10/18:c.3514+516C>T::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs55873563	0.1188	0.1582	1820,.	0.0308,0.2150,0.1281,0.1751,0.1460	-0.1870			9.37					0.2149	0.4718	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557678	219557678	C	G	hom	off-target	QUAL=10367;DP=381;AF=1.00;MQM=60;SAP=472;ABP=0	OBSL1	intron	OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3790+145G>C::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron11/13:c.3791-60G>C::	OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron11/13:c.3791-60G>C::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron11/14:c.3791-60G>C::,OBSL1:XM_011510864.2:intron_variant:MODIFIER:intron11/13:c.3791-60G>C::,OBSL1:XM_011510865.2:intron_variant:MODIFIER:intron11/14:c.3791-60G>C::,OBSL1:XM_011510866.2:intron_variant:MODIFIER:intron10/12:c.3515-60G>C::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron11/19:c.3790+145G>C::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron10/19:c.3515-60G>C::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron10/18:c.3514+145G>C::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs2278200	0.4087	0.4558	16092,.		-0.4970			2.35				COSV54704518,COSV54704992	-0.0139	0.4819	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557964	219557964	C	T	het		QUAL=529;DP=61;AF=0.44;MQM=60;SAP=38;ABP=5	OBSL1	missense	OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:,OBSL1:XM_011510857.2:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:,OBSL1:XM_011510863.3:missense_variant:MODERATE:exon11/15:c.3649G>A:p.Glu1217Lys:,OBSL1:XM_011510864.2:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:,OBSL1:XM_011510865.2:missense_variant:MODERATE:exon11/15:c.3649G>A:p.Glu1217Lys:,OBSL1:XM_011510866.2:missense_variant:MODERATE:exon10/13:c.3373G>A:p.Glu1125Lys:,OBSL1:XM_017003696.2:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:,OBSL1:XM_017003697.2:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:,OBSL1:XM_017003698.1:missense_variant:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys:,OBSL1:XM_017003699.1:missense_variant:MODERATE:exon10/20:c.3373G>A:p.Glu1125Lys:,OBSL1:XM_017003700.1:missense_variant:MODERATE:exon10/19:c.3373G>A:p.Glu1125Lys:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	193901 [benign/likely benign DISEASE=Three M syndrome 2,not specified,not provided];			rs72957510	0.0070	0.0071	3,.	0.0162,0.0019,0.0000,0.0072,0.0023	0.7730	T(0.22),T(0.50),T(0.41)	P(0.79),P(0.77),B(0.01)	15.09	0.03				-0.0453	0.0913	0	0	18	0 / 1					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219558052	219558052	A	G	hom		QUAL=23993;DP=753;AF=1.00;MQM=60;SAP=9;ABP=0	OBSL1	synonymous	OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon11/20:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173431.2:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:,OBSL1:XM_011510863.3:synonymous_variant:LOW:exon11/15:c.3561T>C:p.Pro1187=:,OBSL1:XM_011510864.2:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:,OBSL1:XM_011510865.2:synonymous_variant:LOW:exon11/15:c.3561T>C:p.Pro1187=:,OBSL1:XM_011510866.2:synonymous_variant:LOW:exon10/13:c.3285T>C:p.Pro1095=:,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon11/20:c.3561T>C:p.Pro1187=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon10/20:c.3285T>C:p.Pro1095=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon10/19:c.3285T>C:p.Pro1095=:		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334496 [benign DISEASE=Three M syndrome 2];			rs2278201	0.4191	0.4649	16868,.	0.5183,0.5484,0.4187,0.4398,0.2543	-4.6040			0.08				COSV54706224	0.0323	0.0926	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219563659	219563659	A	T	het	off-target	QUAL=3399;DP=280;AF=0.45;MQM=60;SAP=15;ABP=9	OBSL1	intron	OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron6/8:c.1169-32T>A::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron6/8:c.2408-32T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron6/19:c.2408-32T>A::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron6/13:c.2408-32T>A::	OBSL1:NM_001173408.2:intron_variant:MODIFIER:intron6/8:c.2408-32T>A::,OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron6/13:c.2408-32T>A::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron6/14:c.2408-32T>A::,OBSL1:XM_011510864.2:intron_variant:MODIFIER:intron6/13:c.2408-32T>A::,OBSL1:XM_011510865.2:intron_variant:MODIFIER:intron6/14:c.2408-32T>A::,OBSL1:XM_011510866.2:intron_variant:MODIFIER:intron6/12:c.2408-32T>A::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron6/19:c.2408-32T>A::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron6/19:c.2408-32T>A::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron6/18:c.2408-32T>A::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs2303543		0.6444	26428,.	0.2967,0.5308,0.6842,0.6796,0.7502	0.9790			7.05					0.3084	0.5595	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219565481	219565481	C	T	hom		QUAL=23710;DP=741;AF=1.00;MQM=60;SAP=15;ABP=0	OBSL1	missense	OBSL1:ENST00000289656.3:missense_variant:MODERATE:exon6/9:c.929G>A:p.Arg310Lys:,OBSL1:ENST00000373873.8:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:	OBSL1:NM_001173408.2:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:NM_001173431.2:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:,OBSL1:NM_015311.3:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:XM_011510857.2:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:XM_011510863.3:missense_variant:MODERATE:exon6/15:c.2168G>A:p.Arg723Lys:,OBSL1:XM_011510864.2:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:,OBSL1:XM_011510865.2:missense_variant:MODERATE:exon6/15:c.2168G>A:p.Arg723Lys:,OBSL1:XM_011510866.2:missense_variant:MODERATE:exon6/13:c.2168G>A:p.Arg723Lys:,OBSL1:XM_017003696.2:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:XM_017003697.2:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:XM_017003698.1:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:XM_017003699.1:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:XM_017003700.1:missense_variant:MODERATE:exon6/19:c.2168G>A:p.Arg723Lys:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334508 [benign DISEASE=Three M syndrome 2];			rs1039898		0.8673	52358,.	0.6290,0.8312,0.9160,0.9036,0.8350	-0.3080	T(0.80),T(0.80),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.53	0.05			COSV54726542,COSV54731761	0.1636	0.3859	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219567987	219567987	A	T	het	off-target	QUAL=9163;DP=724;AF=0.48;MQM=60;SAP=3;ABP=5	OBSL1	intron	OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron2/8:c.44-18T>A::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron2/8:c.1283-18T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron2/19:c.1283-18T>A::,OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron2/13:c.1283-18T>A::	OBSL1:NM_001173408.2:intron_variant:MODIFIER:intron2/8:c.1283-18T>A::,OBSL1:NM_001173431.2:intron_variant:MODIFIER:intron2/13:c.1283-18T>A::,OBSL1:NM_015311.3:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:XM_011510857.2:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:XM_011510863.3:intron_variant:MODIFIER:intron2/14:c.1283-18T>A::,OBSL1:XM_011510864.2:intron_variant:MODIFIER:intron2/13:c.1283-18T>A::,OBSL1:XM_011510865.2:intron_variant:MODIFIER:intron2/14:c.1283-18T>A::,OBSL1:XM_011510866.2:intron_variant:MODIFIER:intron2/12:c.1283-18T>A::,OBSL1:XM_017003696.2:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:XM_017003697.2:intron_variant:MODIFIER:intron2/20:c.1283-18T>A::,OBSL1:XM_017003698.1:intron_variant:MODIFIER:intron2/19:c.1283-18T>A::,OBSL1:XM_017003699.1:intron_variant:MODIFIER:intron2/19:c.1283-18T>A::,OBSL1:XM_017003700.1:intron_variant:MODIFIER:intron2/18:c.1283-18T>A::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]				rs2292360	0.3678	0.4229	11489,.	0.1795,0.3641,0.4921,0.4523,0.4414	-1.0910			2.08		6.52>5.43		COSV54726835	-0.4298	0.872	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570312	219570312	A	G	hom		QUAL=20371;DP=649;AF=1.00;MQM=60;SAP=3;ABP=0	OBSL1	intron,synonymous	OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+1082T>C::,OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173408.2:synonymous_variant:LOW:exon1/9:c.921T>C:p.Leu307=:,OBSL1:NM_001173431.2:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:,OBSL1:XM_011510863.3:synonymous_variant:LOW:exon1/15:c.921T>C:p.Leu307=:,OBSL1:XM_011510864.2:synonymous_variant:LOW:exon1/14:c.921T>C:p.Leu307=:,OBSL1:XM_011510865.2:synonymous_variant:LOW:exon1/15:c.921T>C:p.Leu307=:,OBSL1:XM_011510866.2:synonymous_variant:LOW:exon1/13:c.921T>C:p.Leu307=:,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon1/21:c.921T>C:p.Leu307=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon1/20:c.921T>C:p.Leu307=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon1/19:c.921T>C:p.Leu307=:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	193382 [benign DISEASE=Three M syndrome 2,not specified];			rs10180675		0.8651	51711,.	0.6051,0.8299,0.9153,0.9035,0.8331	-0.3330			13.57				COSV54725784	0.0231	0.8817	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570653	219570653	G	A	het		QUAL=384;DP=19;AF=0.84;MQM=60;SAP=4;ABP=22	OBSL1	intron,synonymous	OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+741C>T::,OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain]	OBSL1:NM_001173408.2:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:,OBSL1:NM_001173431.2:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:,OBSL1:NM_015311.3:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:,OBSL1:XM_011510857.2:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:,OBSL1:XM_011510863.3:synonymous_variant:LOW:exon1/15:c.580C>T:p.Leu194=:,OBSL1:XM_011510864.2:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:,OBSL1:XM_011510865.2:synonymous_variant:LOW:exon1/15:c.580C>T:p.Leu194=:,OBSL1:XM_011510866.2:synonymous_variant:LOW:exon1/13:c.580C>T:p.Leu194=:,OBSL1:XM_017003696.2:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:,OBSL1:XM_017003697.2:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:,OBSL1:XM_017003698.1:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:,OBSL1:XM_017003699.1:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:,OBSL1:XM_017003700.1:synonymous_variant:LOW:exon1/19:c.580C>T:p.Leu194=:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	290129 [benign DISEASE=Three M syndrome 2,not specified];			rs1061399	0.3588	0.4289	11133,.	0.1596,0.3684,0.4918,0.4562,0.4435	3.2570			13.56				COSV54727864	0.0447	0.9102	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr3	10035164	10035165	TT	-	het	off-target	QUAL=1941;DP=168;AF=0.45;MQM=60;SAP=10;ABP=7	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron4/7:c.378-6_378-5del::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron5/43:c.378-6_378-5del::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron5/41:c.378-6_378-5del::,FANCD2:NM_001374255.1:intron_variant:MODIFIER:intron5/9:c.378-6_378-5del::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron5/42:c.378-6_378-5del::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342255 [benign/likely benign DISEASE=Fanconi anemia,not provided];			rs55973240		0.2327	4993,.	0.4744,0.2346,0.0966,0.2132,0.2534	0.3340			4.32					-0.6462	0.5413	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035291	10035291	A	C	het	off-target	QUAL=1279;DP=99;AF=0.48;MQM=60;SAP=12;ABP=3	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.438+58A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.438+58A>C::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron6/41:c.438+58A>C::,FANCD2:NM_001374255.1:intron_variant:MODIFIER:intron6/9:c.438+58A>C::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron6/42:c.438+58A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]				rs17032276	0.1811	0.1969	3454,.		2.2790			14.26					-0.022	0.1335	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10036271	10036271	A	G	het	off-target	QUAL=553;DP=46;AF=0.63;MQM=60;SAP=66;ABP=10	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.439-16A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.439-16A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.439-16A>G::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron6/43:c.439-16A>G::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron6/42:c.439-16A>G::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron6/41:c.439-16A>G::,FANCD2:NM_001374255.1:intron_variant:MODIFIER:intron6/9:c.439-16A>G::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron6/42:c.439-16A>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257083 [benign DISEASE=not specified];			rs17032278	0.1821	0.1965	3419,.	0.3358,0.1545,0.0657,0.1590,0.1770	-0.7230			0.15		10.11>10.91			0.4466	0.0179	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10039861	10039861	G	C	het	off-target	QUAL=5185;DP=484;AF=0.47;MQM=60;SAP=3;ABP=6	FANCD2	intron,synonymous	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron9/42:c.695+16G>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:ENST00000431693.1:synonymous_variant:LOW:exon8/8:c.711G>C:p.Leu237=:,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron9/43:c.695+16G>C::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron9/43:c.695+16G>C::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron9/42:c.695+16G>C::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron9/41:c.695+16G>C::,FANCD2:NM_001374255.1:intron_variant:MODIFIER:intron9/9:c.695+16G>C::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron9/42:c.695+16G>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257086 [benign DISEASE=not specified];			rs17032283	0.1821	0.1971	3453,.	0.3332,0.1546,0.0657,0.1586,0.1767	-0.1270			2.65				COSV55047412	0.1779	0.948	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10042540	10042540	C	T	het	off-target	QUAL=14508;DP=1027;AF=0.54;MQM=60;SAP=3;ABP=14	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron10/42:c.784-19C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron10/43:c.784-19C>T::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron10/43:c.784-19C>T::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron10/42:c.784-19C>T::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron10/41:c.784-19C>T::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron10/42:c.784-19C>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257087 [benign DISEASE=not specified];			rs9879080	0.2107	0.2257	5005,.	0.4323,0.1579,0.0654,0.1593,0.1753	0.8720			7.43		12.10>11.70		COSV55047416	0.3101	0.058	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10043446	10043446	C	G	het	off-target	QUAL=62;DP=10;AF=0.40;MQM=60;SAP=12;ABP=4	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron12/43:c.990-38C>G::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron12/41:c.990-38C>G::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron12/42:c.990-38C>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257088 [benign DISEASE=not specified];			rs9809061	0.2117	0.2261	5019,.	0.4320,0.1572,0.0653,0.1583,0.1770	-0.9250			4.88					-0.2598	0.2771	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10043852	10043852	A	G	het		QUAL=2140;DP=295;AF=0.43;MQM=60;SAP=182;ABP=17	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.3:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:,FANCD2:NM_001374253.1:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:,FANCD2:NM_001374254.1:synonymous_variant:LOW:exon14/42:c.1122A>G:p.Val374=:,FANCD2:NM_033084.6:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257065 [benign DISEASE=Fanconi anemia, complementation group D2,Fanconi anemia, complementation group A,Fanconi anemia,not specified];			rs34046352		0.1929	235,.	0.2875,0.0988,0.0387,0.0796,0.0881	-0.0460			1.33				COSV55037937	-0.0486	0.1597	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10048039	10048039	G	A	het		QUAL=91;DP=148;AF=0.22;MQM=36;SAP=14;ABP=102	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.3:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon16/44:c.1401G>A:p.Thr467=:,FANCD2:NM_001374253.1:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467=:,FANCD2:NM_001374254.1:synonymous_variant:LOW:exon16/42:c.1401G>A:p.Thr467=:,FANCD2:NM_033084.6:synonymous_variant:LOW:exon16/43:c.1401G>A:p.Thr467=:		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342267 [benign DISEASE=Fanconi anemia, complementation group D2,not specified];			rs12330369		0.4610	0,.	0.4704,0.3503,0.3800,0.4470,0.3738	0.0140			4.83				COSV55032260	-0.1003	0.9383	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10048089	10048089	A	C	het	off-target	QUAL=1150;DP=119;AF=0.40;MQM=60;SAP=25;ABP=13	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron16/41:c.1413+38A>C::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257067 [benign DISEASE=not specified];			rs7615646	0.1791	0.2203	222,.	0.3487,0.2143,0.1183,0.2236,0.2492	0.4020			7.18				COSV55031871	-0.214	0.1802	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10052534	10052534	-	T	het	off-target	QUAL=110;DP=25;AF=0.36;MQM=60;SAP=23;ABP=7	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron18/42:c.1656+38dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron18/43:c.1656+38dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron18/43:c.1656+38dup::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron18/43:c.1656+38dup::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron18/43:c.1656+38dup::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron17/42:c.1545+3030dup::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron18/41:c.1656+38dup::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron18/42:c.1656+38dup::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]				rs544799101		0.2114	2965,.	0.3753,0.2432,0.0424,0.2038,0.1953				2.30					-0.0045	0.1156	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10064848	10064848	C	T	het		QUAL=1275;DP=75;AF=0.64;MQM=60;SAP=4;ABP=16	FANCD2	missense	FANCD2:ENST00000287647.7:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.3:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:,FANCD2:NM_001319984.2:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:,FANCD2:NM_001374253.1:missense_variant:MODERATE:exon22/43:c.2030C>T:p.Pro677Leu:,FANCD2:NM_001374254.1:missense_variant:MODERATE:exon23/42:c.2141C>T:p.Pro714Leu:,FANCD2:NM_033084.6:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	134315 [benign DISEASE=Fanconi anemia, complementation group D2,Fanconi anemia, complementation group A,Fanconi anemia,not specified];	CM1814115 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCD2];		rs3864017		0.1880	1866,.	0.2614,0.1393,0.0524,0.1409,0.1622	-0.0900	T(0.31),T(0.31),T(0.31)	B(0.00),B(0.00),B(0.00)	0.88	0.03			COSV55033303	-0.1527	0.7078	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10065836	10065836	G	T	het	off-target	QUAL=12204;DP=1013;AF=0.48;MQM=60;SAP=3;ABP=7	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron24/42:c.2270-28G>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron23/42:c.2159-28G>T::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron24/41:c.2270-28G>T::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron24/42:c.2270-28G>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257074 [benign DISEASE=not specified];			rs34608006	0.1753	0.1937	3256,.	0.3185,0.1537,0.0650,0.1587,0.1780	1.0360			8.29					0.004	0.1054	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10078233	10078233	T	C	het	off-target	QUAL=741;DP=72;AF=0.46;MQM=60;SAP=4;ABP=4	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron30/42:c.2976+36T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron29/42:c.2865+36T>C::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron30/41:c.2976+36T>C::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron30/42:c.2976+36T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257077 [benign DISEASE=not specified];			rs6805869	0.2115	0.2258	5011,.	0.4329,0.1583,0.0657,0.1591,0.1806	0.3540			6.45				COSV55037214	-0.0815	0.3142	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10087300	10087300	-	T	het	off-target	QUAL=92;DP=33;AF=0.18;MQM=60;SAP=16;ABP=32	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron34/42:c.3466+36dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-5751dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron34/43:c.3466+36dup::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron34/43:c.3466+36dup::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron33/42:c.3355+36dup::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron34/41:c.3466+36dup::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron34/42:c.3466+36dup::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*44-5751dup::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]				rs371321981		0.0514	94,.	0.0784,0.0395,0.0279,0.0499,0.0774				4.26					0.2098	0.8087	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10090443	10090443	A	T	het	off-target	QUAL=48;DP=25;AF=0.20;MQM=60;SAP=14;ABP=23	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron37/42:c.3777+58A>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-8912T>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron37/43:c.3777+58A>T::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron36/42:c.3666+58A>T::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron37/41:c.3777+58A>T::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron37/42:c.3777+58A>T::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*44-8912T>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]				rs1276937447		0.0006	0,.		-0.2200			1.84					0.0465	0.1785	0.01	0	0	0 / 0					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10092265	10092265	A	G	het	off-target	QUAL=2563;DP=176;AF=0.55;MQM=60;SAP=5;ABP=6	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron38/42:c.3849+13A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron38/43:c.3849+13A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-10734T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron38/43:c.3849+13A>G::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron38/43:c.3849+13A>G::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron38/43:c.3849+13A>G::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron37/42:c.3738+13A>G::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron38/41:c.3849+13A>G::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron38/42:c.3849+13A>G::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*44-10734T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257079 [benign DISEASE=Fanconi anemia, complementation group D2,not specified];			rs9811771	0.2542	0.2490	6440,.	0.5004,0.1825,0.0893,0.1598,0.2263	0.7300			15.61				COSV55047434	0.3473	0.0097	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10096385	10096385	T	G	het		QUAL=9105;DP=785;AF=0.47;MQM=60;SAP=3;ABP=9	FANCD2,FANCD2OS	synonymous,intron	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::,FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease]	FANCD2:NM_001018115.3:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:,FANCD2:NM_001319984.2:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:,FANCD2:NM_001374253.1:synonymous_variant:LOW:exon41/43:c.3987T>G:p.Leu1329=:,FANCD2:NM_001374254.1:synonymous_variant:LOW:exon41/42:c.4059T>G:p.Leu1353=:,FANCD2:NM_033084.6:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257081 [benign DISEASE=Fanconi anemia, complementation group D2,not specified];	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2];		rs2272125	0.2422	0.2417	5942,.	0.4778,0.1816,0.0893,0.1593,0.2085	1.9740			7.05				COSV55037985	0.0377	0.1318	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10096505	10096505	T	C	het	off-target	QUAL=2791;DP=206;AF=0.52;MQM=60;SAP=4;ABP=4	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron42/42:c.4185+33T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7693A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron41/42:c.4074+33T>C::,FANCD2:NM_001374254.1:intron_variant:MODIFIER:intron41/41:c.4146+33T>C::,FANCD2:NM_033084.6:intron_variant:MODIFIER:intron42/42:c.4185+33T>C::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*43+7693A>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257082 [benign DISEASE=not specified];			rs2272124	0.2418	0.2417	5940,.	0.4778,0.1815,0.0894,0.1593,0.2084	-0.0720			4.69				COSV55047440	0.0818	0.1305	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10098987	10098987	G	A	het	off-target	QUAL=10311;DP=680;AF=0.54;MQM=60;SAP=3;ABP=15	FANCD2,FANCD2OS	3'UTR,intron	FANCD2:ENST00000287647.7:3_prime_UTR_variant:MODIFIER:exon43/43:c.*37G>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+5211C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::	FANCD2:NM_001018115.3:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2:NM_001319984.2:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2:NM_001374253.1:intron_variant:MODIFIER:intron42/42:c.4170+172G>A::,FANCD2:NM_001374254.1:3_prime_UTR_variant:MODIFIER:exon42/42:c.*37G>A::,FANCD2:NM_033084.6:3_prime_UTR_variant:MODIFIER:exon43/43:c.*37G>A::,FANCD2OS:NM_173472.2:intron_variant:MODIFIER:intron2/2:c.*43+5211C>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342381 [benign DISEASE=Fanconi anemia, complementation group D2];			rs7626117	0.3452	0.3372	13612,.	0.7649,0.2070,0.0894,0.1795,0.2321	-0.0220			3.53				COSV55047455	-0.0404	0.9487	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=n/a oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	37025606	37025606	A	T	het	off-target	QUAL=1193;DP=247;AF=0.25;MQM=60;SAP=33;ABP=140	MLH1	intron	MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron11/18:c.1039-31A>T::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron11/14:c.316-31A>T::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron11/15:c.1039-31A>T::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron8/14:c.678-3178A>T::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron12/19:c.316-31A>T::	MLH1:NM_000249.4:intron_variant:MODIFIER:intron11/18:c.1039-31A>T::,MLH1:NM_001167617.3:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:NM_001167618.3:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:NM_001167619.3:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:NM_001258271.2:intron_variant:MODIFIER:intron11/16:c.1039-31A>T::,MLH1:NM_001258273.2:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:NM_001258274.3:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:NM_001354615.2:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:NM_001354616.2:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:NM_001354617.2:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:NM_001354618.2:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:NM_001354619.2:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:NM_001354620.2:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:NM_001354621.2:intron_variant:MODIFIER:intron9/16:c.16-31A>T::,MLH1:NM_001354622.2:intron_variant:MODIFIER:intron10/17:c.16-31A>T::,MLH1:NM_001354623.2:intron_variant:MODIFIER:intron9/16:c.16-31A>T::,MLH1:NM_001354624.2:intron_variant:MODIFIER:intron9/16:c.-36-31A>T::,MLH1:NM_001354625.2:intron_variant:MODIFIER:intron8/15:c.-36-31A>T::,MLH1:NM_001354626.2:intron_variant:MODIFIER:intron9/16:c.-36-31A>T::,MLH1:NM_001354627.2:intron_variant:MODIFIER:intron9/16:c.-36-31A>T::,MLH1:NM_001354628.2:intron_variant:MODIFIER:intron11/17:c.1039-31A>T::,MLH1:NM_001354629.2:intron_variant:MODIFIER:intron10/17:c.940-31A>T::,MLH1:NM_001354630.2:intron_variant:MODIFIER:intron11/17:c.1039-31A>T::,MLH1:XM_005265161.2:intron_variant:MODIFIER:intron9/16:c.832-31A>T::,MLH1:XM_017006450.2:intron_variant:MODIFIER:intron9/16:c.16-31A>T::	regulatory_region_variant:promoter_flanking_region	120436_[GENE=MLH1_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	629888 [likely benign DISEASE=Hereditary cancer-predisposing syndrome];		(TA)n (Simple_repeat)	rs59684491		0.3316	1751,.	0.0391,0.0449,0.0412,0.0274,0.0401	-0.4710			1.11				COSV51624244	-0.0298	0.8389	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37025608	37025608	A	T	het	off-target	QUAL=1193;DP=247;AF=0.25;MQM=60;SAP=33;ABP=140	MLH1	intron	MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron11/18:c.1039-29A>T::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron11/18:c.745-29A>T::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron11/14:c.316-29A>T::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron11/15:c.1039-29A>T::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron8/14:c.678-3176A>T::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron12/19:c.316-29A>T::	MLH1:NM_000249.4:intron_variant:MODIFIER:intron11/18:c.1039-29A>T::,MLH1:NM_001167617.3:intron_variant:MODIFIER:intron11/18:c.745-29A>T::,MLH1:NM_001167618.3:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:NM_001167619.3:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:NM_001258271.2:intron_variant:MODIFIER:intron11/16:c.1039-29A>T::,MLH1:NM_001258273.2:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:NM_001258274.3:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:NM_001354615.2:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:NM_001354616.2:intron_variant:MODIFIER:intron10/17:c.316-29A>T::,MLH1:NM_001354617.2:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:NM_001354618.2:intron_variant:MODIFIER:intron11/18:c.316-29A>T::,MLH1:NM_001354619.2:intron_variant:MODIFIER:intron12/19:c.316-29A>T::,MLH1:NM_001354620.2:intron_variant:MODIFIER:intron11/18:c.745-29A>T::,MLH1:NM_001354621.2:intron_variant:MODIFIER:intron9/16:c.16-29A>T::,MLH1:NM_001354622.2:intron_variant:MODIFIER:intron10/17:c.16-29A>T::,MLH1:NM_001354623.2:intron_variant:MODIFIER:intron9/16:c.16-29A>T::,MLH1:NM_001354624.2:intron_variant:MODIFIER:intron9/16:c.-36-29A>T::,MLH1:NM_001354625.2:intron_variant:MODIFIER:intron8/15:c.-36-29A>T::,MLH1:NM_001354626.2:intron_variant:MODIFIER:intron9/16:c.-36-29A>T::,MLH1:NM_001354627.2:intron_variant:MODIFIER:intron9/16:c.-36-29A>T::,MLH1:NM_001354628.2:intron_variant:MODIFIER:intron11/17:c.1039-29A>T::,MLH1:NM_001354629.2:intron_variant:MODIFIER:intron10/17:c.940-29A>T::,MLH1:NM_001354630.2:intron_variant:MODIFIER:intron11/17:c.1039-29A>T::,MLH1:XM_005265161.2:intron_variant:MODIFIER:intron9/16:c.832-29A>T::,MLH1:XM_017006450.2:intron_variant:MODIFIER:intron9/16:c.16-29A>T::	regulatory_region_variant:promoter_flanking_region	120436_[GENE=MLH1_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	629889 [benign DISEASE=Hereditary cancer-predisposing syndrome];		(TA)n (Simple_repeat)	rs6771325		0.4828	4177,.	0.0448,0.0302,0.1222,0.0359,0.0505	0.1950			1.14				COSV51617601	-0.0537	0.8559	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	142449489	142449489	C	T	hom		QUAL=1594;DP=49;AF=1.00;MQM=60;SAP=4;ABP=0	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:PF02260 [FATC domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:PF02260 [FATC domain]	ATR:NM_001184.4:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:,ATR:XM_011512924.1:synonymous_variant:LOW:exon47/47:c.7881G>A:p.Gln2627=:,ATR:XM_011512925.1:synonymous_variant:LOW:exon46/46:c.7689G>A:p.Gln2563=:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon48/48:n.8101G>A::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon48/48:n.8107G>A::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93669 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs1802904		0.8866	60074,.	0.9733,0.7565,0.9333,0.8561,0.9373	1.2390			6.93				COSV99377126	0.0243	0.9305	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					XRN1 (inh=n/a oe_syn=0.94 oe_mis=0.80 oe_lof=0.12), ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142459302	142459302	C	T	het		QUAL=1052;DP=77;AF=0.55;MQM=60;SAP=8;ABP=4	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase],ATR:ENST00000661310.1:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase]	ATR:NM_001184.4:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:,ATR:NM_001354579.2:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:,ATR:XM_011512924.1:missense_variant:MODERATE:exon43/47:c.7280G>A:p.Arg2427Gln:,ATR:XM_011512925.1:missense_variant:MODERATE:exon42/46:c.7088G>A:p.Arg2363Gln:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon43/48:n.7363G>A::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon43/48:n.7369G>A::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136470 [benign DISEASE=Seckel syndrome 1,not specified,not provided];	CM1010619 [CLASS=DP MUT=ALT PHEN="Acute rejection in kidney transplantation association with" GENE=ATR];		rs2229032	0.1022	0.1306	1340,.	0.0795,0.0994,0.0982,0.1599,0.0957	0.0370	T(0.23),T(0.23)	B(0.00),B(0.00)	0.70	0.17			COSV63383988	-0.029	0.1133	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142469495	142469495	A	C	het		QUAL=9936;DP=681;AF=0.56;MQM=60;SAP=4;ABP=26	ATR,	missense,intron&non_coding_transcript	ATR:ENST00000350721.9:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,:ENST00000460977.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.268+2575T>G::,ATR:ENST00000661310.1:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:	ATR:NM_001184.4:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:NM_001354579.2:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:,ATR:XM_011512924.1:missense_variant:MODERATE:exon38/47:c.6400T>G:p.Tyr2134Asp:,ATR:XM_011512925.1:missense_variant:MODERATE:exon37/46:c.6208T>G:p.Tyr2070Asp:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon38/48:n.6483T>G::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon38/48:n.6489T>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	158000 [likely benign(replaced by megSAP based on classifications:1x1,4x2,1x3) DISEASE=Seckel syndrome 1,not specified,not provided];	CM1725174 [CLASS=DP MUT=ALT PHEN="Haematological traits association with" GENE=ATR];		rs28910273	0.0020	0.0034	0,.	0.0016,0.0016,0.0000,0.0056,0.0014	2.4040	T(0.06), ,T(0.07)	B(0.01), ,B(0.01)	20.90	0.05			COSV63384218	0.1884	0.1512	0.03	0	8	0 / 1					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496329	142496329	T	C	het	off-target	QUAL=124;DP=8;AF=0.75;MQM=60;SAP=16;ABP=7	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::	ATR:NM_001184.4:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::,ATR:XM_011512924.1:intron_variant:MODIFIER:intron34/46:c.5904+32A>G::,ATR:XM_011512925.1:intron_variant:MODIFIER:intron33/45:c.5712+32A>G::,ATR:XR_001740179.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/47:n.5987+32A>G::,ATR:XR_001740180.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5993+32A>G::,ATR:XR_001740181.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5872+32A>G::,ATR:XR_001740182.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5872+32A>G::,ATR:XR_002959543.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/38:n.5993+32A>G::,ATR:XR_924148.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/47:n.5993+32A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157998 [likely benign DISEASE=not specified];		(TA)n (Simple_repeat)	rs11719960		0.0439	406,.	0.0000,0.0001,0.0003,0.0002,0.0002	-1.5210			0.12				COSV63384221	-0.0109	0.156	0.01	19	217	0 / 2					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496336	142496336	A	C	het	off-target	QUAL=124;DP=8;AF=0.75;MQM=60;SAP=16;ABP=7	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+25T>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+25T>G::	ATR:NM_001184.4:intron_variant:MODIFIER:intron34/46:c.5898+25T>G::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron33/45:c.5706+25T>G::,ATR:XM_011512924.1:intron_variant:MODIFIER:intron34/46:c.5904+25T>G::,ATR:XM_011512925.1:intron_variant:MODIFIER:intron33/45:c.5712+25T>G::,ATR:XR_001740179.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/47:n.5987+25T>G::,ATR:XR_001740180.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5993+25T>G::,ATR:XR_001740181.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5872+25T>G::,ATR:XR_001740182.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/37:n.5872+25T>G::,ATR:XR_002959543.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/38:n.5993+25T>G::,ATR:XR_924148.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron34/47:n.5993+25T>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157997 [likely benign DISEASE=not specified];		(TA)n (Simple_repeat)	rs7620648		0.6327	17186,.	0.8447,0.4206,0.4360,0.5578,0.3542	-0.6440			0.33				COSV63391396	-0.0901	0.1565	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142498695	142498695	A	G	het		QUAL=3564;DP=350;AF=0.51;MQM=60;SAP=345;ABP=3	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:PF02259 [FAT domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:PF02259 [FAT domain]	ATR:NM_001184.4:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:,ATR:XM_011512924.1:synonymous_variant:LOW:exon32/47:c.5466T>C:p.Tyr1822=:,ATR:XM_011512925.1:synonymous_variant:LOW:exon31/46:c.5274T>C:p.Tyr1758=:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon32/48:n.5549T>C::,ATR:XR_001740180.2:non_coding_transcript_exon_variant:MODIFIER:exon32/38:n.5555T>C::,ATR:XR_001740181.2:non_coding_transcript_exon_variant:MODIFIER:exon32/38:n.5555T>C::,ATR:XR_001740182.1:non_coding_transcript_exon_variant:MODIFIER:exon32/38:n.5555T>C::,ATR:XR_002959543.1:non_coding_transcript_exon_variant:MODIFIER:exon32/39:n.5555T>C::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon32/48:n.5555T>C::	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136471 [benign/likely benign DISEASE=Seckel syndrome 1,not specified];			rs2227932	0.0669	0.0922	669,.	0.0161,0.0401,0.0014,0.1098,0.1610	1.4980			9.41				COSV100637634	0.1877	0.4608	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142512238	142512238	-	A	het	off-target	QUAL=20;DP=21;AF=0.19;MQM=60;SAP=12;ABP=20	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron27/46:c.4852+39dup::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron26/45:c.4660+39dup::	ATR:NM_001184.4:intron_variant:MODIFIER:intron27/46:c.4852+39dup::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron26/45:c.4660+39dup::,ATR:XM_011512924.1:intron_variant:MODIFIER:intron27/46:c.4858+39dup::,ATR:XM_011512925.1:intron_variant:MODIFIER:intron26/45:c.4666+39dup::,ATR:XR_001740179.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/47:n.4941+39dup::,ATR:XR_001740180.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4947+39dup::,ATR:XR_001740181.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4947+39dup::,ATR:XR_001740182.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/37:n.4947+39dup::,ATR:XR_002959543.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/38:n.4947+39dup::,ATR:XR_924148.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/47:n.4947+39dup::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]				rs74269486		0.4605	12438,.	0.1935,0.1566,0.1714,0.1151,0.0902				0.18					0.0114	0.3272	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142536248	142536248	T	C	het	off-target	QUAL=1313;DP=111;AF=0.46;MQM=60;SAP=6;ABP=5	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron19/46:c.3726-47A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron18/45:c.3534-47A>G::	ATR:NM_001184.4:intron_variant:MODIFIER:intron19/46:c.3726-47A>G::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron18/45:c.3534-47A>G::,ATR:XM_011512924.1:intron_variant:MODIFIER:intron19/46:c.3726-47A>G::,ATR:XM_011512925.1:intron_variant:MODIFIER:intron18/45:c.3534-47A>G::,ATR:XR_001740179.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron19/47:n.3815-47A>G::,ATR:XR_001740180.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron19/37:n.3815-47A>G::,ATR:XR_001740181.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron19/37:n.3815-47A>G::,ATR:XR_001740182.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron19/37:n.3815-47A>G::,ATR:XR_002959543.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron19/38:n.3815-47A>G::,ATR:XR_924148.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron19/47:n.3815-47A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157979 [benign DISEASE=not specified,not provided];			rs73240314	0.1172	0.1378	1474,.	0.1166,0.1051,0.0996,0.1624,0.0990	-0.2480			10.30				COSV63384224	0.0621	0.1668	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142540878	142540878	A	-	het	off-target	QUAL=9092;DP=875;AF=0.43;MQM=60;SAP=4;ABP=46	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron18/46:c.3581+39del::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron17/45:c.3389+39del::	ATR:NM_001184.4:intron_variant:MODIFIER:intron18/46:c.3581+39del::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron17/45:c.3389+39del::,ATR:XM_011512924.1:intron_variant:MODIFIER:intron18/46:c.3581+39del::,ATR:XM_011512925.1:intron_variant:MODIFIER:intron17/45:c.3389+39del::,ATR:XR_001740179.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/47:n.3670+39del::,ATR:XR_001740180.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/37:n.3670+39del::,ATR:XR_001740181.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/37:n.3670+39del::,ATR:XR_001740182.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/37:n.3670+39del::,ATR:XR_002959543.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/38:n.3670+39del::,ATR:XR_924148.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/47:n.3670+39del::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]				rs201551475		0.4587	1543,.	0.4479,0.4599,0.4625,0.4623,0.4558	3.0930			8.47					-0.0507	0.2602	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558585	142558585	A	G	het	off-target	QUAL=6988;DP=587;AF=0.48;MQM=60;SAP=5;ABP=6	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron8/46:c.1885+39T>C::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron7/45:c.1693+39T>C::	ATR:NM_001184.4:intron_variant:MODIFIER:intron8/46:c.1885+39T>C::,ATR:NM_001354579.2:intron_variant:MODIFIER:intron7/45:c.1693+39T>C::,ATR:XM_011512924.1:intron_variant:MODIFIER:intron8/46:c.1885+39T>C::,ATR:XM_011512925.1:intron_variant:MODIFIER:intron7/45:c.1693+39T>C::,ATR:XR_001740179.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/47:n.1974+39T>C::,ATR:XR_001740180.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/37:n.1974+39T>C::,ATR:XR_001740181.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/37:n.1974+39T>C::,ATR:XR_001740182.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/37:n.1974+39T>C::,ATR:XR_002959543.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/38:n.1974+39T>C::,ATR:XR_924148.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/47:n.1974+39T>C::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157967 [likely benign DISEASE=not specified];		(TAGA)n (Simple_repeat)	rs73240318	0.1122	0.1056	832,.	0.0197,0.0408,0.0637,0.0969,0.0639	-0.5170			0.26				COSV63383992	-0.0084	0.4733	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558733	142558733	A	T	het		QUAL=3159;DP=274;AF=0.47;MQM=60;SAP=13;ABP=6	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:ENST00000661310.1:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:	ATR:NM_001184.4:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:NM_001354579.2:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:,ATR:XM_011512924.1:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:XM_011512925.1:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon8/48:n.1865T>A::,ATR:XR_001740180.2:non_coding_transcript_exon_variant:MODIFIER:exon8/38:n.1865T>A::,ATR:XR_001740181.2:non_coding_transcript_exon_variant:MODIFIER:exon8/38:n.1865T>A::,ATR:XR_001740182.1:non_coding_transcript_exon_variant:MODIFIER:exon8/38:n.1865T>A::,ATR:XR_002959543.1:non_coding_transcript_exon_variant:MODIFIER:exon8/39:n.1865T>A::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon8/48:n.1865T>A::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157965 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,not provided];			rs2227930		0.6263	30739,.	0.8003,0.4534,0.4689,0.5786,0.4321	-0.2640			7.02				COSV63383320	0.3434	0.4804	0.34	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142562770	142562770	A	G	het		QUAL=6583;DP=530;AF=0.49;MQM=60;SAP=3;ABP=4	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:ENST00000661310.1:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:	ATR:NM_001184.4:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:NM_001354579.2:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:,ATR:XM_011512924.1:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:XM_011512925.1:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:,ATR:XR_001740179.2:non_coding_transcript_exon_variant:MODIFIER:exon4/48:n.721T>C::,ATR:XR_001740180.2:non_coding_transcript_exon_variant:MODIFIER:exon4/38:n.721T>C::,ATR:XR_001740181.2:non_coding_transcript_exon_variant:MODIFIER:exon4/38:n.721T>C::,ATR:XR_001740182.1:non_coding_transcript_exon_variant:MODIFIER:exon4/38:n.721T>C::,ATR:XR_002959543.1:non_coding_transcript_exon_variant:MODIFIER:exon4/39:n.721T>C::,ATR:XR_924148.2:non_coding_transcript_exon_variant:MODIFIER:exon4/48:n.721T>C::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93668 [benign/likely benign DISEASE=Seckel syndrome 1,not specified];			rs2227928	0.5974	0.6255	30655,.	0.7970,0.4558,0.4701,0.5796,0.4362	1.4770	T(0.63),T(0.58)	B(0.00),B(0.00)	14.16	0.09			COSV63383325	0.0192	0.0922	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	156703736	156703736	G	T	het	off-target	QUAL=6009;DP=474;AF=0.52;MQM=60;SAP=3;ABP=4	TIPARP	intron	TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::	TIPARP:NM_001184717.1:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:NM_001184718.2:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:NM_015508.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::	regulatory_region_variant:promoter_flanking_region				AluYm1 (SINE/Alu)	rs34277251	0.3832	0.4411	10993,.	0.0786,0.5687,0.7189,0.4184,0.3793	-0.1810			1.04					-0.0709	0.0671	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	179199217	179199217	A	G	het	off-target	QUAL=850;DP=54;AF=0.63;MQM=60;SAP=3;ABP=11	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron2/20:c.352+40A>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron2/21:c.352+40A>G::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron2/20:c.352+40A>G::,PIK3CA:XM_006713658.4:intron_variant:MODIFIER:intron2/20:c.352+40A>G::,PIK3CA:XM_011512894.2:intron_variant:MODIFIER:intron2/20:c.352+40A>G::		171834_[GENE=PIK3CA_PHENOS=Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); CLAPO syndrome, somatic, 613089 (3); Cowden syndrome 5, 615108 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Macrodactyly, somatic, 155500 (3); Keratosis, seborrheic, somatic, 182000 (3); Gastric cancer, somatic, 613659 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Nevus, epidermal, somatic, 162900 (3); CLOVE syndrome, somatic, 612918 (3); Nonsmall cell lung cancer, somatic, 211980 (3)]	873175 [uncertain significance DISEASE=Squamous cell lung carcinoma];			rs3729674	0.2734	0.2566	5940,.	0.4297,0.2068,0.1035,0.1964,0.2430	0.6980			7.27				COSV55876899	-0.1074	0.4406	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204486	179204486	C	A	hom	off-target	QUAL=13699;DP=480;AF=1.00;MQM=60;SAP=643;ABP=0	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron5/20:c.1060-17C>A::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron5/21:c.1060-17C>A::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron5/20:c.1060-17C>A::,PIK3CA:XM_006713658.4:intron_variant:MODIFIER:intron5/20:c.1060-17C>A::,PIK3CA:XM_011512894.2:intron_variant:MODIFIER:intron5/20:c.1060-17C>A::		171834_[GENE=PIK3CA_PHENOS=Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); CLAPO syndrome, somatic, 613089 (3); Cowden syndrome 5, 615108 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Macrodactyly, somatic, 155500 (3); Keratosis, seborrheic, somatic, 182000 (3); Gastric cancer, somatic, 613659 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Nevus, epidermal, somatic, 162900 (3); CLOVE syndrome, somatic, 612918 (3); Nonsmall cell lung cancer, somatic, 211980 (3)]	259957 [benign DISEASE=not specified];			rs2699896		0.6368	32547,.	0.8648,0.4871,0.2627,0.5840,0.5599	-0.5230			0.61		11.00>10.43		COSV55874930	0.1186	0.0228	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204642	179204642	A	G	hom	off-target	QUAL=1931;DP=64;AF=1.00;MQM=60;SAP=8;ABP=0	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron6/21:c.1145+54A>G::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::,PIK3CA:XM_006713658.4:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::,PIK3CA:XM_011512894.2:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::		171834_[GENE=PIK3CA_PHENOS=Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); CLAPO syndrome, somatic, 613089 (3); Cowden syndrome 5, 615108 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Macrodactyly, somatic, 155500 (3); Keratosis, seborrheic, somatic, 182000 (3); Gastric cancer, somatic, 613659 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Nevus, epidermal, somatic, 162900 (3); CLOVE syndrome, somatic, 612918 (3); Nonsmall cell lung cancer, somatic, 211980 (3)]				rs3729679	0.5180	0.5725	26093,.		-1.2590			0.67				COSV55874940	-0.0413	0.096	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179220959	179220959	A	T	het	off-target	QUAL=4429;DP=375;AF=0.47;MQM=55;SAP=10;ABP=6	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron13/21:c.2016-27A>T::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::,PIK3CA:XM_006713658.4:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::,PIK3CA:XM_011512894.2:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::		171834_[GENE=PIK3CA_PHENOS=Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); CLAPO syndrome, somatic, 613089 (3); Cowden syndrome 5, 615108 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Macrodactyly, somatic, 155500 (3); Keratosis, seborrheic, somatic, 182000 (3); Gastric cancer, somatic, 613659 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Nevus, epidermal, somatic, 162900 (3); CLOVE syndrome, somatic, 612918 (3); Nonsmall cell lung cancer, somatic, 211980 (3)]				rs6443625	0.2730	0.2563	5907,.	0.4394,0.2084,0.1105,0.1987,0.2440	-0.4160			0.12				COSV55887980	0.0551	0.1557	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179224643	179224643	C	G	hom	off-target	QUAL=183;DP=7;AF=1.00;MQM=60;SAP=18;ABP=0	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron15/21:c.2295-57C>G::	PIK3CA:NM_006218.4:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::,PIK3CA:XM_006713658.4:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::,PIK3CA:XM_011512894.2:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::		171834_[GENE=PIK3CA_PHENOS=Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); CLAPO syndrome, somatic, 613089 (3); Cowden syndrome 5, 615108 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Macrodactyly, somatic, 155500 (3); Keratosis, seborrheic, somatic, 182000 (3); Gastric cancer, somatic, 613659 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Nevus, epidermal, somatic, 162900 (3); CLOVE syndrome, somatic, 612918 (3); Nonsmall cell lung cancer, somatic, 211980 (3)]				rs2699889		0.6684	36073,.		0.2750			5.62				COSV55874955	0.011	0.5305	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr4	185078433	185078433	T	A	het	off-target	QUAL=686;DP=71;AF=0.46;MQM=60;SAP=75;ABP=4	LINC02436	intron&non_coding_transcript	LINC02436:ENST00000509017.6:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1499+6360T>A::,LINC02436:ENST00000653833.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.889+6360T>A::,LINC02436:ENST00000655167.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/11:n.959+6360T>A::,LINC02436:ENST00000655383.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1001+6360T>A::,LINC02436:ENST00000658467.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/5:n.1129-2665T>A::,LINC02436:ENST00000668759.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/7:n.529+6360T>A::,LINC02436:ENST00000669078.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.638+6360T>A::,LINC02436:ENST00000671007.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.490-2665T>A::	LINC02436:NR_147059.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.1340+6360T>A::,LOC105377588:XR_002959837.1:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.846A>T::,LOC105377588:XR_939565.3:non_coding_transcript_exon_variant:MODIFIER:exon4/5:n.1192A>T::	regulatory_region_variant:promoter_flanking_region					rs6818170	0.6675	0.6988	37911,.	0.8328,0.5467,0.4189,0.6699,0.6606	0.1640			3.91								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LINC02436 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	58321576	58321576	G	C	het		QUAL=11940;DP=940;AF=0.50;MQM=60;SAP=3;ABP=3		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::	regulatory_region_variant:enhancer				MLT1E1A (LTR/ERVL-MaLR)	rs37535		0.5920	26748,.		0.8590			3.18								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr5	80654689	80654689	C	T	hom	off-target	QUAL=3032;DP=109;AF=1.00;MQM=60;SAP=5;ABP=0	MSH3,DHFR	5'UTR	MSH3:ENST00000265081.7:5_prime_UTR_variant:MODIFIER:exon1/24:c.-39C>T::,DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-200G>A::	DHFR:NM_000791.4:5_prime_UTR_variant:MODIFIER:exon1/6:c.-200G>A::,DHFR:NM_001290354.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-306G>A::,DHFR:NM_001290357.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-200G>A::,MSH3:NM_002439.5:5_prime_UTR_variant:MODIFIER:exon1/24:c.-39C>T::,DHFR:NR_110936.2:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.295G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]				rs1105525	0.1230	0.1561	1639,.	0.0442,0.0786,0.0686,0.1763,0.2386	-0.0080			8.40				COSV54143671	-0.0496	0.5137	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MTRNR2L2 (inh=n/a oe_syn=0.73 oe_mis=1.01 oe_lof=n/a), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80654693	80654693	A	G	hom	off-target	QUAL=3032;DP=109;AF=1.00;MQM=60;SAP=5;ABP=0	MSH3,DHFR	5'UTR	MSH3:ENST00000265081.7:5_prime_UTR_variant:MODIFIER:exon1/24:c.-35A>G::,DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-204T>C::	DHFR:NM_000791.4:5_prime_UTR_variant:MODIFIER:exon1/6:c.-204T>C::,DHFR:NM_001290354.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-310T>C::,DHFR:NM_001290357.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-204T>C::,MSH3:NM_002439.5:5_prime_UTR_variant:MODIFIER:exon1/24:c.-35A>G::,DHFR:NR_110936.2:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.291T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]				rs1105524		0.7244	40944,.	0.9248,0.4874,0.3586,0.6609,0.7608	-4.8940			3.10				COSV54143681	0.0512	0.5189	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MTRNR2L2 (inh=n/a oe_syn=0.73 oe_mis=1.01 oe_lof=n/a), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80654962	80654962	A	G	het		QUAL=420;DP=38;AF=0.47;MQM=60;SAP=27;ABP=3	MSH3,DHFR	missense&splice_region,5'UTR	MSH3:ENST00000265081.7:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::,MSH3:ENST00000667069.1:missense_variant&splice_region_variant:MODERATE:exon1/22:c.235A>G:p.Ile79Val:	DHFR:NM_000791.4:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::,DHFR:NM_001290354.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-579T>C::,DHFR:NM_001290357.2:5_prime_UTR_variant:MODIFIER:exon1/5:c.-473T>C::,MSH3:NM_002439.5:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,DHFR:NR_110936.2:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.22T>C::	regulatory_region_variant:promoter	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	402591 [benign DISEASE=Megaloblastic anemia due to dihydrofolate reductase deficiency,Hereditary cancer-predisposing syndrome,not specified];			rs1650697		0.8570	48045,.	0.9671,0.9134,0.8262,0.8662,0.8358	-0.2430	T(1.00), ,T(0.74)	B(0.00), ,B(0.00)	3.55	0.24	4.07>2.71	0.002/0.082	COSV54144023	-0.4102	0.8527	0.43	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MTRNR2L2 (inh=n/a oe_syn=0.73 oe_mis=1.01 oe_lof=n/a), MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80670359	80670359	G	A	het	off-target	QUAL=5454;DP=416;AF=0.50;MQM=60;SAP=3;ABP=3	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron4/23:c.792+50G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron4/23:c.624+50G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron4/21:c.792+50G>A::	MSH3:NM_002439.5:intron_variant:MODIFIER:intron4/23:c.792+50G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]				rs6151630	0.0232	0.0404	141,.	0.0109,0.0170,0.0001,0.0546,0.0352	0.0690			11.74				COSV54144136	0.1679	0.0578	0	4	103	1 / 1					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80854162	80854162	A	G	hom		QUAL=28040;DP=903;AF=1.00;MQM=60;SAP=3;ABP=0	MSH3	missense	MSH3:ENST00000265081.7:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:PF00488 [MutS domain V],MSH3:ENST00000658259.1:missense_variant:MODERATE:exon21/24:c.2678A>G:p.Gln893Arg:PF00488 [MutS domain V],MSH3:ENST00000667069.1:missense_variant:MODERATE:exon19/22:c.2651A>G:p.Gln884Arg:PF00488 [MutS domain V]	MSH3:NM_002439.5:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	821892 [benign DISEASE=Hereditary cancer-predisposing syndrome,none provided];			rs184967		0.8735	57227,.	0.8933,0.9129,0.9994,0.8404,0.8820	0.4290	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	4.96	0.28			COSV54143790	0.2074	0.1983	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80864778	80864781	AATG	-	het	off-target	QUAL=58;DP=16;AF=0.38;MQM=60;SAP=16;ABP=5	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron21/23:c.3001-33_3001-30del::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron21/23:c.2833-33_2833-30del::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron19/21:c.2806-33_2806-30del::	MSH3:NM_002439.5:intron_variant:MODIFIER:intron21/23:c.3001-33_3001-30del::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]				rs3991216		0.4851	16672,.	0.2306,0.3526,0.3830,0.5513,0.5265	3.5250			6.79					-0.0889	0.062	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80873118	80873118	G	A	hom		QUAL=3771;DP=114;AF=1.00;MQM=60;SAP=16;ABP=0	MSH3	missense&splice_region	MSH3:ENST00000265081.7:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:PF00488 [MutS domain V],MSH3:ENST00000658259.1:missense_variant&splice_region_variant:MODERATE:exon23/24:c.2965G>A:p.Ala989Thr:PF00488 [MutS domain V],MSH3:ENST00000667069.1:missense_variant&splice_region_variant:MODERATE:exon21/22:c.2938G>A:p.Ala980Thr:PF00488 [MutS domain V]	MSH3:NM_002439.5:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	822964 [benign DISEASE=Hereditary cancer-predisposing syndrome,none provided];			rs26279	0.7202	0.7294	37881,.	0.6635,0.7560,0.7469,0.7137,0.7934	1.9220	T(0.54),T(0.54),T(0.54)	B(0.04),B(0.05),B(0.00)	6.56	0.11	10.88>10.94		COSV54143807	-0.2109	0.6586	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	112827157	112827157	T	C	het		QUAL=1671;DP=182;AF=0.42;MQM=60;SAP=58;ABP=14	APC	synonymous	APC:ENST00000257430.9:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000508376.6:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:	APC:NM_000038.6:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:NM_001127510.3:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:,APC:NM_001127511.3:synonymous_variant:LOW:exon10/14:c.1404T>C:p.Tyr468=:,APC:NM_001354895.2:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:NM_001354896.2:synonymous_variant:LOW:exon13/17:c.1512T>C:p.Tyr504=:,APC:NM_001354897.2:synonymous_variant:LOW:exon11/15:c.1488T>C:p.Tyr496=:,APC:NM_001354898.2:synonymous_variant:LOW:exon12/16:c.1383T>C:p.Tyr461=:,APC:NM_001354899.2:synonymous_variant:LOW:exon11/15:c.1374T>C:p.Tyr458=:,APC:NM_001354900.2:synonymous_variant:LOW:exon12/16:c.1335T>C:p.Tyr445=:,APC:NM_001354901.2:synonymous_variant:LOW:exon11/15:c.1281T>C:p.Tyr427=:,APC:NM_001354902.2:synonymous_variant:LOW:exon11/15:c.1185T>C:p.Tyr395=:,APC:NM_001354903.2:synonymous_variant:LOW:exon12/16:c.1155T>C:p.Tyr385=:,APC:NM_001354904.2:synonymous_variant:LOW:exon12/16:c.1080T>C:p.Tyr360=:,APC:NM_001354905.2:synonymous_variant:LOW:exon11/15:c.978T>C:p.Tyr326=:,APC:NM_001354906.2:synonymous_variant:LOW:exon13/17:c.609T>C:p.Tyr203=:		611731_[GENE=APC_PHENOS=Adenoma, periampullary, somatic, 175100 (3); Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Hepatoblastoma, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3)]	42238 [benign DISEASE=Hepatocellular carcinoma,Neoplasm of stomach,Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,Desmoid disease, hereditary,not specified,APC-Associated Polyposis Disorders];	CS1822474 [CLASS=DFP MUT=ALT PHEN="Adenomatous polyposis coli predisposition to" GENE=APC];		rs2229992		0.5844	20034,.	0.1960,0.6976,0.6734,0.5922,0.6386	1.2980			8.94				COSV57321592	0.1199	0.1616	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112828864	112828864	G	A	het		QUAL=2531;DP=179;AF=0.51;MQM=60;SAP=3;ABP=3	APC,	synonymous,synonymous&NMD_transcript	APC:ENST00000257430.9:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],:ENST00000520401.1:synonymous_variant&NMD_transcript_variant:LOW:exon3/8:c.123G>A:p.Ala41=:	APC:NM_000038.6:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:,APC:NM_001127510.3:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:,APC:NM_001127511.3:synonymous_variant:LOW:exon12/14:c.1581G>A:p.Ala527=:,APC:NM_001354895.2:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:,APC:NM_001354896.2:synonymous_variant:LOW:exon15/17:c.1689G>A:p.Ala563=:,APC:NM_001354897.2:synonymous_variant:LOW:exon13/15:c.1665G>A:p.Ala555=:,APC:NM_001354898.2:synonymous_variant:LOW:exon14/16:c.1560G>A:p.Ala520=:,APC:NM_001354899.2:synonymous_variant:LOW:exon13/15:c.1551G>A:p.Ala517=:,APC:NM_001354900.2:synonymous_variant:LOW:exon14/16:c.1512G>A:p.Ala504=:,APC:NM_001354901.2:synonymous_variant:LOW:exon13/15:c.1458G>A:p.Ala486=:,APC:NM_001354902.2:synonymous_variant:LOW:exon13/15:c.1362G>A:p.Ala454=:,APC:NM_001354903.2:synonymous_variant:LOW:exon14/16:c.1332G>A:p.Ala444=:,APC:NM_001354904.2:synonymous_variant:LOW:exon14/16:c.1257G>A:p.Ala419=:,APC:NM_001354905.2:synonymous_variant:LOW:exon13/15:c.1155G>A:p.Ala385=:,APC:NM_001354906.2:synonymous_variant:LOW:exon15/17:c.786G>A:p.Ala262=:		611731_[GENE=APC_PHENOS=Adenoma, periampullary, somatic, 175100 (3); Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Hepatoblastoma, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3)]	42239 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs351771		0.6492	27971,.	0.5317,0.7330,0.8218,0.6187,0.7136	1.6090			11.07				COSV57321606	-0.0108	0.8845	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840073	112840073	G	A	het		QUAL=5170;DP=423;AF=0.49;MQM=60;SAP=3;ABP=3	APC,	synonymous,intron&NMD_transcript	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11101G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.4425G>A:p.Thr1475=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.4533G>A:p.Thr1511=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.4509G>A:p.Thr1503=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.4404G>A:p.Thr1468=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.4395G>A:p.Thr1465=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.4356G>A:p.Thr1452=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.4302G>A:p.Thr1434=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4206G>A:p.Thr1402=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4176G>A:p.Thr1392=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4101G>A:p.Thr1367=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.3999G>A:p.Thr1333=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.3630G>A:p.Thr1210=:		611731_[GENE=APC_PHENOS=Adenoma, periampullary, somatic, 175100 (3); Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Hepatoblastoma, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3)]	42242 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs41115	0.6655	0.6497	27950,.	0.5328,0.7339,0.8216,0.6188,0.7128	0.0920			2.72				COSV57321403,COSV57381675	-0.0042	0.8999	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840628	112840628	G	A	het		QUAL=233;DP=26;AF=0.50;MQM=60;SAP=31;ABP=3	APC,	synonymous,intron&NMD_transcript	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP],:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11656G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.4980G>A:p.Gly1660=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5088G>A:p.Gly1696=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5064G>A:p.Gly1688=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.4959G>A:p.Gly1653=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.4950G>A:p.Gly1650=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.4911G>A:p.Gly1637=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.4857G>A:p.Gly1619=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4761G>A:p.Gly1587=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4731G>A:p.Gly1577=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4656G>A:p.Gly1552=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.4554G>A:p.Gly1518=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.4185G>A:p.Gly1395=:		611731_[GENE=APC_PHENOS=Adenoma, periampullary, somatic, 175100 (3); Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Hepatoblastoma, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3)]	42243 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs42427		0.6524	28255,.	0.5353,0.7363,0.8218,0.6235,0.7127	0.4930			6.19				COSV57321627	0.0138	0.9001	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840862	112840862	T	G	het		QUAL=3249;DP=261;AF=0.49;MQM=60;SAP=4;ABP=3	APC,	synonymous,intron&NMD_transcript	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr],:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+11890T>G::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.5214T>G:p.Ser1738=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5322T>G:p.Ser1774=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5298T>G:p.Ser1766=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.5193T>G:p.Ser1731=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.5184T>G:p.Ser1728=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.5145T>G:p.Ser1715=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.5091T>G:p.Ser1697=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.4995T>G:p.Ser1665=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.4965T>G:p.Ser1655=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.4890T>G:p.Ser1630=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.4788T>G:p.Ser1596=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.4419T>G:p.Ser1473=:		611731_[GENE=APC_PHENOS=Adenoma, periampullary, somatic, 175100 (3); Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Hepatoblastoma, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3)]	42245 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs866006		0.6513	28119,.	0.5340,0.7343,0.8213,0.6209,0.7135	0.1690			0.45				COSV57321636,COSV57325918	0.0043	0.9	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112841059	112841059	T	A	het		QUAL=4290;DP=381;AF=0.45;MQM=60;SAP=8;ABP=11	APC,	missense,intron&NMD_transcript	APC:ENST00000257430.9:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000508376.6:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+12087T>A::	APC:NM_000038.6:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:NM_001127510.3:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:,APC:NM_001127511.3:missense_variant:MODERATE:exon14/14:c.5411T>A:p.Val1804Asp:,APC:NM_001354895.2:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:,APC:NM_001354896.2:missense_variant:MODERATE:exon17/17:c.5519T>A:p.Val1840Asp:,APC:NM_001354897.2:missense_variant:MODERATE:exon15/15:c.5495T>A:p.Val1832Asp:,APC:NM_001354898.2:missense_variant:MODERATE:exon16/16:c.5390T>A:p.Val1797Asp:,APC:NM_001354899.2:missense_variant:MODERATE:exon15/15:c.5381T>A:p.Val1794Asp:,APC:NM_001354900.2:missense_variant:MODERATE:exon16/16:c.5342T>A:p.Val1781Asp:,APC:NM_001354901.2:missense_variant:MODERATE:exon15/15:c.5288T>A:p.Val1763Asp:,APC:NM_001354902.2:missense_variant:MODERATE:exon15/15:c.5192T>A:p.Val1731Asp:,APC:NM_001354903.2:missense_variant:MODERATE:exon16/16:c.5162T>A:p.Val1721Asp:,APC:NM_001354904.2:missense_variant:MODERATE:exon16/16:c.5087T>A:p.Val1696Asp:,APC:NM_001354905.2:missense_variant:MODERATE:exon15/15:c.4985T>A:p.Val1662Asp:,APC:NM_001354906.2:missense_variant:MODERATE:exon17/17:c.4616T>A:p.Val1539Asp:		611731_[GENE=APC_PHENOS=Adenoma, periampullary, somatic, 175100 (3); Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Hepatoblastoma, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3)]	21030 [benign DISEASE=Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders,not provided];			rs459552		0.8200	51821,.	0.9587,0.8269,0.9029,0.7706,0.7820	2.3600	T(0.50),T(0.50), 	B(0.00),B(0.00), 	16.08	0.19			COSV57321643	0.0053	0.9	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112841474	112841474	G	A	het		QUAL=9917;DP=812;AF=0.49;MQM=60;SAP=4;ABP=5	APC,	synonymous,intron&NMD_transcript	APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],:ENST00000520401.1:intron_variant&NMD_transcript_variant:MODIFIER:intron3/7:c.230+12502G>A::	APC:NM_000038.6:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:,APC:NM_001127510.3:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:,APC:NM_001127511.3:synonymous_variant:LOW:exon14/14:c.5826G>A:p.Pro1942=:,APC:NM_001354895.2:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:,APC:NM_001354896.2:synonymous_variant:LOW:exon17/17:c.5934G>A:p.Pro1978=:,APC:NM_001354897.2:synonymous_variant:LOW:exon15/15:c.5910G>A:p.Pro1970=:,APC:NM_001354898.2:synonymous_variant:LOW:exon16/16:c.5805G>A:p.Pro1935=:,APC:NM_001354899.2:synonymous_variant:LOW:exon15/15:c.5796G>A:p.Pro1932=:,APC:NM_001354900.2:synonymous_variant:LOW:exon16/16:c.5757G>A:p.Pro1919=:,APC:NM_001354901.2:synonymous_variant:LOW:exon15/15:c.5703G>A:p.Pro1901=:,APC:NM_001354902.2:synonymous_variant:LOW:exon15/15:c.5607G>A:p.Pro1869=:,APC:NM_001354903.2:synonymous_variant:LOW:exon16/16:c.5577G>A:p.Pro1859=:,APC:NM_001354904.2:synonymous_variant:LOW:exon16/16:c.5502G>A:p.Pro1834=:,APC:NM_001354905.2:synonymous_variant:LOW:exon15/15:c.5400G>A:p.Pro1800=:,APC:NM_001354906.2:synonymous_variant:LOW:exon17/17:c.5031G>A:p.Pro1677=:		611731_[GENE=APC_PHENOS=Adenoma, periampullary, somatic, 175100 (3); Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Hepatoblastoma, somatic, 114550 (3); Colorectal cancer, somatic, 114500 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3)]	42247 [benign DISEASE=Carcinoma of colon,Hereditary cancer-predisposing syndrome,Familial adenomatous polyposis 1,Familial colorectal cancer,not specified,APC-Associated Polyposis Disorders];			rs465899		0.6497	28072,.	0.5367,0.7336,0.8217,0.6188,0.7122	-0.1460			4.85				COSV57321652	-0.0026	0.8999	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	132557287	132557287	G	A	hom	off-target	QUAL=1592;DP=66;AF=0.98;MQM=60;SAP=144;ABP=0	RAD50,	5'UTR,intron	RAD50:ENST00000378823.8:5_prime_UTR_variant:MODIFIER:exon1/25:c.-38G>A::,:ENST00000638452.2:intron_variant:MODIFIER:intron3/26:c.-168-1997G>A::,:ENST00000638568.2:intron_variant:MODIFIER:intron4/27:c.-169+814G>A::,:ENST00000640655.2:intron_variant:MODIFIER:intron2/25:c.-168-1997G>A::	RAD50:NM_005732.4:5_prime_UTR_variant:MODIFIER:exon1/25:c.-38G>A::	regulatory_region_variant:promoter	604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]				rs4526098		0.9791	66576,.	0.7535,0.9847,0.9999,0.9967,0.9918	2.2570			14.68				COSV99528532	0.1717	0.1177	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132579521	132579521	G	A	het	off-target	QUAL=1499;DP=145;AF=0.46;MQM=60;SAP=69;ABP=5	RAD50,	intron	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron4/24:c.551+19G>A::,:ENST00000638452.2:intron_variant:MODIFIER:intron6/26:c.254+19G>A::,:ENST00000638568.2:intron_variant:MODIFIER:intron7/27:c.254+19G>A::,:ENST00000640655.2:intron_variant:MODIFIER:intron5/25:c.254+19G>A::	RAD50:NM_005732.4:intron_variant:MODIFIER:intron4/24:c.551+19G>A::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	259870 [benign DISEASE=Nijmegen breakage syndrome-like disorder,not specified,not provided];	CS139954 [CLASS=DFP MUT=ALT PHEN="Acute lymphoblastic leukaemia decreased risk" GENE=RAD50];		rs17166050	0.1677	0.1972	2697,.	0.1125,0.1442,0.1684,0.2076,0.2282	-0.1920			1.50				COSV99528535	0.1438	0.3112	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132589791	132589791	G	C	het		QUAL=814;DP=67;AF=0.49;MQM=60;SAP=3;ABP=3	RAD50,	missense	RAD50:ENST00000378823.8:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:,:ENST00000638452.2:missense_variant:MODERATE:exon11/27:c.1109G>C:p.Gly370Ala:,:ENST00000638568.2:missense_variant:MODERATE:exon12/28:c.1109G>C:p.Gly370Ala:,:ENST00000640655.2:missense_variant:MODERATE:exon10/26:c.1109G>C:p.Gly370Ala:	RAD50:NM_005732.4:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	216618 [uncertain significance DISEASE=Hereditary cancer-predisposing syndrome];			rs55653181	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	6.4160	T(0.20),T(0.21),T(0.21),T(0.21)	B(0.19),B(0.19),B(0.19),B(0.19)	22.50	0.26				-0.0234	0.5698	0	0	1	0 / 1					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	176907194	176907194	C	T	het	off-target	QUAL=11593;DP=625;AF=0.69;MQM=60;SAP=3;ABP=205	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron12/14:c.1351-17G>A::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron8/10:c.739-17G>A::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::	UIMC1:NM_001199297.2:intron_variant:MODIFIER:intron13/15:c.1849-17G>A::,UIMC1:NM_001199298.2:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::,UIMC1:NM_001317961.1:intron_variant:MODIFIER:intron12/14:c.1351-17G>A::,UIMC1:NM_016290.4:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::,UIMC1:NR_146149.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/15:n.2084-17G>A::,UIMC1:NR_146150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/14:n.2010-17G>A::,UIMC1:XM_005265930.2:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::,UIMC1:XM_005265932.3:intron_variant:MODIFIER:intron10/12:c.1006-17G>A::,UIMC1:XM_005265933.2:intron_variant:MODIFIER:intron10/12:c.1006-17G>A::,UIMC1:XM_005265934.2:intron_variant:MODIFIER:intron12/14:c.940-17G>A::,UIMC1:XM_005265935.2:intron_variant:MODIFIER:intron12/14:c.940-17G>A::,UIMC1:XM_005265936.2:intron_variant:MODIFIER:intron11/13:c.739-17G>A::,UIMC1:XM_006714871.2:intron_variant:MODIFIER:intron12/14:c.1849-17G>A::,UIMC1:XM_006714874.2:intron_variant:MODIFIER:intron12/14:c.940-17G>A::,UIMC1:XM_017009574.2:intron_variant:MODIFIER:intron11/13:c.1615-17G>A::,UIMC1:XM_017009575.1:intron_variant:MODIFIER:intron13/15:c.1552-17G>A::,UIMC1:XM_017009576.1:intron_variant:MODIFIER:intron10/12:c.1006-17G>A::,UIMC1:XM_017009577.1:intron_variant:MODIFIER:intron10/12:c.1006-17G>A::,UIMC1:XM_017009578.1:intron_variant:MODIFIER:intron11/13:c.739-17G>A::,UIMC1:XM_017009579.1:intron_variant:MODIFIER:intron11/13:c.739-17G>A::						rs2292255		0.5801	27397,.	0.8281,0.3515,0.4827,0.5003,0.4703	-3.9000			0.00		12.99>12.00		COSV65894272	-0.331	0.1466	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176911287	176911287	C	T	het	off-target	QUAL=3694;DP=318;AF=0.49;MQM=60;SAP=111;ABP=3	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron11/14:c.1178+24G>A::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron7/10:c.566+24G>A::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::	UIMC1:NM_001199297.2:intron_variant:MODIFIER:intron12/15:c.1676+24G>A::,UIMC1:NM_001199298.2:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:NM_001317961.1:intron_variant:MODIFIER:intron11/14:c.1178+24G>A::,UIMC1:NM_016290.4:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:NR_146149.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/15:n.1911+24G>A::,UIMC1:NR_146150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/14:n.1837+16G>A::,UIMC1:XM_005265930.2:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:XM_005265932.3:intron_variant:MODIFIER:intron9/12:c.833+24G>A::,UIMC1:XM_005265933.2:intron_variant:MODIFIER:intron9/12:c.833+24G>A::,UIMC1:XM_005265934.2:intron_variant:MODIFIER:intron11/14:c.767+24G>A::,UIMC1:XM_005265935.2:intron_variant:MODIFIER:intron11/14:c.767+24G>A::,UIMC1:XM_005265936.2:intron_variant:MODIFIER:intron10/13:c.566+24G>A::,UIMC1:XM_006714871.2:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:XM_006714874.2:intron_variant:MODIFIER:intron11/14:c.767+24G>A::,UIMC1:XM_011534568.2:intron_variant:MODIFIER:intron12/12:c.*47+16G>A::,UIMC1:XM_017009574.2:intron_variant:MODIFIER:intron10/13:c.1442+24G>A::,UIMC1:XM_017009575.1:intron_variant:MODIFIER:intron12/15:c.1379+24G>A::,UIMC1:XM_017009576.1:intron_variant:MODIFIER:intron9/12:c.833+24G>A::,UIMC1:XM_017009577.1:intron_variant:MODIFIER:intron9/12:c.833+24G>A::,UIMC1:XM_017009578.1:intron_variant:MODIFIER:intron10/13:c.566+24G>A::,UIMC1:XM_017009579.1:intron_variant:MODIFIER:intron10/13:c.566+24G>A::	regulatory_region_variant:promoter_flanking_region					rs17078630	0.0092	0.0239	57,.	0.0058,0.0125,0.0001,0.0364,0.0056	-2.9070			0.02					0.0869	0.4062	0.02	4	48	0 / 1					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr6	35452851	35452851	A	C	het	off-target	QUAL=67;DP=8;AF=0.50;MQM=60;SAP=3;ABP=3	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron1/9:c.248+58A>C::	FANCE:NM_021922.3:intron_variant:MODIFIER:intron1/9:c.248+58A>C::,FANCE:XM_005248885.2:intron_variant:MODIFIER:intron1/9:c.248+58A>C::,FANCE:XM_005248886.2:intron_variant:MODIFIER:intron1/8:c.248+58A>C::,FANCE:XM_005248887.2:intron_variant:MODIFIER:intron1/8:c.248+58A>C::,FANCE:XM_005248888.3:intron_variant:MODIFIER:intron1/7:c.248+58A>C::,FANCE:XM_011514343.2:5_prime_UTR_variant:MODIFIER:exon1/10:c.-192A>C::,FANCE:XR_001743226.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.455+58A>C::,FANCE:XR_002956267.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.455+58A>C::	regulatory_region_variant:promoter,TF_binding_site_variant	613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	929571 [uncertain significance DISEASE=not provided];			rs9470029		0.6186	29198,.		-2.3380			2.41				COSV57691516	-0.045	0.2037	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MKRN6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35455712	35455712	A	G	het	off-target	QUAL=7908;DP=635;AF=0.49;MQM=60;SAP=3;ABP=4	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron1/9:c.249-35A>G::	FANCE:NM_021922.3:intron_variant:MODIFIER:intron1/9:c.249-35A>G::,FANCE:XM_005248885.2:intron_variant:MODIFIER:intron1/9:c.249-35A>G::,FANCE:XM_005248886.2:intron_variant:MODIFIER:intron1/8:c.249-35A>G::,FANCE:XM_005248887.2:intron_variant:MODIFIER:intron1/8:c.249-35A>G::,FANCE:XM_005248888.3:intron_variant:MODIFIER:intron1/7:c.249-35A>G::,FANCE:XM_011514343.2:intron_variant:MODIFIER:intron1/9:c.-46-35A>G::,FANCE:XR_001743226.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.456-35A>G::,FANCE:XR_002956267.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.456-35A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261434 [benign DISEASE=not specified];			rs7757405		0.7413	42316,.	0.8668,0.8195,0.6817,0.6734,0.7467	1.6900			8.49				COSV57690099	-0.0598	0.1841	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35455885	35455885	A	C	het		QUAL=871;DP=98;AF=0.40;MQM=60;SAP=3;ABP=12	FANCE	synonymous	FANCE:ENST00000229769.3:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:	FANCE:NM_021922.3:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:,FANCE:XM_005248885.2:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:,FANCE:XM_005248886.2:synonymous_variant:LOW:exon2/9:c.387A>C:p.Pro129=:,FANCE:XM_005248887.2:synonymous_variant:LOW:exon2/9:c.387A>C:p.Pro129=:,FANCE:XM_005248888.3:synonymous_variant:LOW:exon2/8:c.387A>C:p.Pro129=:,FANCE:XM_011514343.2:synonymous_variant:LOW:exon2/10:c.93A>C:p.Pro31=:,FANCE:XR_001743226.1:non_coding_transcript_exon_variant:MODIFIER:exon2/9:n.594A>C::,FANCE:XR_002956267.1:non_coding_transcript_exon_variant:MODIFIER:exon2/8:n.594A>C::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261435 [benign DISEASE=Fanconi anemia, complementation group E,not specified,not provided];			rs4713867		0.7429	42567,.	0.8720,0.8209,0.6819,0.6734,0.7478	-1.1030			1.46				COSV57690669	-0.0146	0.3199	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456411	35456411	A	G	het	off-target	QUAL=1441;DP=106;AF=0.53;MQM=60;SAP=7;ABP=4	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+58A>G::	FANCE:NM_021922.3:intron_variant:MODIFIER:intron2/9:c.855+58A>G::,FANCE:XM_005248885.2:intron_variant:MODIFIER:intron2/9:c.855+58A>G::,FANCE:XM_005248886.2:intron_variant:MODIFIER:intron2/8:c.855+58A>G::,FANCE:XM_005248887.2:intron_variant:MODIFIER:intron2/8:c.855+58A>G::,FANCE:XM_005248888.3:intron_variant:MODIFIER:intron2/7:c.855+58A>G::,FANCE:XM_011514343.2:intron_variant:MODIFIER:intron2/9:c.561+58A>G::,FANCE:XR_001743226.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.1062+58A>G::,FANCE:XR_002956267.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.1062+58A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	929575 [uncertain significance DISEASE=not provided];			rs3800377		0.7150	39600,.		-1.5070			0.07					0.0348	0.3203	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35457639	35457639	A	G	het	off-target	QUAL=10898;DP=830;AF=0.50;MQM=60;SAP=3;ABP=3	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron3/9:c.900+39A>G::	FANCE:NM_021922.3:intron_variant:MODIFIER:intron3/9:c.900+39A>G::,FANCE:XM_005248885.2:intron_variant:MODIFIER:intron3/9:c.900+39A>G::,FANCE:XM_005248886.2:intron_variant:MODIFIER:intron3/8:c.900+39A>G::,FANCE:XM_005248887.2:intron_variant:MODIFIER:intron3/8:c.900+39A>G::,FANCE:XM_005248888.3:intron_variant:MODIFIER:intron3/7:c.900+39A>G::,FANCE:XM_011514343.2:intron_variant:MODIFIER:intron3/9:c.606+39A>G::,FANCE:XR_001743226.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/8:n.1107+39A>G::,FANCE:XR_002956267.1:non_coding_transcript_exon_variant:MODIFIER:exon3/8:n.1146A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261436 [benign DISEASE=not specified,not provided];			rs13214239	0.3596	0.5019	16449,.	0.1291,0.6321,0.3569,0.5547,0.4297	-0.6330			0.59				COSV57690016	-0.0469	0.2528	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	130827723	130827723	A	T	het		QUAL=4396;DP=373;AF=0.52;MQM=60;SAP=222;ABP=4	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+72A>T::	SMLR1:NM_001195597.2:intron_variant:MODIFIER:intron1/1:c.238+72A>T::	regulatory_region_variant:TF_binding_site					rs9388856	0.4794	0.3714	11121,.		0.2310			2.92					0.1163	0.1141	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827763	130827763	-	AT	het	off-target	QUAL=6746;DP=703;AF=0.41;MQM=60;SAP=6;ABP=53	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::	SMLR1:NM_001195597.2:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::	regulatory_region_variant:TF_binding_site					rs113795427		0.3941	12529,.					3.79					0.0006	0.1146	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr7	5987144	5987144	T	C	hom		QUAL=524;DP=21;AF=1.00;MQM=60;SAP=49;ABP=0	PMS2	missense,intron	PMS2:ENST00000265849.12:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron7/10:c.804-4153A>G::,PMS2:ENST00000441476.6:missense_variant:MODERATE:exon10/14:c.1303A>G:p.Lys435Glu:,PMS2:ENST00000642292.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000642456.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000644110.1:missense_variant:MODERATE:exon8/12:c.1303A>G:p.Lys435Glu:	PMS2:NM_000535.7:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:NM_001322003.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322004.2:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322005.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322006.2:missense_variant:MODERATE:exon10/14:c.1465A>G:p.Lys489Glu:,PMS2:NM_001322007.2:missense_variant:MODERATE:exon10/14:c.1303A>G:p.Lys435Glu:,PMS2:NM_001322008.2:missense_variant:MODERATE:exon9/13:c.1303A>G:p.Lys435Glu:,PMS2:NM_001322009.2:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:NM_001322010.2:missense_variant:MODERATE:exon9/13:c.1060A>G:p.Lys354Glu:,PMS2:NM_001322011.2:missense_variant:MODERATE:exon11/15:c.688A>G:p.Lys230Glu:,PMS2:NM_001322012.2:missense_variant:MODERATE:exon11/15:c.688A>G:p.Lys230Glu:,PMS2:NM_001322013.2:missense_variant:MODERATE:exon10/14:c.1048A>G:p.Lys350Glu:,PMS2:NM_001322014.2:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:NM_001322015.2:missense_variant:MODERATE:exon11/15:c.1312A>G:p.Lys438Glu:,PMS2:NR_136154.1:non_coding_transcript_exon_variant:MODIFIER:exon11/15:n.1708A>G::,PMS2:XM_006715744.4:missense_variant:MODERATE:exon4/8:c.688A>G:p.Lys230Glu:,PMS2:XM_017012342.2:missense_variant:MODERATE:exon10/14:c.688A>G:p.Lys230Glu:,PMS2:XM_024446800.1:missense_variant:MODERATE:exon10/14:c.1060A>G:p.Lys354Glu:		600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	135065 [benign DISEASE=Hereditary nonpolyposis colorectal cancer type 4,Hereditary nonpolyposis colorectal neoplasms,not specified];			rs2228006		0.8654	57124,.	0.9247,0.6690,0.9212,0.8498,0.8953	1.5020	T(1.00), ,T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00), ,B(0.00),B(0.00),B(0.00),B(0.00)	5.90	0.16			COSV56223170	0.0514	0.8612	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5997349	5997349	G	C	hom		QUAL=748;DP=24;AF=1.00;MQM=60;SAP=3;ABP=0	PMS2	synonymous	PMS2:ENST00000265849.12:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000382321.5:synonymous_variant:LOW:exon7/11:c.780C>G:p.Ser260=:,PMS2:ENST00000441476.6:synonymous_variant:LOW:exon6/14:c.462C>G:p.Ser154=:,PMS2:ENST00000642292.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000642456.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000644110.1:synonymous_variant:LOW:exon4/12:c.462C>G:p.Ser154=:	PMS2:NM_000535.7:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:NM_001322003.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322004.2:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:NM_001322005.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322006.2:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:NM_001322007.2:synonymous_variant:LOW:exon6/14:c.462C>G:p.Ser154=:,PMS2:NM_001322008.2:synonymous_variant:LOW:exon5/13:c.462C>G:p.Ser154=:,PMS2:NM_001322009.2:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:NM_001322010.2:synonymous_variant:LOW:exon6/13:c.375C>G:p.Ser125=:,PMS2:NM_001322011.2:5_prime_UTR_variant:MODIFIER:exon7/15:c.-154C>G::,PMS2:NM_001322012.2:5_prime_UTR_variant:MODIFIER:exon7/15:c.-154C>G::,PMS2:NM_001322013.2:synonymous_variant:LOW:exon6/14:c.207C>G:p.Ser69=:,PMS2:NM_001322014.2:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:NM_001322015.2:synonymous_variant:LOW:exon7/15:c.471C>G:p.Ser157=:,PMS2:NR_136154.1:non_coding_transcript_exon_variant:MODIFIER:exon7/15:n.867C>G::,PMS2:XM_017012342.2:5_prime_UTR_variant:MODIFIER:exon7/14:c.-54C>G::,PMS2:XM_024446800.1:synonymous_variant:LOW:exon7/14:c.375C>G:p.Ser125=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	36693 [benign DISEASE=Endometrial carcinoma,Lynch syndrome,Hereditary nonpolyposis colorectal cancer type 4,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,none provided];			rs1805319		0.8169	50590,.	0.8425,0.6511,0.9207,0.8166,0.8173	-2.2610			0.03				COSV56223185	0.1633	0.368	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5997426	5997426	-	A	het		QUAL=230;DP=27;AF=0.44;MQM=60;SAP=6;ABP=4	PMS2	splice_region&intron	PMS2:ENST00000265849.12:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000382321.5:splice_region_variant&intron_variant:LOW:intron6/10:c.706-4dup::,PMS2:ENST00000441476.6:splice_region_variant&intron_variant:LOW:intron5/13:c.388-4dup::,PMS2:ENST00000642292.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000642456.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000644110.1:splice_region_variant&intron_variant:LOW:intron3/11:c.388-4dup::	PMS2:NM_000535.7:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:NM_001322003.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322004.2:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:NM_001322005.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322006.2:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:NM_001322007.2:splice_region_variant&intron_variant:LOW:intron5/13:c.388-4dup::,PMS2:NM_001322008.2:splice_region_variant&intron_variant:LOW:intron4/12:c.388-4dup::,PMS2:NM_001322009.2:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:NM_001322010.2:splice_region_variant&intron_variant:LOW:intron5/12:c.301-4dup::,PMS2:NM_001322011.2:splice_region_variant&intron_variant:LOW:intron6/14:c.-228-4dup::,PMS2:NM_001322012.2:splice_region_variant&intron_variant:LOW:intron6/14:c.-228-4dup::,PMS2:NM_001322013.2:splice_region_variant&intron_variant:LOW:intron5/13:c.133-4dup::,PMS2:NM_001322014.2:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:NM_001322015.2:splice_region_variant&intron_variant:LOW:intron6/14:c.397-4dup::,PMS2:NR_136154.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron6/14:n.793-4dup::,PMS2:XM_017012342.2:splice_region_variant&intron_variant:LOW:intron6/13:c.-128-4dup::,PMS2:XM_024446800.1:splice_region_variant&intron_variant:LOW:intron6/13:c.301-4dup::	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	600259_[GENE=PMS2_PHENOS=Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	198429 [benign(replaced by megSAP based on classifications:6x1,2x2,1x3) DISEASE=Lynch syndrome,Lynch syndrome I,Hereditary nonpolyposis colorectal cancer type 4,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified];			rs60794673		0.1014	655,.	0.0783,0.0866,0.0270,0.0766,0.0460				3.73					-0.0729	0.2591	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	129203328	129203328	C	T	hom	off-target	QUAL=315;DP=12;AF=1.00;MQM=60;SAP=29;ABP=0	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron1/11:c.332-56C>T::	SMO:NM_005631.5:intron_variant:MODIFIER:intron1/11:c.332-56C>T::,SMO:XM_024446891.1:intron_variant:MODIFIER:intron1/11:c.-59-56C>T::		601500_[GENE=SMO_PHENOS=Curry-Jones syndrome, somatic mosaic, 601707 (3); Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3)]				rs2566871	0.4615	0.4919	18493,.		-1.2520			0.59				COSV50824292	0.0735	0.0753	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205177	129205177	C	T	hom	off-target	QUAL=6757;DP=205;AF=1.00;MQM=60;SAP=24;ABP=0	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron2/11:c.538-26C>T::	SMO:NM_005631.5:intron_variant:MODIFIER:intron2/11:c.538-26C>T::,SMO:XM_024446891.1:intron_variant:MODIFIER:intron2/11:c.148-26C>T::		601500_[GENE=SMO_PHENOS=Curry-Jones syndrome, somatic mosaic, 601707 (3); Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3)]				rs2703091		0.7965	47256,.	0.6834,0.7157,0.7553,0.8411,0.7655	0.0620			4.15				COSV99976307	-0.0077	0.4554	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205436	129205436	G	C	hom	off-target	QUAL=1590;DP=55;AF=1.00;MQM=60;SAP=83;ABP=0	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron3/11:c.747+24G>C::	SMO:NM_005631.5:intron_variant:MODIFIER:intron3/11:c.747+24G>C::,SMO:XM_024446891.1:intron_variant:MODIFIER:intron3/11:c.357+24G>C::		601500_[GENE=SMO_PHENOS=Curry-Jones syndrome, somatic mosaic, 601707 (3); Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3)]				rs2075777		0.7966	47291,.	0.6836,0.7166,0.7563,0.8417,0.7633	-0.0750			1.81					-0.1939	0.5852	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206487	129206487	G	C	hom		QUAL=28443;DP=908;AF=1.00;MQM=60;SAP=3;ABP=0	SMO	synonymous	SMO:ENST00000249373.8:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:PF01534 [Frizzled/Smoothened family membrane region]	SMO:NM_005631.5:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:,SMO:XM_024446891.1:synonymous_variant:LOW:exon6/12:c.774G>C:p.Gly258=:		601500_[GENE=SMO_PHENOS=Curry-Jones syndrome, somatic mosaic, 601707 (3); Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3)]	403462 [benign DISEASE=not specified];			rs2228617		0.7981	47468,.	0.6878,0.7170,0.7677,0.8413,0.7658	1.1650			10.22				COSV50829466	0.0729	0.0701	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206628	129206628	A	G	hom	off-target	QUAL=27683;DP=857;AF=1.00;MQM=60;SAP=3;ABP=0	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron6/11:c.1264+41A>G::	SMO:NM_005631.5:intron_variant:MODIFIER:intron6/11:c.1264+41A>G::,SMO:XM_024446891.1:intron_variant:MODIFIER:intron6/11:c.874+41A>G::		601500_[GENE=SMO_PHENOS=Curry-Jones syndrome, somatic mosaic, 601707 (3); Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3)]				rs2735842	0.7532	0.7969	47388,.	0.6878,0.7171,0.7558,0.8411,0.7659	0.2220			6.39				COSV50829472	-0.0436	0.0692	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	142749434	142749434	G	C	het	off-target	QUAL=185;DP=191;AF=0.20;MQM=44;SAP=77;ABP=153	PRSS1	upstream_gene	PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000619214.4:upstream_gene_variant:MODIFIER::::	PRSS1:XM_011516411.1:missense_variant:MODERATE:exon3/7:c.625G>C:p.Val209Leu:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs764706324		0.3949	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	-0.4660			1.58								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749435	142749435	T	A	het	off-target	QUAL=185;DP=191;AF=0.20;MQM=44;SAP=77;ABP=153	PRSS1	upstream_gene	PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000619214.4:upstream_gene_variant:MODIFIER::::	PRSS1:XM_011516411.1:missense_variant:MODERATE:exon3/7:c.626T>A:p.Val209Glu:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs780768878		0.3942	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	-0.6810			0.90								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749439	142749439	G	C	het	off-target	QUAL=185;DP=191;AF=0.20;MQM=44;SAP=77;ABP=153	PRSS1	upstream_gene	PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000619214.4:upstream_gene_variant:MODIFIER::::	PRSS1:XM_011516411.1:missense_variant:MODERATE:exon3/7:c.630G>C:p.Arg210Ser:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs372312254		0.3931	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	0.0310			1.44								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749450	142749450	A	G	het	off-target	QUAL=201;DP=191;AF=0.20;MQM=44;SAP=77;ABP=153	PRSS1	upstream_gene	PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000619214.4:upstream_gene_variant:MODIFIER::::	PRSS1:XM_011516411.1:missense_variant:MODERATE:exon3/7:c.641A>G:p.Glu214Gly:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs972712999		0.3860	0,.		-0.3940			0.53								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749452	142749452	T	C	het	off-target	QUAL=201;DP=191;AF=0.20;MQM=44;SAP=77;ABP=153	PRSS1	upstream_gene	PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000619214.4:upstream_gene_variant:MODIFIER::::	PRSS1:XM_011516411.1:missense_variant:MODERATE:exon3/7:c.643T>C:p.Ser215Pro:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1387019363		0.3857	0,.		-0.6900			0.90								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749454	142749454	C	T	het	off-target	QUAL=201;DP=191;AF=0.20;MQM=44;SAP=77;ABP=153	PRSS1	upstream_gene	PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000619214.4:upstream_gene_variant:MODIFIER::::	PRSS1:XM_011516411.1:synonymous_variant:LOW:exon3/7:c.645C>T:p.Ser215=:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1431962420		0.3835	0,.		-0.1290			1.95								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749466	142749466	T	A	het	off-target	QUAL=109;DP=214;AF=0.18;MQM=44;SAP=79;ABP=191	PRSS1	upstream_gene	PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000619214.4:upstream_gene_variant:MODIFIER::::	PRSS1:XM_011516411.1:missense_variant:MODERATE:exon3/7:c.657T>A:p.Ser219Arg:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1170526371		0.3791	0,.		-2.0710			0.15								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749472	142749472	A	G	het	off-target	QUAL=111;DP=214;AF=0.18;MQM=44;SAP=79;ABP=191	PRSS1	5'UTR	PRSS1:ENST00000311737.12:5_prime_UTR_variant:MODIFIER:exon1/5:c.-13A>G::,PRSS1:ENST00000486171.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-13A>G::,PRSS1:ENST00000619214.4:5_prime_UTR_variant:MODIFIER:exon1/6:c.-13A>G::	PRSS1:NM_002769.5:5_prime_UTR_variant:MODIFIER:exon1/5:c.-13A>G::,PRSS1:XM_011516411.1:synonymous_variant:LOW:exon3/7:c.663A>G:p.Ala221=:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs748424130		0.3681	0,.		1.0320			6.54								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749506	142749506	A	G	het		QUAL=233;DP=187;AF=0.20;MQM=44;SAP=77;ABP=146	PRSS1	missense	PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon1/5:c.22A>G:p.Thr8Ala:,PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon1/6:c.22A>G:p.Thr8Ala:,PRSS1:ENST00000619214.4:missense_variant:MODERATE:exon1/6:c.22A>G:p.Thr8Ala:	PRSS1:NM_002769.5:missense_variant:MODERATE:exon1/5:c.22A>G:p.Thr8Ala:,PRSS1:XM_011516411.1:missense_variant:MODERATE:exon3/7:c.697A>G:p.Thr233Ala:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs749856663		0.3297	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	1.2940	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.03	0.24			COSV100298375				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749516	142749516	C	G	het		QUAL=204;DP=192;AF=0.20;MQM=44;SAP=77;ABP=155	PRSS1	missense	PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon1/5:c.32C>G:p.Ala11Gly:,PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon1/6:c.32C>G:p.Ala11Gly:,PRSS1:ENST00000619214.4:missense_variant:MODERATE:exon1/6:c.32C>G:p.Ala11Gly:	PRSS1:NM_002769.5:missense_variant:MODERATE:exon1/5:c.32C>G:p.Ala11Gly:,PRSS1:XM_011516411.1:missense_variant:MODERATE:exon3/7:c.707C>G:p.Ala236Gly:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs748442280		0.3390	0,.		2.7440	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	7.26	0.26							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749524	142749524	C	G	het		QUAL=230;DP=165;AF=0.22;MQM=44;SAP=83;ABP=112	PRSS1	missense&splice_region	PRSS1:ENST00000311737.12:missense_variant&splice_region_variant:MODERATE:exon1/5:c.40C>G:p.Leu14Val:,PRSS1:ENST00000486171.5:missense_variant&splice_region_variant:MODERATE:exon1/6:c.40C>G:p.Leu14Val:,PRSS1:ENST00000619214.4:missense_variant&splice_region_variant:MODERATE:exon1/6:c.40C>G:p.Leu14Val:	PRSS1:NM_002769.5:missense_variant&splice_region_variant:MODERATE:exon1/5:c.40C>G:p.Leu14Val:,PRSS1:XM_011516411.1:missense_variant&splice_region_variant:MODERATE:exon3/7:c.715C>G:p.Leu239Val:	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	939930 [uncertain significance DISEASE=Hereditary pancreatitis];			rs747228052		0.3493	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	2.0030	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	6.17	0.22	8.41>10.10	0.000/0.172		2.2081	0.018	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749531	142749531	A	T	het		QUAL=215;DP=166;AF=0.22;MQM=44;SAP=83;ABP=114	PRSS1	splice_region&intron	PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron1/4:c.40+7A>T::,PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron1/5:c.40+7A>T::,PRSS1:ENST00000619214.4:splice_region_variant&intron_variant:LOW:intron1/5:c.40+7A>T::	PRSS1:NM_002769.5:splice_region_variant&intron_variant:LOW:intron1/4:c.40+7A>T::,PRSS1:XM_011516411.1:splice_region_variant&intron_variant:LOW:intron3/6:c.715+7A>T::	regulatory_region_variant:open_chromatin_region	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796173487		0.3543	0,.		-1.9840			0.04			0.001/0.084		-0.9211	0.8002	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752462	142752462	T	C	het		QUAL=4335;DP=189;AF=0.87;MQM=60;SAP=13;ABP=225	PRSS1	synonymous	PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:PF00089 [Trypsin],PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.528T>C:p.Asp176=:PF00089 [Trypsin],PRSS1:ENST00000619214.4:synonymous_variant:LOW:exon5/6:c.456T>C:p.Asp152=:PF00089 [Trypsin]	PRSS1:NM_002769.5:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:,PRSS1:XM_011516411.1:synonymous_variant:LOW:exon6/7:c.1161T>C:p.Asp387=:		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	239391 [benign/likely benign DISEASE=Hereditary pancreatitis,Inborn genetic diseases,not specified];			rs6666	0.3966	0.4273	1829,.	0.3600,0.4294,0.2078,0.4259,0.2607	-3.8310			0.17				COSV61190814	0.0154	0.5151	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752561	142752561	A	C	het		QUAL=101;DP=326;AF=0.15;MQM=50;SAP=3;ABP=343	PRSS1	synonymous	PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.585A>C:p.Ser195=:PF00089 [Trypsin],PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.627A>C:p.Ser209=:PF00089 [Trypsin],PRSS1:ENST00000619214.4:synonymous_variant:LOW:exon5/6:c.555A>C:p.Ser185=:PF00089 [Trypsin]	PRSS1:NM_002769.5:synonymous_variant:LOW:exon4/5:c.585A>C:p.Ser195=:,PRSS1:XM_011516411.1:synonymous_variant:LOW:exon6/7:c.1260A>C:p.Ser420=:		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	826012 [benign DISEASE=Inborn genetic diseases];			rs758274784		0.3985	0,.	0.1469,0.0597,0.0380,0.1750,0.0684	0.0750			10.23				COSV61192546	0.4949	0.5203	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752564	142752564	T	C	het		QUAL=101;DP=326;AF=0.15;MQM=50;SAP=3;ABP=343	PRSS1	synonymous	PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.588T>C:p.Cys196=:PF00089 [Trypsin],PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.630T>C:p.Cys210=:PF00089 [Trypsin],PRSS1:ENST00000619214.4:synonymous_variant:LOW:exon5/6:c.558T>C:p.Cys186=:PF00089 [Trypsin]	PRSS1:NM_002769.5:synonymous_variant:LOW:exon4/5:c.588T>C:p.Cys196=:,PRSS1:XM_011516411.1:synonymous_variant:LOW:exon6/7:c.1263T>C:p.Cys421=:		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	826034 [benign DISEASE=Inborn genetic diseases];			rs751264273		0.3993	0,.	0.1443,0.0588,0.0353,0.1706,0.0693	2.0850			12.49				COSV61192554	0.3801	0.3042	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752574	142752574	T	A	het		QUAL=90;DP=324;AF=0.15;MQM=50;SAP=3;ABP=345	PRSS1	splice_region&intron	PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.591+7T>A::,PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.633+7T>A::,PRSS1:ENST00000619214.4:splice_region_variant&intron_variant:LOW:intron5/5:c.561+7T>A::	PRSS1:NM_002769.5:splice_region_variant&intron_variant:LOW:intron4/4:c.591+7T>A::,PRSS1:XM_011516411.1:splice_region_variant&intron_variant:LOW:intron6/6:c.1266+7T>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1437923103		0.4016	0,.		-2.2470			0.22			0.000/0.024					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752596	142752596	G	T	het	off-target	QUAL=801;DP=189;AF=0.26;MQM=50;SAP=3;ABP=94	PRSS1	intron	PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+29G>T::,PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+29G>T::,PRSS1:ENST00000619214.4:intron_variant:MODIFIER:intron5/5:c.561+29G>T::	PRSS1:NM_002769.5:intron_variant:MODIFIER:intron4/4:c.591+29G>T::,PRSS1:XM_011516411.1:intron_variant:MODIFIER:intron6/6:c.1266+29G>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1194632115		0.4030	0,.		-2.3330			0.58								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752598	142752598	C	T	het	off-target	QUAL=801;DP=189;AF=0.26;MQM=50;SAP=3;ABP=94	PRSS1	intron	PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+31C>T::,PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+31C>T::,PRSS1:ENST00000619214.4:intron_variant:MODIFIER:intron5/5:c.561+31C>T::	PRSS1:NM_002769.5:intron_variant:MODIFIER:intron4/4:c.591+31C>T::,PRSS1:XM_011516411.1:intron_variant:MODIFIER:intron6/6:c.1266+31C>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1287891250		0.4030	0,.		0.0720			0.27								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752612	142752612	T	C	het	off-target	QUAL=395;DP=45;AF=0.56;MQM=40;SAP=57;ABP=4	PRSS1	intron	PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+45T>C::,PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+45T>C::,PRSS1:ENST00000619214.4:intron_variant:MODIFIER:intron5/5:c.561+45T>C::	PRSS1:NM_002769.5:intron_variant:MODIFIER:intron4/4:c.591+45T>C::,PRSS1:XM_011516411.1:intron_variant:MODIFIER:intron6/6:c.1266+45T>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs751484562		0.4027	0,.	0.2911,0.2520,0.2306,0.3608,0.3036	-1.0110			6.36				COSV61192569	-0.1249	0.5158	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752616	142752616	C	A	het	off-target	QUAL=395;DP=45;AF=0.56;MQM=40;SAP=57;ABP=4	PRSS1	intron	PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.591+49C>A::,PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.633+49C>A::,PRSS1:ENST00000619214.4:intron_variant:MODIFIER:intron5/5:c.561+49C>A::	PRSS1:NM_002769.5:intron_variant:MODIFIER:intron4/4:c.591+49C>A::,PRSS1:XM_011516411.1:intron_variant:MODIFIER:intron6/6:c.1266+49C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1277061180		0.4025	0,.		-0.6130			0.97				COSV100298220				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752812	142752812	A	C	het	off-target	QUAL=1404;DP=146;AF=0.41;MQM=60;SAP=3;ABP=13	PRSS1	intron	PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-56A>C::,PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-56A>C::,PRSS1:ENST00000619214.4:intron_variant:MODIFIER:intron5/5:c.562-56A>C::	PRSS1:NM_002769.5:intron_variant:MODIFIER:intron4/4:c.592-56A>C::,PRSS1:XM_011516411.1:intron_variant:MODIFIER:intron6/6:c.1267-56A>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs571822942		0.4186	0,.		-1.0180			0.85					0.0255	0.9199	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752844	142752844	C	A	het	off-target	QUAL=127;DP=410;AF=0.15;MQM=60;SAP=3;ABP=448	PRSS1	intron	PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-24C>A::,PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-24C>A::,PRSS1:ENST00000619214.4:intron_variant:MODIFIER:intron5/5:c.562-24C>A::	PRSS1:NM_002769.5:intron_variant:MODIFIER:intron4/4:c.592-24C>A::,PRSS1:XM_011516411.1:intron_variant:MODIFIER:intron6/6:c.1267-24C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs192452846		0.4130	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	-0.8660			1.78				COSV104411417				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752861	142752861	C	A	het		QUAL=108;DP=410;AF=0.15;MQM=60;SAP=3;ABP=448	PRSS1	splice_region&intron	PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-7C>A::,PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-7C>A::,PRSS1:ENST00000619214.4:splice_region_variant&intron_variant:LOW:intron5/5:c.562-7C>A::	PRSS1:NM_002769.5:splice_region_variant&intron_variant:LOW:intron4/4:c.592-7C>A::,PRSS1:XM_011516411.1:splice_region_variant&intron_variant:LOW:intron6/6:c.1267-7C>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1443925968		0.4090	0,.	0.0000,0.0000,0.0000,0.0000,0.0000	-1.6010			0.05		11.40>8.71	0.000/0.072					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752862	142752862	C	T	het		QUAL=108;DP=410;AF=0.15;MQM=60;SAP=3;ABP=448	PRSS1	splice_region&intron	PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-6C>T::,PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-6C>T::,PRSS1:ENST00000619214.4:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::	PRSS1:NM_002769.5:splice_region_variant&intron_variant:LOW:intron4/4:c.592-6C>T::,PRSS1:XM_011516411.1:splice_region_variant&intron_variant:LOW:intron6/6:c.1267-6C>T::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1345716315		0.4084	0,.	0.0000,0.0000,0.0000,0.0000,0.0000	-0.5380			1.24		11.40>9.68	0.000/0.004					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752863	142752863	C	G	het		QUAL=108;DP=410;AF=0.15;MQM=60;SAP=3;ABP=448	PRSS1	splice_region&intron	PRSS1:ENST00000311737.12:splice_region_variant&intron_variant:LOW:intron4/4:c.592-5C>G::,PRSS1:ENST00000486171.5:splice_region_variant&intron_variant:LOW:intron5/5:c.634-5C>G::,PRSS1:ENST00000619214.4:splice_region_variant&intron_variant:LOW:intron5/5:c.562-5C>G::	PRSS1:NM_002769.5:splice_region_variant&intron_variant:LOW:intron4/4:c.592-5C>G::,PRSS1:XM_011516411.1:splice_region_variant&intron_variant:LOW:intron6/6:c.1267-5C>G::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1220665540		0.4078	0,.	0.0000,0.0000,0.0000,0.0000,0.0000	-0.8100			0.37		11.40>9.70	0.000/0.030					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142753014	142753014	T	C	hom		QUAL=10156;DP=357;AF=1.00;MQM=60;SAP=411;ABP=0	PRSS1	synonymous	PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:,PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon6/6:c.780T>C:p.Asn260=:,PRSS1:ENST00000619214.4:synonymous_variant:LOW:exon6/6:c.708T>C:p.Asn236=:	PRSS1:NM_002769.5:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:,PRSS1:XM_011516411.1:synonymous_variant:LOW:exon7/7:c.1413T>C:p.Asn471=:		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	258803 [benign/likely benign DISEASE=Hereditary pancreatitis,Inborn genetic diseases,not specified];			rs6667	0.3938	0.5271	21011,.	0.4323,0.5609,0.2287,0.5783,0.3051	0.2440			2.45				COSV61193305	0.354	0.9275	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr8	89943396	89943396	T	A	het	off-target	QUAL=411;DP=31;AF=0.55;MQM=60;SAP=18;ABP=4	NBN	intron	NBN:ENST00000265433.8:intron_variant:MODIFIER:intron13/15:c.2071-30A>T::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron13/15:c.1825-30A>T::	NBN:NM_001024688.3:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:NM_002485.5:intron_variant:MODIFIER:intron13/15:c.2071-30A>T::,NBN:XM_011517045.1:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:XM_017013460.1:intron_variant:MODIFIER:intron15/17:c.1192-30A>T::,NBN:XM_017013462.2:intron_variant:MODIFIER:intron13/15:c.1192-30A>T::,NBN:XM_024447163.1:intron_variant:MODIFIER:intron13/15:c.1825-30A>T::,NBN:XM_024447164.1:intron_variant:MODIFIER:intron12/14:c.1825-30A>T::,NBN:XM_024447165.1:intron_variant:MODIFIER:intron14/16:c.1192-30A>T::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive; Aplastic anemia, 609135 (3)]	258769 [benign DISEASE=not specified];			rs3736639	0.3792	0.3539	8507,.	0.3207,0.3539,0.4561,0.3254,0.4290	-0.7230			0.74				COSV55378350	0.0416	0.927	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89946194	89946194	T	C	het		QUAL=584;DP=47;AF=0.55;MQM=60;SAP=11;ABP=4	NBN	synonymous	NBN:ENST00000265433.8:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:,NBN:ENST00000409330.5:synonymous_variant:LOW:exon13/16:c.1770A>G:p.Pro590=:	NBN:NM_001024688.3:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:NM_002485.5:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:,NBN:XM_011517045.1:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:XM_017013460.1:synonymous_variant:LOW:exon15/18:c.1137A>G:p.Pro379=:,NBN:XM_017013462.2:synonymous_variant:LOW:exon13/16:c.1137A>G:p.Pro379=:,NBN:XM_024447163.1:synonymous_variant:LOW:exon13/16:c.1770A>G:p.Pro590=:,NBN:XM_024447164.1:synonymous_variant:LOW:exon12/15:c.1770A>G:p.Pro590=:,NBN:XM_024447165.1:synonymous_variant:LOW:exon14/17:c.1137A>G:p.Pro379=:	regulatory_region_variant:CTCF_binding_site	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive; Aplastic anemia, 609135 (3)]	183696 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified];			rs1061302	0.3528	0.3467	7452,.	0.2298,0.3492,0.4561,0.3250,0.4285	-2.5830			0.68				COSV55371426	0.066	0.2521	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89946302	89946302	T	C	het		QUAL=380;DP=35;AF=0.46;MQM=60;SAP=12;ABP=4	NBN	splice_region&intron	NBN:ENST00000265433.8:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::,NBN:ENST00000409330.5:splice_region_variant&intron_variant:LOW:intron12/15:c.1669-7A>G::	NBN:NM_001024688.3:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:NM_002485.5:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::,NBN:XM_011517045.1:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:XM_017013460.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1036-7A>G::,NBN:XM_017013462.2:splice_region_variant&intron_variant:LOW:intron12/15:c.1036-7A>G::,NBN:XM_024447163.1:splice_region_variant&intron_variant:LOW:intron12/15:c.1669-7A>G::,NBN:XM_024447164.1:splice_region_variant&intron_variant:LOW:intron11/14:c.1669-7A>G::,NBN:XM_024447165.1:splice_region_variant&intron_variant:LOW:intron13/16:c.1036-7A>G::	regulatory_region_variant:CTCF_binding_site	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive; Aplastic anemia, 609135 (3)]	258768 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified];			rs2308962	0.3790	0.3535	8448,.	0.3186,0.3539,0.4561,0.3253,0.4278	-1.9330			0.03		3.91>3.28	0.000/0.036	COSV55371846	0.0539	0.222	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89955483	89955483	A	G	het		QUAL=349;DP=37;AF=0.43;MQM=60;SAP=4;ABP=4	NBN	synonymous	NBN:ENST00000265433.8:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:,NBN:ENST00000409330.5:synonymous_variant:LOW:exon10/16:c.951T>C:p.Asp317=:	NBN:NM_001024688.3:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:NM_002485.5:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:,NBN:XM_011517045.1:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:XM_011517046.1:synonymous_variant:LOW:exon10/11:c.1197T>C:p.Asp399=:,NBN:XM_017013460.1:synonymous_variant:LOW:exon12/18:c.318T>C:p.Asp106=:,NBN:XM_017013462.2:synonymous_variant:LOW:exon10/16:c.318T>C:p.Asp106=:,NBN:XM_024447163.1:synonymous_variant:LOW:exon10/16:c.951T>C:p.Asp317=:,NBN:XM_024447164.1:synonymous_variant:LOW:exon9/15:c.951T>C:p.Asp317=:,NBN:XM_024447165.1:synonymous_variant:LOW:exon11/17:c.318T>C:p.Asp106=:		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive; Aplastic anemia, 609135 (3)]	183701 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,none provided];			rs709816		0.5089	21973,.	0.7781,0.5773,0.6480,0.3625,0.5115	-0.0610			1.13				COSV55371961	0.0447	0.2201	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89958707	89958707	G	A	het	off-target	QUAL=463;DP=48;AF=0.42;MQM=60;SAP=19;ABP=6	NBN	intron	NBN:ENST00000265433.8:intron_variant:MODIFIER:intron9/15:c.1124+18C>T::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron9/15:c.878+18C>T::	NBN:NM_001024688.3:intron_variant:MODIFIER:intron10/16:c.878+18C>T::,NBN:NM_002485.5:intron_variant:MODIFIER:intron9/15:c.1124+18C>T::,NBN:XM_011517045.1:intron_variant:MODIFIER:intron10/16:c.878+18C>T::,NBN:XM_011517046.1:intron_variant:MODIFIER:intron9/10:c.1124+18C>T::,NBN:XM_017013460.1:intron_variant:MODIFIER:intron11/17:c.245+18C>T::,NBN:XM_017013462.2:intron_variant:MODIFIER:intron9/15:c.245+18C>T::,NBN:XM_024447163.1:intron_variant:MODIFIER:intron9/15:c.878+18C>T::,NBN:XM_024447164.1:intron_variant:MODIFIER:intron8/14:c.878+18C>T::,NBN:XM_024447165.1:intron_variant:MODIFIER:intron10/16:c.245+18C>T::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive; Aplastic anemia, 609135 (3)]	199080 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs2234744	0.3530	0.3465	7468,.	0.2297,0.3489,0.4559,0.3250,0.4279	-0.3950			0.75				COSV55373621	0.0455	0.3193	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89978251	89978251	C	G	het		QUAL=10738;DP=828;AF=0.50;MQM=60;SAP=3;ABP=3	NBN	missense	NBN:ENST00000265433.8:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:,NBN:ENST00000409330.5:missense_variant:MODERATE:exon5/16:c.307G>C:p.Glu103Gln:	NBN:NM_001024688.3:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:NM_002485.5:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:,NBN:XM_011517045.1:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:XM_011517046.1:missense_variant:MODERATE:exon5/11:c.553G>C:p.Glu185Gln:,NBN:XM_017013460.1:5_prime_UTR_variant:MODIFIER:exon7/18:c.-327G>C::,NBN:XM_017013462.2:intron_variant:MODIFIER:intron5/15:c.-296+2483G>C::,NBN:XM_024447163.1:missense_variant:MODERATE:exon5/16:c.307G>C:p.Glu103Gln:,NBN:XM_024447164.1:missense_variant:MODERATE:exon4/15:c.307G>C:p.Glu103Gln:,NBN:XM_024447165.1:5_prime_UTR_variant:MODIFIER:exon6/17:c.-327G>C::	regulatory_region_variant:promoter	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive; Aplastic anemia, 609135 (3)]	134876 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified,none provided];	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN];		rs1805794	0.3570	0.3470	7536,.	0.2363,0.3494,0.4562,0.3246,0.4281	2.2150	T(1.00),T(1.00)	B(0.00),B(0.00)	14.16	0.10			COSV55371261,COSV55372457,COSV55375647	0.001	0.4491	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89982791	89982791	C	T	het		QUAL=99;DP=19;AF=0.37;MQM=60;SAP=18;ABP=6	NBN	synonymous,5'UTR	NBN:ENST00000265433.8:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000409330.5:5_prime_UTR_variant:MODIFIER:exon2/16:c.-145G>A::	NBN:NM_001024688.3:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:NM_002485.5:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:,NBN:XM_011517045.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:XM_011517046.1:synonymous_variant:LOW:exon2/11:c.102G>A:p.Leu34=:,NBN:XM_017013460.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-918G>A::,NBN:XM_017013462.2:5_prime_UTR_variant:MODIFIER:exon2/16:c.-724G>A::,NBN:XM_024447163.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-145G>A::,NBN:XM_024447165.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-868G>A::	regulatory_region_variant:promoter	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive; Aplastic anemia, 609135 (3)]	183697 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,not specified];			rs1063045	0.3792	0.3535	8469,.	0.3184,0.3540,0.4563,0.3253,0.4283	-0.1370			5.51				COSV55371979	-0.2882	0.9483	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	106224052	106224052	G	T	hom		QUAL=20602;DP=650;AF=1.00;MQM=60;SAP=4;ABP=0		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393978	0.6096	0.5621	26584,.		-0.5960			0.86								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	5921881	5921881	G	A	het		QUAL=15232;DP=1060;AF=0.54;MQM=60;SAP=5;ABP=15	KIAA2026	missense	KIAA2026:ENST00000381461.6:missense_variant:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile:,KIAA2026:ENST00000399933.8:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:	KIAA2026:NM_001017969.3:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:,KIAA2026:XM_005251385.3:missense_variant:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile:,KIAA2026:XM_011517759.3:missense_variant:MODERATE:exon8/10:c.4115C>T:p.Thr1372Ile:,KIAA2026:XM_011517760.3:missense_variant:MODERATE:exon8/10:c.4115C>T:p.Thr1372Ile:,KIAA2026:XM_011517761.2:missense_variant:MODERATE:exon5/5:c.1640C>T:p.Thr547Ile:,KIAA2026:XM_017014331.2:missense_variant:MODERATE:exon8/9:c.4115C>T:p.Thr1372Ile:,KIAA2026:XM_017014332.1:missense_variant:MODERATE:exon4/4:c.1640C>T:p.Thr547Ile:,KIAA2026:XM_017014333.1:missense_variant:MODERATE:exon5/5:c.1640C>T:p.Thr547Ile:,KIAA2026:XM_017014334.1:missense_variant:MODERATE:exon4/4:c.1640C>T:p.Thr547Ile:,KIAA2026:XM_017014335.2:intron_variant:MODIFIER:intron6/7:c.2514-11174C>T::,KIAA2026:XM_017014336.2:intron_variant:MODIFIER:intron6/6:c.2514-7819C>T::,KIAA2026:XM_024447429.1:missense_variant:MODERATE:exon7/7:c.1757C>T:p.Thr586Ile:,KIAA2026:XR_001746198.2:non_coding_transcript_exon_variant:MODIFIER:exon8/10:n.4816C>T::,KIAA2026:XR_001746199.2:non_coding_transcript_exon_variant:MODIFIER:exon8/11:n.4816C>T::,KIAA2026:XR_001746200.2:non_coding_transcript_exon_variant:MODIFIER:exon8/10:n.4816C>T::,KIAA2026:XR_001746201.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/10:n.4092+724C>T::,KIAA2026:XR_001746202.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/10:n.4092+724C>T::,KIAA2026:XR_001746203.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.3387+2777C>T::,KIAA2026:XR_001746204.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.3216-11174C>T::,KIAA2026:XR_001746205.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/8:n.3216-7819C>T::,KIAA2026:XR_001746206.2:non_coding_transcript_exon_variant:MODIFIER:exon9/9:n.4948C>T::,KIAA2026:XR_929192.3:non_coding_transcript_exon_variant:MODIFIER:exon8/16:n.4816C>T::,KIAA2026:XR_929193.3:non_coding_transcript_exon_variant:MODIFIER:exon8/15:n.4816C>T::,KIAA2026:XR_929197.3:non_coding_transcript_exon_variant:MODIFIER:exon8/12:n.4816C>T::						rs72697396	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0001	2.5130	D(0.02),D(0.02)	B(0.08),B(0.08)	14.15	0.03				-0.0005	0.9431	0	0	3	0 / 1					KIAA2026 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	17235645	17235645	T	-	het	off-target	QUAL=521;DP=40;AF=0.60;MQM=60;SAP=16;ABP=6	CNTLN	intron	CNTLN:ENST00000380641.4:intron_variant:MODIFIER:intron3/6:c.535-7del::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron3/25:c.535-7del::	CNTLN:NM_001114395.3:intron_variant:MODIFIER:intron3/6:c.535-7del::,CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron3/25:c.535-7del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron3/25:c.535-7del::,CNTLN:XM_006716793.4:intron_variant:MODIFIER:intron3/25:c.346-7del::,CNTLN:XM_011517941.2:intron_variant:MODIFIER:intron3/19:c.535-7del::,CNTLN:XM_017014839.1:intron_variant:MODIFIER:intron3/26:c.535-7del::,CNTLN:XM_017014840.2:intron_variant:MODIFIER:intron3/25:c.535-7del::,CNTLN:XM_017014841.1:intron_variant:MODIFIER:intron3/24:c.535-7del::,CNTLN:XM_017014842.1:intron_variant:MODIFIER:intron3/18:c.535-7del::,CNTLN:XM_017014843.1:intron_variant:MODIFIER:intron3/18:c.535-7del::,CNTLN:XM_024447583.1:intron_variant:MODIFIER:intron3/23:c.535-7del::,CNTLN:XR_929282.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/19:n.610-7del::						rs67017076		0.8172	51837,.	0.9558,0.9055,0.9998,0.7338,0.9304	1.4780			7.52					-0.8629	0.9043	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273880	17273880	A	G	het		QUAL=1145;DP=64;AF=0.72;MQM=60;SAP=4;ABP=30	CNTLN	intron	CNTLN:ENST00000380641.4:intron_variant:MODIFIER:intron6/6:c.983+14A>G::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron6/25:c.983+14A>G::	CNTLN:NM_001114395.3:intron_variant:MODIFIER:intron6/6:c.983+14A>G::,CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron6/25:c.983+14A>G::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron6/25:c.983+14A>G::,CNTLN:XM_006716793.4:intron_variant:MODIFIER:intron6/25:c.794+14A>G::,CNTLN:XM_011517941.2:intron_variant:MODIFIER:intron6/19:c.983+14A>G::,CNTLN:XM_017014839.1:intron_variant:MODIFIER:intron6/26:c.983+14A>G::,CNTLN:XM_017014840.2:intron_variant:MODIFIER:intron6/25:c.983+14A>G::,CNTLN:XM_017014841.1:intron_variant:MODIFIER:intron6/24:c.983+14A>G::,CNTLN:XM_017014842.1:intron_variant:MODIFIER:intron6/18:c.983+14A>G::,CNTLN:XM_017014843.1:intron_variant:MODIFIER:intron6/18:c.983+14A>G::,CNTLN:XM_024447583.1:intron_variant:MODIFIER:intron6/23:c.983+14A>G::,CNTLN:XR_929282.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/19:n.1058+14A>G::						rs12376938	0.2258	0.2498	4464,.	0.1713,0.1941,0.0717,0.2631,0.3574	-1.4110			0.27					-0.1456	0.7194	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273928	17273928	C	G	het	off-target	QUAL=173;DP=16;AF=0.50;MQM=60;SAP=3;ABP=3	CNTLN	intron	CNTLN:ENST00000380641.4:intron_variant:MODIFIER:intron6/6:c.983+62C>G::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron6/25:c.983+62C>G::	CNTLN:NM_001114395.3:intron_variant:MODIFIER:intron6/6:c.983+62C>G::,CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron6/25:c.983+62C>G::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron6/25:c.983+62C>G::,CNTLN:XM_006716793.4:intron_variant:MODIFIER:intron6/25:c.794+62C>G::,CNTLN:XM_011517941.2:intron_variant:MODIFIER:intron6/19:c.983+62C>G::,CNTLN:XM_017014839.1:intron_variant:MODIFIER:intron6/26:c.983+62C>G::,CNTLN:XM_017014840.2:intron_variant:MODIFIER:intron6/25:c.983+62C>G::,CNTLN:XM_017014841.1:intron_variant:MODIFIER:intron6/24:c.983+62C>G::,CNTLN:XM_017014842.1:intron_variant:MODIFIER:intron6/18:c.983+62C>G::,CNTLN:XM_017014843.1:intron_variant:MODIFIER:intron6/18:c.983+62C>G::,CNTLN:XM_024447583.1:intron_variant:MODIFIER:intron6/23:c.983+62C>G::,CNTLN:XR_929282.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/19:n.1058+62C>G::						rs12379655	0.3343	0.2936	6598,.		-2.0210			0.13				COSV52090650,COSV52097738	-0.0598	0.915	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17342385	17342385	C	T	hom		QUAL=983;DP=30;AF=1.00;MQM=60;SAP=13;ABP=0	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:XM_006716793.4:synonymous_variant:LOW:exon12/26:c.1638C>T:p.Asp546=:,CNTLN:XM_011517941.2:synonymous_variant:LOW:exon12/20:c.1827C>T:p.Asp609=:,CNTLN:XM_017014839.1:synonymous_variant:LOW:exon12/27:c.1827C>T:p.Asp609=:,CNTLN:XM_017014840.2:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:,CNTLN:XM_017014841.1:synonymous_variant:LOW:exon11/25:c.1632C>T:p.Asp544=:,CNTLN:XM_017014842.1:synonymous_variant:LOW:exon12/19:c.1827C>T:p.Asp609=:,CNTLN:XM_017014843.1:synonymous_variant:LOW:exon12/19:c.1827C>T:p.Asp609=:,CNTLN:XM_017014844.1:synonymous_variant:LOW:exon5/19:c.447C>T:p.Asp149=:,CNTLN:XM_017014845.2:synonymous_variant:LOW:exon3/17:c.126C>T:p.Asp42=:,CNTLN:XM_017014846.1:5_prime_UTR_variant:MODIFIER:exon1/14:c.-128C>T::,CNTLN:XM_024447583.1:synonymous_variant:LOW:exon12/24:c.1827C>T:p.Asp609=:,CNTLN:XR_929282.2:non_coding_transcript_exon_variant:MODIFIER:exon12/20:n.1902C>T::						rs1442527	0.9495	0.9887	69900,.	0.8435,0.9919,1.0000,0.9995,0.9998	2.1420			4.88					-0.0475	0.3743	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394538	17394538	C	T	hom		QUAL=1783;DP=56;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	missense	CNTLN:ENST00000380647.8:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:	CNTLN:NM_001365029.1:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:NM_017738.4:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:XM_006716793.4:missense_variant:MODERATE:exon15/26:c.1895C>T:p.Thr632Ile:,CNTLN:XM_011517941.2:missense_variant:MODERATE:exon15/20:c.2084C>T:p.Thr695Ile:,CNTLN:XM_017014839.1:missense_variant:MODERATE:exon15/27:c.2084C>T:p.Thr695Ile:,CNTLN:XM_017014840.2:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:,CNTLN:XM_017014841.1:missense_variant:MODERATE:exon14/25:c.1889C>T:p.Thr630Ile:,CNTLN:XM_017014842.1:missense_variant:MODERATE:exon15/19:c.2084C>T:p.Thr695Ile:,CNTLN:XM_017014843.1:missense_variant:MODERATE:exon15/19:c.2084C>T:p.Thr695Ile:,CNTLN:XM_017014844.1:missense_variant:MODERATE:exon8/19:c.704C>T:p.Thr235Ile:,CNTLN:XM_017014845.2:missense_variant:MODERATE:exon6/17:c.383C>T:p.Thr128Ile:,CNTLN:XM_017014846.1:missense_variant:MODERATE:exon3/14:c.29C>T:p.Thr10Ile:,CNTLN:XM_017014847.2:missense_variant:MODERATE:exon3/14:c.29C>T:p.Thr10Ile:,CNTLN:XM_024447583.1:missense_variant:MODERATE:exon15/24:c.2084C>T:p.Thr695Ile:,CNTLN:XR_929282.2:non_coding_transcript_exon_variant:MODIFIER:exon15/20:n.2159C>T::	regulatory_region_variant:promoter_flanking_region					rs7035276		0.8300	51286,.	0.6917,0.7734,0.8094,0.8725,0.7405	0.3660	T(0.27)	B(0.00)	14.49	0.06			COSV52066811	-0.0335	0.0775	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394998	17394998	T	C	hom		QUAL=3143;DP=98;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:XM_006716793.4:synonymous_variant:LOW:exon15/26:c.2355T>C:p.His785=:,CNTLN:XM_011517941.2:synonymous_variant:LOW:exon15/20:c.2544T>C:p.His848=:,CNTLN:XM_017014839.1:synonymous_variant:LOW:exon15/27:c.2544T>C:p.His848=:,CNTLN:XM_017014840.2:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:,CNTLN:XM_017014841.1:synonymous_variant:LOW:exon14/25:c.2349T>C:p.His783=:,CNTLN:XM_017014842.1:synonymous_variant:LOW:exon15/19:c.2544T>C:p.His848=:,CNTLN:XM_017014843.1:synonymous_variant:LOW:exon15/19:c.2544T>C:p.His848=:,CNTLN:XM_017014844.1:synonymous_variant:LOW:exon8/19:c.1164T>C:p.His388=:,CNTLN:XM_017014845.2:synonymous_variant:LOW:exon6/17:c.843T>C:p.His281=:,CNTLN:XM_017014846.1:synonymous_variant:LOW:exon3/14:c.489T>C:p.His163=:,CNTLN:XM_017014847.2:synonymous_variant:LOW:exon3/14:c.489T>C:p.His163=:,CNTLN:XM_024447583.1:synonymous_variant:LOW:exon15/24:c.2544T>C:p.His848=:,CNTLN:XR_929282.2:non_coding_transcript_exon_variant:MODIFIER:exon15/20:n.2619T>C::	regulatory_region_variant:promoter_flanking_region					rs3739489		0.8779	57902,.	0.7731,0.7920,0.8121,0.9165,0.8706	0.5350			6.62					0.0187	0.0783	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17395110	17395110	C	T	hom	off-target	QUAL=6825;DP=215;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::,CNTLN:XM_006716793.4:intron_variant:MODIFIER:intron15/25:c.2426+41C>T::,CNTLN:XM_011517941.2:intron_variant:MODIFIER:intron15/19:c.2615+41C>T::,CNTLN:XM_017014839.1:intron_variant:MODIFIER:intron15/26:c.2615+41C>T::,CNTLN:XM_017014840.2:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::,CNTLN:XM_017014841.1:intron_variant:MODIFIER:intron14/24:c.2420+41C>T::,CNTLN:XM_017014842.1:intron_variant:MODIFIER:intron15/18:c.2615+41C>T::,CNTLN:XM_017014843.1:intron_variant:MODIFIER:intron15/18:c.2615+41C>T::,CNTLN:XM_017014844.1:intron_variant:MODIFIER:intron8/18:c.1235+41C>T::,CNTLN:XM_017014845.2:intron_variant:MODIFIER:intron6/16:c.914+41C>T::,CNTLN:XM_017014846.1:intron_variant:MODIFIER:intron3/13:c.560+41C>T::,CNTLN:XM_017014847.2:intron_variant:MODIFIER:intron3/13:c.560+41C>T::,CNTLN:XM_024447583.1:intron_variant:MODIFIER:intron15/23:c.2615+41C>T::,CNTLN:XR_929282.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/19:n.2690+41C>T::	regulatory_region_variant:promoter_flanking_region					rs3739488	0.7819	0.8306	51336,.	0.6973,0.7766,0.8106,0.8739,0.7485	3.8150			16.14					0.1713	0.0775	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409368	17409368	G	A	hom		QUAL=12154;DP=384;AF=1.00;MQM=60;SAP=3;ABP=0	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:	CNTLN:NM_001365029.1:synonymous_variant:LOW:exon16/26:c.2688G>A:p.Thr896=:,CNTLN:NM_017738.4:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:,CNTLN:XM_006716793.4:synonymous_variant:LOW:exon16/26:c.2502G>A:p.Thr834=:,CNTLN:XM_011517941.2:synonymous_variant:LOW:exon16/20:c.2691G>A:p.Thr897=:,CNTLN:XM_017014839.1:synonymous_variant:LOW:exon16/27:c.2691G>A:p.Thr897=:,CNTLN:XM_017014840.2:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:,CNTLN:XM_017014841.1:synonymous_variant:LOW:exon15/25:c.2496G>A:p.Thr832=:,CNTLN:XM_017014842.1:synonymous_variant:LOW:exon16/19:c.2691G>A:p.Thr897=:,CNTLN:XM_017014843.1:synonymous_variant:LOW:exon16/19:c.2691G>A:p.Thr897=:,CNTLN:XM_017014844.1:synonymous_variant:LOW:exon9/19:c.1311G>A:p.Thr437=:,CNTLN:XM_017014845.2:synonymous_variant:LOW:exon7/17:c.990G>A:p.Thr330=:,CNTLN:XM_017014846.1:synonymous_variant:LOW:exon4/14:c.636G>A:p.Thr212=:,CNTLN:XM_017014847.2:synonymous_variant:LOW:exon4/14:c.636G>A:p.Thr212=:,CNTLN:XM_024447583.1:synonymous_variant:LOW:exon16/24:c.2691G>A:p.Thr897=:,CNTLN:XR_929282.2:non_coding_transcript_exon_variant:MODIFIER:exon16/20:n.2766G>A::						rs2780211		0.8730	57514,.	0.7732,0.7924,0.8113,0.9133,0.8500	0.6420			5.75				COSV52096895	-0.1125	0.3485	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457515	17457515	A	-	hom	low_conf_region	QUAL=104;DP=4;AF=1.00;MQM=60;SAP=12;ABP=0	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron18/25:c.3115-2del::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron18/25:c.3112-2del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron18/25:c.3115-2del::,CNTLN:XM_006716793.4:intron_variant:MODIFIER:intron18/25:c.2926-2del::,CNTLN:XM_011517941.2:intron_variant:MODIFIER:intron19/19:c.*-2del::,CNTLN:XM_017014839.1:intron_variant:MODIFIER:intron18/26:c.3115-2del::,CNTLN:XM_017014840.2:intron_variant:MODIFIER:intron18/25:c.3115-2del::,CNTLN:XM_017014841.1:intron_variant:MODIFIER:intron17/24:c.2920-2del::,CNTLN:XM_017014844.1:intron_variant:MODIFIER:intron11/18:c.1735-2del::,CNTLN:XM_017014845.2:intron_variant:MODIFIER:intron9/16:c.1414-2del::,CNTLN:XM_017014846.1:intron_variant:MODIFIER:intron6/13:c.1060-2del::,CNTLN:XM_017014847.2:intron_variant:MODIFIER:intron6/13:c.1060-2del::,CNTLN:XM_024447583.1:intron_variant:MODIFIER:intron18/23:c.3115-2del::,CNTLN:XR_929282.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron19/19:n.3392-2del::					(TATATT)n (Simple_repeat)	rs35399020		0.8540	49329,.	0.5934,0.7533,0.6981,0.9105,0.7931	0.1530			0.54				COSV52086669	-0.0709	0.3299	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494877	17494877	T	-	het	off-target;low_conf_region	QUAL=222;DP=30;AF=0.20;MQM=60;SAP=9;ABP=26	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4120-7653del::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron25/25:c.4117-7653del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron25/25:c.4120-7653del::,CNTLN:XM_006716793.4:intron_variant:MODIFIER:intron25/25:c.3931-7653del::,CNTLN:XM_017014839.1:intron_variant:MODIFIER:intron25/26:c.4120-9del::,CNTLN:XM_017014840.2:intron_variant:MODIFIER:intron25/25:c.4119+7832del::,CNTLN:XM_017014841.1:intron_variant:MODIFIER:intron24/24:c.3925-7653del::,CNTLN:XM_017014844.1:intron_variant:MODIFIER:intron18/18:c.2740-7653del::,CNTLN:XM_017014845.2:intron_variant:MODIFIER:intron16/16:c.2419-7653del::,CNTLN:XM_017014846.1:intron_variant:MODIFIER:intron13/13:c.2065-7653del::,CNTLN:XM_017014847.2:intron_variant:MODIFIER:intron13/13:c.2065-7653del::					Tigger3b (DNA/TcMar-Tigger), AluSx (SINE/Alu)	rs35224903		0.6010	8274,.	0.2348,0.2082,0.2046,0.0996,0.0997	0.1770			0.52					-0.1407	0.917	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494877	17494879	TTT	-	het	off-target;low_conf_region	QUAL=222;DP=30;AF=0.17;MQM=60;SAP=14;ABP=32	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4120-7655_4120-7653del::	CNTLN:NM_001365029.1:intron_variant:MODIFIER:intron25/25:c.4117-7655_4117-7653del::,CNTLN:NM_017738.4:intron_variant:MODIFIER:intron25/25:c.4120-7655_4120-7653del::,CNTLN:XM_006716793.4:intron_variant:MODIFIER:intron25/25:c.3931-7655_3931-7653del::,CNTLN:XM_017014839.1:intron_variant:MODIFIER:intron25/26:c.4120-11_4120-9del::,CNTLN:XM_017014840.2:intron_variant:MODIFIER:intron25/25:c.4119+7830_4119+7832del::,CNTLN:XM_017014841.1:intron_variant:MODIFIER:intron24/24:c.3925-7655_3925-7653del::,CNTLN:XM_017014844.1:intron_variant:MODIFIER:intron18/18:c.2740-7655_2740-7653del::,CNTLN:XM_017014845.2:intron_variant:MODIFIER:intron16/16:c.2419-7655_2419-7653del::,CNTLN:XM_017014846.1:intron_variant:MODIFIER:intron13/13:c.2065-7655_2065-7653del::,CNTLN:XM_017014847.2:intron_variant:MODIFIER:intron13/13:c.2065-7655_2065-7653del::					Tigger3b (DNA/TcMar-Tigger), AluSx (SINE/Alu)	rs35224903		0.0485	0,.	0.0642,0.0742,0.0702,0.0441,0.0279	0.1770			0.61					-0.0355	0.8661	0.04	6	292	0 / 5					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	21971138	21971138	T	G	het		QUAL=264;DP=53;AF=0.45;MQM=60;SAP=55;ABP=4	CDKN2A,	missense,intron&NMD_transcript,synonymous	CDKN2A:ENST00000304494.10:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,:ENST00000404796.3:intron_variant&NMD_transcript_variant:MODIFIER:intron4/4:c.348-58295T>G::,CDKN2A:ENST00000479692.2:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000494262.5:missense_variant:MODERATE:exon3/4:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000497750.1:missense_variant:MODERATE:exon2/2:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000498124.1:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000498628.6:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000530628.2:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:ENST00000578845.2:missense_variant:MODERATE:exon1/2:c.68A>C:p.Asp23Ala:,CDKN2A:ENST00000579122.1:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:ENST00000579755.2:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:	CDKN2A:NM_000077.5:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:NM_001195132.2:missense_variant:MODERATE:exon2/4:c.221A>C:p.Asp74Ala:,CDKN2A:NM_001363763.2:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:NM_058195.4:synonymous_variant:LOW:exon2/3:c.264A>C:p.Arg88=:,CDKN2A:NM_058197.5:3_prime_UTR_variant:MODIFIER:exon2/3:c.*144A>C::,CDKN2A:XM_005251343.1:missense_variant:MODERATE:exon2/3:c.68A>C:p.Asp23Ala:,CDKN2A:XM_011517675.2:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:XM_011517676.2:missense_variant:MODERATE:exon2/3:c.221A>C:p.Asp74Ala:,CDKN2A:XR_929159.2:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.551A>C::		600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]	802463 [uncertain significance DISEASE=Melanoma-pancreatic cancer syndrome];	CM165602 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=CDKN2A];		rs200429615		0.0013	0,.	0.0007,0.0005,0.0000,0.0019,0.0007	7.4100	D(0.00), ,D(0.00),D(0.00),D(0.00),D(0.00),D(0.00), ,D(0.00),D(0.00), 	D(1.00), ,D(1.00),D(1.00),D(1.00),D(1.00),D(1.00), ,D(1.00),P(0.87), 	32.00	0.88			COSV104609655,COSV58684939,COSV58689077	-0.0702	0.8399	0.01	0	0	0 / 0					CDKN2A-DT (inh=n/a oe_syn=0.99 oe_mis=0.75 oe_lof=n/a), CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21974672	21974672	A	C	het		QUAL=122;DP=20;AF=0.70;MQM=60;SAP=33;ABP=10	CDKN2A,	splice_region&intron,intron&NMD_transcript,intron	CDKN2A:ENST00000304494.10:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,:ENST00000404796.3:intron_variant&NMD_transcript_variant:MODIFIER:intron4/4:c.348-54761A>C::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3464T>G::,CDKN2A:ENST00000498124.1:splice_region_variant&intron_variant:LOW:intron1/3:c.150+6T>G::,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3464T>G::,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::,CDKN2A:ENST00000579122.1:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::	CDKN2A:NM_000077.5:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:NM_001195132.2:splice_region_variant&intron_variant:LOW:intron1/3:c.150+6T>G::,CDKN2A:NM_001363763.2:intron_variant:MODIFIER:intron1/2:c.-3-3464T>G::,CDKN2A:NM_058195.4:intron_variant:MODIFIER:intron1/2:c.194-3464T>G::,CDKN2A:NM_058197.5:synonymous_variant:LOW:exon1/3:c.156T>G:p.Gly52=:,CDKN2A:XM_011517675.2:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:XM_011517676.2:splice_region_variant&intron_variant:LOW:intron1/2:c.150+6T>G::,CDKN2A:XR_929159.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron1/3:n.480+6T>G::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]									0.6550			10.22		8.56>6.92			-1.2625	0.9626	0.11	0	0	0 / 0					CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	21974676	21974676	A	C	het		QUAL=122;DP=20;AF=0.70;MQM=60;SAP=33;ABP=10	CDKN2A,	splice_donor,intron&NMD_transcript,intron	CDKN2A:ENST00000304494.10:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,:ENST00000404796.3:intron_variant&NMD_transcript_variant:MODIFIER:intron4/4:c.348-54757A>C::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3468T>G::,CDKN2A:ENST00000498124.1:splice_donor_variant:HIGH:intron1/3:c.150+2T>G::,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3468T>G::,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::,CDKN2A:ENST00000579122.1:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::	CDKN2A:NM_000077.5:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,CDKN2A:NM_001195132.2:splice_donor_variant:HIGH:intron1/3:c.150+2T>G::,CDKN2A:NM_001363763.2:intron_variant:MODIFIER:intron1/2:c.-3-3468T>G::,CDKN2A:NM_058195.4:intron_variant:MODIFIER:intron1/2:c.194-3468T>G::,CDKN2A:NM_058197.5:missense_variant:MODERATE:exon1/3:c.152T>G:p.Val51Gly:,CDKN2A:XM_011517675.2:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,CDKN2A:XM_011517676.2:splice_donor_variant:HIGH:intron1/2:c.150+2T>G::,CDKN2A:XR_929159.2:splice_donor_variant&non_coding_transcript_variant:HIGH:intron1/3:n.480+2T>G::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]									5.5950			32.00		8.56>0.92		COSV58686447,COSV58697953	-3.7329	1.0	0.99	0	0	0 / 0					CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	35074920	35074920	T	C	hom		QUAL=3127;DP=99;AF=1.00;MQM=60;SAP=6;ABP=0	FANCG	splice_region&intron	FANCG:ENST00000378643.8:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::	FANCG:NM_004629.2:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::		601023_[GENE=VCP_PHENOS=Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3)]&602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3)]	259477 [benign DISEASE=Fanconi anemia, complementation group G,Fanconi anemia,not specified,Amyotrophic Lateral Sclerosis, Dominant,Inclusion Body Myopathy, Dominant];			rs587118	0.2202	0.4017	12180,.	0.0803,0.5007,0.0032,0.4999,0.2614	0.4790			11.30			0.000/0.002	COSV62719986	-0.673	0.6888	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=n/a oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	35077444	35077444	T	C	hom	off-target	QUAL=6869;DP=207;AF=1.00;MQM=60;SAP=3;ABP=0	FANCG	intron	FANCG:ENST00000378643.8:intron_variant:MODIFIER:intron4/13:c.511-45A>G::	FANCG:NM_004629.2:intron_variant:MODIFIER:intron4/13:c.511-45A>G::		601023_[GENE=VCP_PHENOS=Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3)]&602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3)]	259478 [benign DISEASE=not specified];			rs554098		0.7527	43310,.	0.7437,0.8445,0.4522,0.7779,0.7088	-1.4080			0.43				COSV62719498	0.165	0.5972	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=n/a oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	87447908	87447908	A	G	hom		QUAL=14935;DP=527;AF=1.00;MQM=60;SAP=740;ABP=0		upstream_gene	:ENST00000669921.1:upstream_gene_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs12682834	0.6368	0.6507	27499,.	0.4721,0.6890,0.6846,0.6292,0.7402	-0.5610			0.49								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	95447312	95447312	G	A	het		QUAL=1180;DP=71;AF=0.66;MQM=60;SAP=4;ABP=19	PTCH1	missense	PTCH1:ENST00000331920.11:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:ENST00000429896.6:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000430669.6:missense_variant:MODERATE:exon23/23:c.3746C>T:p.Pro1249Leu:,PTCH1:ENST00000437951.6:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:	PTCH1:NM_000264.5:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:NM_001083602.3:missense_variant:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu:,PTCH1:NM_001083603.3:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:,PTCH1:NM_001083604.3:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083605.3:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083606.3:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001083607.3:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:,PTCH1:NM_001354918.2:missense_variant:MODERATE:exon22/23:c.3788C>T:p.Pro1263Leu:,PTCH1:NR_149061.2:non_coding_transcript_exon_variant:MODIFIER:exon23/24:n.4683C>T::	regulatory_region_variant:promoter_flanking_region	601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Holoprosencephaly 7, 610828 (3), Autosomal dominant]	41663 [benign DISEASE=Gorlin syndrome,Holoprosencephaly 7,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];			rs357564	0.3968	0.3892	8752,.	0.2327,0.4872,0.5627,0.3388,0.4468	9.5400	D(0.01),D(0.01),D(0.01),D(0.01)	B(0.44),B(0.44),P(0.65),P(0.71)	24.70	0.44			COSV59463357	0.0236	0.9089	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95469942	95469942	A	-	het		QUAL=546;DP=59;AF=0.54;MQM=60;SAP=72;ABP=4	PTCH1	intron	PTCH1:ENST00000331920.11:intron_variant:MODIFIER:intron12/23:c.1729-11del::,PTCH1:ENST00000429896.6:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:ENST00000430669.6:intron_variant:MODIFIER:intron12/22:c.1531-11del::,PTCH1:ENST00000437951.6:intron_variant:MODIFIER:intron12/23:c.1726-11del::	PTCH1:NM_000264.5:intron_variant:MODIFIER:intron12/23:c.1729-11del::,PTCH1:NM_001083602.3:intron_variant:MODIFIER:intron12/23:c.1531-11del::,PTCH1:NM_001083603.3:intron_variant:MODIFIER:intron12/23:c.1726-11del::,PTCH1:NM_001083604.3:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083605.3:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083606.3:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001083607.3:intron_variant:MODIFIER:intron12/23:c.1276-11del::,PTCH1:NM_001354918.2:intron_variant:MODIFIER:intron11/22:c.1573-11del::,LOC100507346:NR_038982.1:non_coding_transcript_exon_variant:MODIFIER:exon4/4:n.1887del::,PTCH1:NR_149061.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/23:n.2634-11del::		601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Holoprosencephaly 7, 610828 (3), Autosomal dominant]				rs779000277		0.0011	0,.	0.0001,0.0007,0.0000,0.0020,0.0000	0.9180			0.96				COSV59495096	-0.2837	0.3034	0.01	0	4	0 / 1					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95476908	95476908	G	C	hom	off-target	QUAL=1285;DP=42;AF=1.00;MQM=60;SAP=16;ABP=0	PTCH1	intron	PTCH1:ENST00000331920.11:intron_variant:MODIFIER:intron10/23:c.1504-51C>G::,PTCH1:ENST00000429896.6:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:ENST00000430669.6:intron_variant:MODIFIER:intron10/22:c.1306-51C>G::,PTCH1:ENST00000437951.6:intron_variant:MODIFIER:intron10/23:c.1501-51C>G::	PTCH1:NM_000264.5:intron_variant:MODIFIER:intron10/23:c.1504-51C>G::,PTCH1:NM_001083602.3:intron_variant:MODIFIER:intron10/23:c.1306-51C>G::,PTCH1:NM_001083603.3:intron_variant:MODIFIER:intron10/23:c.1501-51C>G::,PTCH1:NM_001083604.3:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:NM_001083605.3:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:NM_001083606.3:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:NM_001083607.3:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:NM_001354918.2:intron_variant:MODIFIER:intron9/22:c.1348-51C>G::,PTCH1:NR_149061.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/23:n.2409-51C>G::		601309_[GENE=PTCH1_PHENOS=Basal cell carcinoma, somatic, 605462 (3); Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Holoprosencephaly 7, 610828 (3), Autosomal dominant]				rs574688	0.1627	0.2280	3674,.	0.0485,0.2153,0.0600,0.2671,0.2760	0.2170			3.49				COSV100107392	0.0079	0.2941	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr10	43100520	43100520	A	G	hom		QUAL=16186;DP=520;AF=1.00;MQM=60;SAP=4;ABP=0	RET	synonymous	RET:ENST00000340058.6:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000355710.8:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000615310.5:synonymous_variant:LOW:exon2/17:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1]	RET:NM_020630.6:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:,RET:NM_020975.6:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:		164761_[GENE=RET_PHENOS=Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant; {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant]	167589 [benign DISEASE=Multiple endocrine neoplasia, type 2,not specified];			rs1800858		0.7850	47871,.	0.9530,0.7589,0.5513,0.7401,0.7290	-2.1930			0.35				COSV60686024	0.0061	0.2502	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43116778	43116778	C	T	het	off-target	QUAL=2397;DP=316;AF=0.46;MQM=60;SAP=213;ABP=8	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron12/18:c.2284+47C>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron12/19:c.2284+47C>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron10/16:c.1888+47C>T::	RET:NM_001355216.1:intron_variant:MODIFIER:intron9/15:c.1522+47C>T::,RET:NM_020630.6:intron_variant:MODIFIER:intron12/18:c.2284+47C>T::,RET:NM_020975.6:intron_variant:MODIFIER:intron12/19:c.2284+47C>T::		164761_[GENE=RET_PHENOS=Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant; {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant]	261396 [benign DISEASE=not specified];			rs760466	0.1206	0.2074	3405,.	0.0519,0.1823,0.0586,0.2781,0.1330	-0.9730			0.51				COSV60689537	0.02	0.1638	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43118395	43118395	G	T	hom		QUAL=37731;DP=1155;AF=1.00;MQM=60;SAP=3;ABP=0	RET	synonymous	RET:ENST00000340058.6:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000355710.8:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000615310.5:synonymous_variant:LOW:exon11/17:c.1911G>T:p.Leu637=:PF07714 [Protein tyrosine and serine/threonine kinase]	RET:NM_001355216.1:synonymous_variant:LOW:exon10/16:c.1545G>T:p.Leu515=:,RET:NM_020630.6:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:,RET:NM_020975.6:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:		164761_[GENE=RET_PHENOS=Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant; {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant]	167590 [benign DISEASE=Multiple endocrine neoplasia, type 2,not specified];			rs1800861		0.7846	47391,.	0.8846,0.7707,0.5057,0.7688,0.6426	1.2810			7.08				COSV60687116	0.0197	0.2444	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43120057	43120057	G	A	het	off-target	QUAL=9252;DP=734;AF=0.51;MQM=60;SAP=3;ABP=3	RET	intron	RET:ENST00000340058.6:intron_variant:MODIFIER:intron14/18:c.2608-24G>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron14/19:c.2608-24G>A::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron12/16:c.2212-24G>A::	RET:NM_001355216.1:intron_variant:MODIFIER:intron11/15:c.1846-24G>A::,RET:NM_020630.6:intron_variant:MODIFIER:intron14/18:c.2608-24G>A::,RET:NM_020975.6:intron_variant:MODIFIER:intron14/19:c.2608-24G>A::		164761_[GENE=RET_PHENOS=Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant; {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant]	24956 [benign DISEASE=not specified];	CS116395 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2472737	0.1731	0.2041	3272,.	0.1498,0.1531,0.2331,0.2261,0.1595	-0.3050			4.67				COSV60686346	-0.0813	0.2055	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43126769	43126769	T	C	hom	off-target	QUAL=1163;DP=42;AF=1.00;MQM=60;SAP=86;ABP=0	RET	3'UTR,intron	RET:ENST00000340058.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*15T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron19/19:c.3187+47T>C::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*15T>C::	RET:NM_001355216.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*15T>C::,RET:NM_020630.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*15T>C::,RET:NM_020975.6:intron_variant:MODIFIER:intron19/19:c.3187+47T>C::		164761_[GENE=RET_PHENOS=Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant; {Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant]	165056 [benign DISEASE=not specified];	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2075912	0.7550	0.8307	53013,.	0.9172,0.7973,0.5115,0.8266,0.7399	1.4280			13.49				COSV60689472	-0.0949	0.9359	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	86876022	86876022	C	A	het		QUAL=850;DP=71;AF=0.56;MQM=52;SAP=4;ABP=5	BMPR1A	missense	BMPR1A:ENST00000372037.8:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:	BMPR1A:NM_004329.3:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:,BMPR1A:XM_011540103.2:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:,BMPR1A:XM_011540104.2:missense_variant:MODERATE:exon4/14:c.4C>A:p.Pro2Thr:		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	41782 [benign DISEASE=Generalized juvenile polyposis/juvenile polyposis coli,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];			rs11528010	0.4998	0.4040	14968,.	0.6679,0.3900,0.7182,0.2583,0.3004	3.2000	T(1.00)	B(0.00)	11.73	0.21			COSV64406247,COSV64409048	0.0009	0.15	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86890006	86890006	C	T	het	off-target	QUAL=672;DP=53;AF=0.49;MQM=60;SAP=15;ABP=3	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron3/12:c.68-56C>T::	BMPR1A:NM_004329.3:intron_variant:MODIFIER:intron3/12:c.68-56C>T::,BMPR1A:XM_011540103.2:intron_variant:MODIFIER:intron3/12:c.68-56C>T::,BMPR1A:XM_011540104.2:intron_variant:MODIFIER:intron4/13:c.68-56C>T::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]				rs7087358	0.5312	0.4477	17435,.		-0.1980			2.09					0.0021	0.8051	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17), RNU1-19P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr10	86923365	86923365	T	C	het	off-target	QUAL=5533;DP=615;AF=0.44;MQM=60;SAP=431;ABP=22	BMPR1A	intron	BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron11/12:c.1343-11T>C::	BMPR1A:NM_004329.3:intron_variant:MODIFIER:intron11/12:c.1343-11T>C::,BMPR1A:XM_011540103.2:intron_variant:MODIFIER:intron11/12:c.1343-11T>C::,BMPR1A:XM_011540104.2:intron_variant:MODIFIER:intron12/13:c.1343-11T>C::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	259286 [benign DISEASE=Generalized juvenile polyposis/juvenile polyposis coli,Hereditary cancer-predisposing syndrome,not specified,none provided];			rs7074064	0.4966	0.4020	14879,.	0.6705,0.3665,0.7177,0.2576,0.3035	-0.2270			1.82		10.64>9.92	0.000/0.004		-0.3848	0.4603	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	87961150	87961150	T	G	het	off-target	QUAL=251;DP=29;AF=0.52;MQM=60;SAP=36;ABP=3	PTEN	intron	PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron8/8:c.1026+32T>G::	PTEN:NM_000314.8:intron_variant:MODIFIER:intron8/8:c.1026+32T>G::,PTEN:NM_001304717.5:intron_variant:MODIFIER:intron9/9:c.1545+32T>G::,PTEN:NM_001304718.2:intron_variant:MODIFIER:intron8/8:c.436+32T>G::	regulatory_region_variant:promoter_flanking_region	601728_[GENE=PTEN_PHENOS=Prostate cancer, somatic, 176807 (3); {Glioma susceptibility 2}, 613028 (3); Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos syndrome, 158350 (3), Autosomal dominant; Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant; {Meningioma}, 607174 (3), Autosomal dominant]	92810 [benign DISEASE=PTEN hamartoma tumor syndrome,not specified,none provided];	CS1815672 [CLASS=R MUT=ALT PHEN="Cowden disease" GENE=PTEN];		rs555895	0.4325	0.3994	12632,.	0.4981,0.4574,0.4887,0.3352,0.3088	-0.8500			0.60				COSV64292683	-0.0948	0.8421	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	102504350	102504350	C	T	hom		QUAL=9982;DP=411;AF=1.00;MQM=60;SAP=895;ABP=0	SUFU	intron	SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron1/10:c.182+16C>T::,SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron1/11:c.182+16C>T::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron1/9:c.182+16C>T::	SUFU:NM_001178133.2:intron_variant:MODIFIER:intron1/10:c.182+16C>T::,SUFU:NM_016169.4:intron_variant:MODIFIER:intron1/11:c.182+16C>T::,SUFU:XM_011539858.3:intron_variant:MODIFIER:intron1/12:c.182+16C>T::,SUFU:XM_011539860.3:intron_variant:MODIFIER:intron1/12:c.182+16C>T::,SUFU:XM_011539861.3:intron_variant:MODIFIER:intron1/11:c.182+16C>T::,SUFU:XM_011539863.3:intron_variant:MODIFIER:intron1/12:c.8+1364C>T::,SUFU:XM_011539864.3:intron_variant:MODIFIER:intron1/10:c.182+16C>T::	regulatory_region_variant:promoter	607035_[GENE=SUFU_PHENOS=Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Medulloblastoma, desmoplastic, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive]	260689 [benign DISEASE=not specified,not provided];			rs2274351	0.3962	0.4757	17115,.	0.3131,0.2994,0.3222,0.5481,0.4885	-0.1750			16.27				COSV64013811	0.0071	0.5444	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTR1A (inh=n/a oe_syn=0.79 oe_mis=0.44 oe_lof=0.13), SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102597065	102597065	A	G	hom	off-target	QUAL=2286;DP=74;AF=1.00;MQM=60;SAP=3;ABP=0	SUFU	intron	SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron6/10:c.757-75A>G::,SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron6/11:c.757-75A>G::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron6/9:c.757-75A>G::	SUFU:NM_001178133.2:intron_variant:MODIFIER:intron6/10:c.757-75A>G::,SUFU:NM_016169.4:intron_variant:MODIFIER:intron6/11:c.757-75A>G::,SUFU:XM_011539858.3:intron_variant:MODIFIER:intron6/12:c.757-72A>G::,SUFU:XM_011539860.3:intron_variant:MODIFIER:intron6/12:c.757-75A>G::,SUFU:XM_011539861.3:intron_variant:MODIFIER:intron6/11:c.757-72A>G::,SUFU:XM_011539863.3:intron_variant:MODIFIER:intron6/12:c.583-72A>G::,SUFU:XM_011539864.3:intron_variant:MODIFIER:intron6/10:c.757-72A>G::,SUFU:XM_017016323.1:intron_variant:MODIFIER:intron6/12:c.679-72A>G::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	607035_[GENE=SUFU_PHENOS=Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Medulloblastoma, desmoplastic, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive]				rs10786690		0.9927	74890,.		-0.0720			4.54				COSV100882930	-0.0219	0.4785	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102627262	102627262	T	C	het		QUAL=14824;DP=1197;AF=0.49;MQM=60;SAP=4;ABP=5	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron11/11:c.1365+19T>C::	SUFU:NM_016169.4:intron_variant:MODIFIER:intron11/11:c.1365+19T>C::,SUFU:XM_011539858.3:intron_variant:MODIFIER:intron12/12:c.1494+19T>C::,SUFU:XM_011539860.3:intron_variant:MODIFIER:intron12/12:c.1491+19T>C::,SUFU:XM_011539861.3:intron_variant:MODIFIER:intron11/11:c.1368+19T>C::,SUFU:XM_011539863.3:intron_variant:MODIFIER:intron12/12:c.1320+19T>C::,SUFU:XM_017016323.1:intron_variant:MODIFIER:intron12/12:c.1416+19T>C::		607035_[GENE=SUFU_PHENOS=Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Medulloblastoma, desmoplastic, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive]	260688 [benign DISEASE=not specified,not provided];			rs12414407	0.7196	0.6828	35723,.	0.7545,0.5777,0.7448,0.6474,0.7144	0.4520			7.22				COSV64017850	0.0498	0.4218	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102630175	102630175	T	G	hom		QUAL=59563;DP=1886;AF=1.00;MQM=60;SAP=4;ABP=0	SUFU	3'UTR	SUFU:ENST00000369902.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::	SUFU:NM_016169.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::,SUFU:XM_011539858.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*20T>G::,SUFU:XM_011539860.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*20T>G::,SUFU:XM_011539861.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::,SUFU:XM_011539863.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*20T>G::,SUFU:XM_017016323.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*20T>G::		607035_[GENE=SUFU_PHENOS=Basal cell nevus syndrome, 109400 (3), Autosomal dominant; Medulloblastoma, desmoplastic, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive]				rs4917980		0.9995	75835,.	0.9934,0.9994,1.0000,0.9999,1.0000	1.4220			16.48				COSV100883278	-0.0095	0.9153	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr11	13081343	13081343	C	A	het	off-target	QUAL=22540;DP=1762;AF=0.50;MQM=60;SAP=3;ABP=3		intron&non_coding_transcript	:ENST00000531136.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.48-26309G>T::	::intergenic_variant:MODIFIER::::						rs2727397	0.5050	0.5859	26759,.		0.0480			6.75								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	13081377	13081377	G	A	het		QUAL=297;DP=26;AF=0.54;MQM=60;SAP=19;ABP=3		intron&non_coding_transcript	:ENST00000531136.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.48-26343C>T::	::intergenic_variant:MODIFIER::::						rs2583136		0.5858	26761,.		-0.7750			0.63								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	64804546	64804546	T	C	hom		QUAL=8197;DP=256;AF=1.00;MQM=60;SAP=23;ABP=0	MEN1	missense	MEN1:ENST00000312049.11:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000315422.9:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000377313.6:missense_variant:MODERATE:exon9/9:c.1636A>G:p.Thr546Ala:,MEN1:ENST00000377316.6:missense_variant:MODERATE:exon8/8:c.1456A>G:p.Thr486Ala:,MEN1:ENST00000377321.5:missense_variant:MODERATE:exon10/10:c.1516A>G:p.Thr506Ala:,MEN1:ENST00000377326.7:missense_variant:MODERATE:exon9/9:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000450708.7:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000672304.1:missense_variant:MODERATE:exon11/11:c.1747A>G:p.Thr583Ala:	MEN1:NM_000244.3:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_001370251.1:synonymous_variant:LOW:exon11/11:c.1747A>G:p.Ala583=:,MEN1:NM_001370259.2:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:NM_001370260.1:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_001370261.1:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_001370262.1:synonymous_variant:LOW:exon10/10:c.1516A>G:p.Ala506=:,MEN1:NM_001370263.1:synonymous_variant:LOW:exon10/10:c.1516A>G:p.Ala506=:,MEN1:NM_130799.2:synonymous_variant:LOW:exon10/10:c.1621A>G:p.Ala541=:,MEN1:NM_130800.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130801.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130802.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130803.2:synonymous_variant:LOW:exon10/10:c.1636A>G:p.Ala546=:,MEN1:NM_130804.2:synonymous_variant:LOW:exon11/11:c.1636A>G:p.Ala546=:,MEN1:XM_011545040.1:missense_variant:MODERATE:exon11/11:c.1747A>G:p.Thr583Ala:,MEN1:XM_011545041.2:missense_variant:MODERATE:exon11/11:c.1747A>G:p.Thr583Ala:,MEN1:XM_017017765.1:missense_variant:MODERATE:exon11/11:c.1762A>G:p.Thr588Ala:,MEN1:XM_017017766.1:missense_variant:MODERATE:exon11/11:c.1762A>G:p.Thr588Ala:,MEN1:XM_017017767.2:missense_variant:MODERATE:exon11/11:c.1762A>G:p.Thr588Ala:,MEN1:XM_017017768.1:missense_variant:MODERATE:exon11/11:c.1762A>G:p.Thr588Ala:	regulatory_region_variant:CTCF_binding_site	613733_[GENE=MEN1_PHENOS=Angiofibroma, somatic (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3); Lipoma, somatic (3); Carcinoid tumor of lung (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant]	134640 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified];			rs2959656		0.9374	62559,.	0.7063,0.8813,0.6972,0.9960,0.9949	0.1390	T(0.77),T(0.77),T(0.76),T(0.76),T(0.75),T(0.77),T(0.77),T(0.77)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.02)	5.02	0.30			COSV53639974	0.038	0.9201	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64805085	64805085	A	G	hom		QUAL=6551;DP=203;AF=1.00;MQM=60;SAP=38;ABP=0	MEN1	synonymous,intron	MEN1:ENST00000312049.11:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000315422.9:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000377313.6:synonymous_variant:LOW:exon8/9:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000377316.6:intron_variant:MODIFIER:intron7/7:c.1186-269T>C::,MEN1:ENST00000377321.5:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:PF05053 [Menin],MEN1:ENST00000377326.7:synonymous_variant:LOW:exon8/9:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000450708.7:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000672304.1:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:PF05053 [Menin]	MEN1:NM_000244.3:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_001370251.1:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:,MEN1:NM_001370259.2:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370260.1:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370261.1:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_001370262.1:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:,MEN1:NM_001370263.1:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:,MEN1:NM_130799.2:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:,MEN1:NM_130800.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130801.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130802.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130803.2:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:,MEN1:NM_130804.2:synonymous_variant:LOW:exon10/11:c.1314T>C:p.His438=:,MEN1:XM_011545040.1:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:,MEN1:XM_011545041.2:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:,MEN1:XM_017017765.1:synonymous_variant:LOW:exon10/11:c.1440T>C:p.His480=:,MEN1:XM_017017766.1:synonymous_variant:LOW:exon10/11:c.1440T>C:p.His480=:,MEN1:XM_017017767.2:synonymous_variant:LOW:exon10/11:c.1440T>C:p.His480=:,MEN1:XM_017017768.1:synonymous_variant:LOW:exon10/11:c.1440T>C:p.His480=:	regulatory_region_variant:CTCF_binding_site	613733_[GENE=MEN1_PHENOS=Angiofibroma, somatic (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3); Lipoma, somatic (3); Carcinoid tumor of lung (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant]	167288 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified];			rs540012		0.9942	72884,.	0.9189,0.9969,0.9999,0.9999,0.9999	-0.3010			1.30					0.0916	0.1411	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=n/a oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64810148	64810148	G	C	het	off-target	QUAL=195;DP=33;AF=0.45;MQM=60;SAP=36;ABP=4	MEN1	intron,5'UTR	MEN1:ENST00000312049.11:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000315422.9:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000377316.6:5_prime_UTR_variant:MODIFIER:exon1/8:c.-39C>G::,MEN1:ENST00000377321.5:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000377326.7:5_prime_UTR_variant:MODIFIER:exon1/9:c.-39C>G::,MEN1:ENST00000450708.7:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:ENST00000672304.1:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::	MEN1:NM_000244.3:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370251.1:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::,MEN1:NM_001370259.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370260.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370261.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370262.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_001370263.1:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130799.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130800.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130801.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130802.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130803.2:intron_variant:MODIFIER:intron1/9:c.-23-16C>G::,MEN1:NM_130804.2:intron_variant:MODIFIER:intron2/10:c.-23-16C>G::,MEN1:XM_011545040.1:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::,MEN1:XM_011545041.2:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::,MEN1:XM_017017765.1:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::,MEN1:XM_017017766.1:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::,MEN1:XM_017017767.2:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::,MEN1:XM_017017768.1:intron_variant:MODIFIER:intron1/10:c.-23-16C>G::	regulatory_region_variant:promoter	613733_[GENE=MEN1_PHENOS=Angiofibroma, somatic (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3); Lipoma, somatic (3); Carcinoid tumor of lung (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant]	439889 [benign DISEASE=none provided];			rs509606	0.1749	0.1792	1531,.	0.1019,0.3013,0.2891,0.1070,0.1944	0.0940			5.60		11.39>10.32			-0.1285	0.8607	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	108229378	108229378	-	T	het	off-target	QUAL=408;DP=47;AF=0.45;MQM=60;SAP=6;ABP=4	ATM	intron,3'UTR	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron5/63:c.331+69dup::,ATM:ENST00000530958.5:intron_variant:MODIFIER:intron3/3:c.331+69dup::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:ENST00000682465.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*61dup::,ATM:ENST00000684029.1:intron_variant:MODIFIER:intron4/4:c.331+69dup::	ATM:NM_000051.4:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron5/63:c.331+69dup::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron5/63:c.331+69dup::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron4/61:c.331+69dup::,ATM:XM_011542843.2:intron_variant:MODIFIER:intron4/59:c.331+69dup::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron4/62:c.-692+69dup::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron5/63:c.331+69dup::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron4/62:c.331+69dup::,ATM:XM_017017791.1:intron_variant:MODIFIER:intron4/44:c.331+69dup::,ATM:XM_017017792.2:intron_variant:MODIFIER:intron4/35:c.331+69dup::,ATM:XR_002957150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/38:n.1064+69dup::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]				rs11390378		0.5008	18361,.	0.4275,0.4742,0.4678,0.4530,0.4781				0.98					-0.0122	0.3393	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108229378	108229378	-	TT	het	off-target	QUAL=408;DP=47;AF=0.19;MQM=60;SAP=9;ABP=42	ATM	intron,3'UTR	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron5/63:c.331+68_331+69dup::,ATM:ENST00000530958.5:intron_variant:MODIFIER:intron3/3:c.331+68_331+69dup::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron4/62:c.331+68_331+69dup::,ATM:ENST00000682465.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*60_*61dup::,ATM:ENST00000684029.1:intron_variant:MODIFIER:intron4/4:c.331+68_331+69dup::	ATM:NM_000051.4:intron_variant:MODIFIER:intron4/62:c.331+68_331+69dup::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron5/63:c.331+68_331+69dup::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron4/62:c.331+68_331+69dup::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron4/62:c.331+68_331+69dup::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron5/63:c.331+68_331+69dup::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron4/61:c.331+68_331+69dup::,ATM:XM_011542843.2:intron_variant:MODIFIER:intron4/59:c.331+68_331+69dup::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron4/62:c.-692+68_-692+69dup::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron5/63:c.331+68_331+69dup::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron4/62:c.331+68_331+69dup::,ATM:XM_017017791.1:intron_variant:MODIFIER:intron4/44:c.331+68_331+69dup::,ATM:XM_017017792.2:intron_variant:MODIFIER:intron4/35:c.331+68_331+69dup::,ATM:XR_002957150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/38:n.1064+68_1064+69dup::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]				rs11390378		0.1506	90,.	0.0684,0.1806,0.0881,0.1492,0.1866				0.96					-0.0258	0.3394	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108243935	108243935	T	-	het	off-target	QUAL=63;DP=137;AF=0.15;MQM=60;SAP=19;ABP=152	ATM	intron	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron6/63:c.497-4del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron5/62:c.497-4del::	ATM:NM_000051.4:intron_variant:MODIFIER:intron5/62:c.497-4del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron6/63:c.497-4del::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron5/62:c.497-4del::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron5/62:c.497-4del::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron6/63:c.497-4del::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron4/61:c.332-4del::,ATM:XM_011542843.2:intron_variant:MODIFIER:intron5/59:c.497-4del::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron5/62:c.-526-26del::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron6/63:c.497-4del::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron5/62:c.497-4del::,ATM:XM_017017791.1:intron_variant:MODIFIER:intron5/44:c.497-4del::,ATM:XM_017017792.2:intron_variant:MODIFIER:intron5/35:c.497-4del::,ATM:XR_002957150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/38:n.1230-4del::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]	183775 [likely benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs768748099		0.2789	0,.	0.2426,0.2590,0.2417,0.2865,0.3066	-0.2470			0.25					0.012	0.8643	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108248889	108248889	A	-	het	off-target	QUAL=11;DP=32;AF=0.16;MQM=60;SAP=3;ABP=36	ATM	intron	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron9/63:c.1066-31del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron8/62:c.1066-31del::	ATM:NM_000051.4:intron_variant:MODIFIER:intron8/62:c.1066-31del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron9/63:c.1066-31del::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron8/62:c.1066-31del::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron8/62:c.1066-31del::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron9/63:c.1066-31del::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron7/61:c.901-31del::,ATM:XM_011542843.2:intron_variant:MODIFIER:intron8/59:c.1066-31del::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron8/62:c.22-31del::,ATM:XM_011542845.2:intron_variant:MODIFIER:intron1/54:c.-74+1775del::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron9/63:c.1066-31del::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron8/62:c.1066-31del::,ATM:XM_017017791.1:intron_variant:MODIFIER:intron8/44:c.1066-31del::,ATM:XM_017017792.2:intron_variant:MODIFIER:intron8/35:c.1066-31del::,ATM:XR_002957150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/38:n.1799-31del::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]			AluSp (SINE/Alu)	rs35813860		0.3562	2,.	0.3045,0.3572,0.3687,0.3577,0.3752	1.8490			1.86					-0.0133	0.2301	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108258930	108258930	A	G	het	off-target	QUAL=38;DP=16;AF=0.25;MQM=60;SAP=3;ABP=12	ATM	intron	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::	ATM:NM_000051.4:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron14/61:c.2212-56A>G::,ATM:XM_011542843.2:intron_variant:MODIFIER:intron15/59:c.2377-56A>G::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron15/62:c.1333-56A>G::,ATM:XM_011542845.2:intron_variant:MODIFIER:intron7/54:c.1069-56A>G::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:XM_017017791.1:intron_variant:MODIFIER:intron15/44:c.2377-56A>G::,ATM:XM_017017792.2:intron_variant:MODIFIER:intron15/35:c.2377-56A>G::,ATM:XR_002957150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/38:n.3110-56A>G::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]				rs672655	0.4764	0.4945	20105,.		2.1810			17.13				COSV53757995	0.007	0.2641	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108271229	108271230	TT	-	het	off-target	QUAL=340;DP=164;AF=0.17;MQM=60;SAP=3;ABP=157	ATM	intron	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron20/63:c.2922-9_2922-8del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron19/62:c.2922-9_2922-8del::	ATM:NM_000051.4:intron_variant:MODIFIER:intron19/62:c.2922-9_2922-8del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron20/63:c.2922-9_2922-8del::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron19/62:c.2922-9_2922-8del::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron19/62:c.2922-9_2922-8del::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron20/63:c.2922-9_2922-8del::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron18/61:c.2757-9_2757-8del::,ATM:XM_011542843.2:intron_variant:MODIFIER:intron19/59:c.2922-9_2922-8del::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron19/62:c.1878-9_1878-8del::,ATM:XM_011542845.2:intron_variant:MODIFIER:intron11/54:c.1614-9_1614-8del::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron20/63:c.2922-9_2922-8del::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron19/62:c.2922-9_2922-8del::,ATM:XM_017017791.1:intron_variant:MODIFIER:intron19/44:c.2922-9_2922-8del::,ATM:XM_017017792.2:intron_variant:MODIFIER:intron19/35:c.2922-9_2922-8del::,ATM:XR_002957150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron19/38:n.3655-9_3655-8del::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]				rs373881770		0.0153	0,.	0.0103,0.0117,0.0133,0.0156,0.0193	0.1370			1.58					0.1529	0.6147	0.02	0	1	0 / 0					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108279481	108279481	T	-	het		QUAL=889;DP=98;AF=0.39;MQM=60;SAP=3;ABP=14	ATM	intron	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron23/63:c.3285-9del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron22/62:c.3285-9del::	ATM:NM_000051.4:intron_variant:MODIFIER:intron22/62:c.3285-9del::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron23/63:c.3285-9del::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron22/62:c.3285-9del::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron22/62:c.3285-9del::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron23/63:c.3285-9del::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron21/61:c.3120-9del::,ATM:XM_011542843.2:intron_variant:MODIFIER:intron22/59:c.3285-9del::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron22/62:c.2241-9del::,ATM:XM_011542845.2:intron_variant:MODIFIER:intron14/54:c.1977-9del::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron23/63:c.3285-9del::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron22/62:c.3285-9del::,ATM:XM_017017791.1:intron_variant:MODIFIER:intron22/44:c.3285-9del::,ATM:XM_017017792.2:intron_variant:MODIFIER:intron22/35:c.3285-9del::,ATM:XR_002957150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron22/38:n.4018-9del::	regulatory_region_variant:promoter_flanking_region	607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]	181857 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified];		(TTTG)n (Simple_repeat)	rs1799757		0.1130	1202,.	0.0227,0.0614,0.0063,0.1426,0.0768	0.5080			3.27					-0.2079	0.4247	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108280980	108280980	-	A	het	off-target	QUAL=1037;DP=76;AF=0.53;MQM=60;SAP=29;ABP=3	ATM	intron	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron24/63:c.3403-13dup::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron23/62:c.3403-13dup::	ATM:NM_000051.4:intron_variant:MODIFIER:intron23/62:c.3403-13dup::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron24/63:c.3403-13dup::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron23/62:c.3403-13dup::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron23/62:c.3403-13dup::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron24/63:c.3403-13dup::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron22/61:c.3238-13dup::,ATM:XM_011542843.2:intron_variant:MODIFIER:intron23/59:c.3403-13dup::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron23/62:c.2359-13dup::,ATM:XM_011542845.2:intron_variant:MODIFIER:intron15/54:c.2095-13dup::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron24/63:c.3403-13dup::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron23/62:c.3403-13dup::,ATM:XM_017017791.1:intron_variant:MODIFIER:intron23/44:c.3403-13dup::,ATM:XM_017017792.2:intron_variant:MODIFIER:intron23/35:c.3403-13dup::,ATM:XR_002957150.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron23/38:n.4136-13dup::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]	181858 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified];			rs3218681		0.5603	23475,.	0.4510,0.6113,0.3791,0.5616,0.6142				6.87					-0.2853	0.3592	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108304667	108304667	T	C	het		QUAL=161;DP=14;AF=0.57;MQM=60;SAP=13;ABP=4	ATM	splice_region&intron	ATM:ENST00000452508.6:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::,ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::	ATM:NM_000051.4:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:NM_001351834.2:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::,ATM:XM_005271562.5:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:XM_006718843.4:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:XM_006718845.2:splice_region_variant&intron_variant:LOW:intron11/37:c.1453-8T>C::,ATM:XM_011542840.3:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::,ATM:XM_011542842.3:splice_region_variant&intron_variant:LOW:intron35/61:c.5332-8T>C::,ATM:XM_011542843.2:splice_region_variant&intron_variant:LOW:intron36/59:c.5497-8T>C::,ATM:XM_011542844.3:splice_region_variant&intron_variant:LOW:intron36/62:c.4453-8T>C::,ATM:XM_011542845.2:splice_region_variant&intron_variant:LOW:intron28/54:c.4189-8T>C::,ATM:XM_017017789.2:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::,ATM:XM_017017790.2:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:XM_017017791.1:splice_region_variant&intron_variant:LOW:intron36/44:c.5497-8T>C::,ATM:XR_002957150.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron35/38:n.6097-8T>C::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]	132706 [benign/likely benign DISEASE=Triple-negative breast carcinoma,Malignant tumor of breast,Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,none provided];			rs3092829	0.0132	0.0225	36,.	0.0057,0.0186,0.0003,0.0333,0.0061	1.2810			7.67		10.05>8.69	0.000/0.004	COSV53727999	-0.2961	0.5689	0	1	75	0 / 2					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108304735	108304735	G	A	het		QUAL=388;DP=30;AF=0.53;MQM=60;SAP=3;ABP=3	ATM	missense	ATM:ENST00000452508.6:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000675843.1:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:	ATM:NM_000051.4:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:NM_001351834.2:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:,ATM:XM_005271562.5:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:XM_006718843.4:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:XM_006718845.2:missense_variant:MODERATE:exon12/38:c.1513G>A:p.Asp505Asn:,ATM:XM_011542840.3:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:,ATM:XM_011542842.3:missense_variant:MODERATE:exon36/62:c.5392G>A:p.Asp1798Asn:,ATM:XM_011542843.2:missense_variant:MODERATE:exon37/60:c.5557G>A:p.Asp1853Asn:,ATM:XM_011542844.3:missense_variant:MODERATE:exon37/63:c.4513G>A:p.Asp1505Asn:,ATM:XM_011542845.2:missense_variant:MODERATE:exon29/55:c.4249G>A:p.Asp1417Asn:,ATM:XM_017017789.2:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:,ATM:XM_017017790.2:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:XM_017017791.1:missense_variant:MODERATE:exon37/45:c.5557G>A:p.Asp1853Asn:,ATM:XR_002957150.1:non_coding_transcript_exon_variant:MODIFIER:exon36/39:n.6157G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]	128458 [benign DISEASE=Ataxia-telangiectasia syndrome,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM];		rs1801516	0.0669	0.1136	1205,.	0.0227,0.0613,0.0063,0.1435,0.0772	5.9270	T(0.08),T(0.08)	B(0.34),B(0.34)	22.90	0.12			COSV53728020	-0.2021	0.3688	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354756	108354756	C	T	het	off-target	QUAL=1990;DP=159;AF=0.48;MQM=60;SAP=6;ABP=4	ATM,C11orf65	intron	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+159G>A::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::	ATM:NM_000051.4:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron7/8:c.695-19464G>A::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,C11orf65:NR_147053.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.2299+159G>A::,C11orf65:XM_005271414.4:intron_variant:MODIFIER:intron8/9:c.788-19464G>A::,C11orf65:XM_005271415.4:intron_variant:MODIFIER:intron7/8:c.732-19464G>A::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,ATM:XM_006718845.2:intron_variant:MODIFIER:intron35/37:c.4743-55C>T::,C11orf65:XM_011542640.2:intron_variant:MODIFIER:intron8/8:c.788-14392G>A::,C11orf65:XM_011542642.1:intron_variant:MODIFIER:intron7/7:c.732-5683G>A::,C11orf65:XM_011542643.2:intron_variant:MODIFIER:intron7/7:c.732-14392G>A::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron59/61:c.8622-55C>T::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron60/62:c.7743-55C>T::,ATM:XM_011542845.2:intron_variant:MODIFIER:intron52/54:c.7479-55C>T::,C11orf65:XM_017017247.1:intron_variant:MODIFIER:intron9/9:c.904-14392G>A::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]				rs664982		0.5375	22528,.		-1.7010			0.07				COSV53733871	0.0487	0.2419	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354934	108354934	A	G	het	off-target	QUAL=4410;DP=275;AF=0.58;MQM=60;SAP=3;ABP=19	ATM,C11orf65	intron,3'UTR	ATM:ENST00000452508.6:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::,C11orf65:ENST00000615746.4:3_prime_UTR_variant:MODIFIER:exon11/13:c.*1177T>C::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::	ATM:NM_000051.4:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,C11orf65:NM_001330368.2:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::,C11orf65:NM_001351110.2:intron_variant:MODIFIER:intron7/8:c.695-19642T>C::,ATM:NM_001351834.2:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,C11orf65:NR_147053.3:non_coding_transcript_exon_variant:MODIFIER:exon11/13:n.2280T>C::,C11orf65:XM_005271414.4:intron_variant:MODIFIER:intron8/9:c.788-19642T>C::,C11orf65:XM_005271415.4:intron_variant:MODIFIER:intron7/8:c.732-19642T>C::,ATM:XM_005271562.5:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,ATM:XM_006718843.4:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,ATM:XM_006718845.2:intron_variant:MODIFIER:intron36/37:c.4806+60A>G::,C11orf65:XM_011542640.2:intron_variant:MODIFIER:intron8/8:c.788-14570T>C::,C11orf65:XM_011542642.1:intron_variant:MODIFIER:intron7/7:c.732-5861T>C::,C11orf65:XM_011542643.2:intron_variant:MODIFIER:intron7/7:c.732-14570T>C::,ATM:XM_011542840.3:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,ATM:XM_011542842.3:intron_variant:MODIFIER:intron60/61:c.8685+60A>G::,ATM:XM_011542844.3:intron_variant:MODIFIER:intron61/62:c.7806+60A>G::,ATM:XM_011542845.2:intron_variant:MODIFIER:intron53/54:c.7542+60A>G::,C11orf65:XM_017017247.1:intron_variant:MODIFIER:intron9/9:c.904-14570T>C::,ATM:XM_017017789.2:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,ATM:XM_017017790.2:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::		607585_[GENE=ATM_PHENOS=Lymphoma, mantle cell, somatic (3); Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3)]				rs664143		0.6180	29289,.		-0.6960			0.44				COSV53746535	0.0123	0.2617	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=n/a oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	125627571	125627571	G	T	het	off-target	QUAL=1071;DP=108;AF=0.49;MQM=60;SAP=118;ABP=3	CHEK1	intron	CHEK1:ENST00000278916.8:intron_variant:MODIFIER:intron2/11:c.66-36G>T::,CHEK1:ENST00000427383.6:intron_variant:MODIFIER:intron2/11:c.337+738G>T::,CHEK1:ENST00000428830.6:intron_variant:MODIFIER:intron2/13:c.66-36G>T::,CHEK1:ENST00000438015.7:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000532449.6:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000534070.5:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000544373.5:intron_variant:MODIFIER:intron2/11:c.7+738G>T::	CHEK1:NM_001114121.2:intron_variant:MODIFIER:intron2/13:c.66-36G>T::,CHEK1:NM_001114122.3:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:NM_001244846.1:intron_variant:MODIFIER:intron2/11:c.66-36G>T::,CHEK1:NM_001274.5:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:NM_001330427.2:intron_variant:MODIFIER:intron2/12:c.-15+738G>T::,CHEK1:NM_001330428.1:intron_variant:MODIFIER:intron2/11:c.7+738G>T::,CHEK1:NR_045204.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/11:n.962+738G>T::,CHEK1:NR_045205.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/12:n.500-36G>T::,CHEK1:XM_011542560.2:intron_variant:MODIFIER:intron2/12:c.337+738G>T::,CHEK1:XM_017017146.2:intron_variant:MODIFIER:intron2/13:c.66-36G>T::,CHEK1:XM_024448337.1:intron_variant:MODIFIER:intron2/12:c.66-36G>T::	regulatory_region_variant:promoter	601134_[GENE=STT3A_PHENOS=Congenital disorder of glycosylation, type Iw, 615596 (3), Autosomal recessive]				rs491528	0.3530	0.3151	7802,.	0.3758,0.1920,0.4325,0.2944,0.3297	-0.6450			2.27				COSV54022242	0.3716	0.6193	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STT3A (inh=AR oe_syn=0.85 oe_mis=0.50 oe_lof=0.31), CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125644678	125644678	G	A	het	off-target	QUAL=843;DP=107;AF=0.42;MQM=60;SAP=56;ABP=9	CHEK1	intron	CHEK1:ENST00000278916.8:intron_variant:MODIFIER:intron11/11:c.1233+35G>A::,CHEK1:ENST00000427383.6:intron_variant:MODIFIER:intron10/11:c.1281+35G>A::,CHEK1:ENST00000428830.6:intron_variant:MODIFIER:intron11/13:c.1233+35G>A::,CHEK1:ENST00000438015.7:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000532449.6:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000534070.5:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000544373.5:intron_variant:MODIFIER:intron10/11:c.951+35G>A::	CHEK1:NM_001114121.2:intron_variant:MODIFIER:intron11/13:c.1233+35G>A::,CHEK1:NM_001114122.3:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:NM_001244846.1:intron_variant:MODIFIER:intron11/11:c.1233+35G>A::,CHEK1:NM_001274.5:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:NM_001330427.2:intron_variant:MODIFIER:intron10/12:c.930+35G>A::,CHEK1:NM_001330428.1:intron_variant:MODIFIER:intron10/11:c.951+35G>A::,CHEK1:NR_045204.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/11:n.1906+35G>A::,CHEK1:NR_045205.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/12:n.1667+35G>A::,CHEK1:XM_011542560.2:intron_variant:MODIFIER:intron10/12:c.1281+35G>A::,CHEK1:XM_017017146.2:intron_variant:MODIFIER:intron11/13:c.1233+35G>A::,CHEK1:XM_024448337.1:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::						rs521102	0.4361	0.5118	16574,.	0.2771,0.6322,0.3877,0.5184,0.5773	0.6180			8.77					0.2629	0.3834	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125655300	125655300	A	G	hom		QUAL=1971;DP=59;AF=1.00;MQM=60;SAP=11;ABP=0	CHEK1	missense	CHEK1:ENST00000278916.8:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:,CHEK1:ENST00000427383.6:missense_variant:MODERATE:exon12/12:c.1459A>G:p.Ile487Val:,CHEK1:ENST00000428830.6:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000438015.7:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000532449.6:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000534070.5:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000544373.5:missense_variant:MODERATE:exon12/12:c.1129A>G:p.Ile377Val:	CHEK1:NM_001114121.2:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:NM_001114122.3:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:NM_001244846.1:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:,CHEK1:NM_001274.5:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:NM_001330427.2:missense_variant:MODERATE:exon12/13:c.1108A>G:p.Ile370Val:,CHEK1:NM_001330428.1:missense_variant:MODERATE:exon12/12:c.1129A>G:p.Ile377Val:,CHEK1:NR_045204.1:non_coding_transcript_exon_variant:MODIFIER:exon12/12:n.2084A>G::,CHEK1:NR_045205.1:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.1845A>G::,CHEK1:XM_011542560.2:missense_variant:MODERATE:exon12/13:c.1459A>G:p.Ile487Val:,CHEK1:XM_017017146.2:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:XM_024448337.1:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:			496139 [benign DISEASE=not provided];			rs506504		0.9747	72309,.	0.9950,0.9844,0.9996,0.9627,0.9798	1.2110	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	14.31	0.05			COSV104594243	-0.2008	0.9544	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=n/a oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr12	57750882	57750882	C	T	het	off-target	QUAL=1951;DP=162;AF=0.49;MQM=60;SAP=9;ABP=3	CDK4	intron	CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron4/7:c.522+41G>A::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron3/6:c.265-211G>A::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron1/3:c.-158+1293G>A::	CDK4:NM_000075.4:intron_variant:MODIFIER:intron4/7:c.522+41G>A::	regulatory_region_variant:promoter	123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]				rs2069502	0.3367	0.3549	6780,.	0.0762,0.3449,0.6368,0.3213,0.4972	0.5710			9.49				COSV56983640	0.038	0.9579	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=n/a oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr12	57751373	57751373	C	T	het	off-target	QUAL=5467;DP=416;AF=0.58;MQM=60;SAP=223;ABP=24	CDK4	intron	CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron2/7:c.219-31G>A::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron2/6:c.219-31G>A::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron1/3:c.-158+802G>A::	CDK4:NM_000075.4:intron_variant:MODIFIER:intron2/7:c.219-31G>A::	regulatory_region_variant:promoter	123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]				rs2270777	0.2480	0.3412	9617,.	0.1614,0.2341,0.1580,0.4355,0.2380	-1.0380			6.46				COSV56985436	-0.1497	0.9613	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=n/a oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr13	32316435	32316435	G	A	het	off-target	QUAL=1359;DP=118;AF=0.45;MQM=60;SAP=6;ABP=6	BRCA2	5'UTR	BRCA2:ENST00000380152.8:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000544455.6:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::	BRCA2:NM_000059.4:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::	regulatory_region_variant:promoter	600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]	125965 [benign DISEASE=Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided];	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2];		rs1799943	0.2093	0.2455	3894,.	0.1012,0.1908,0.3746,0.2581,0.2847	0.5460			9.46				COSV61525225	-0.1608	0.6771	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZAR1L (inh=n/a oe_syn=0.79 oe_mis=0.65 oe_lof=0.30), BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32329548	32329548	C	T	het	off-target	QUAL=606;DP=44;AF=0.55;MQM=60;SAP=6;ABP=4	BRCA2	intron	BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron8/26:c.681+56C>T::,BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron8/26:c.681+56C>T::	BRCA2:NM_000059.4:intron_variant:MODIFIER:intron8/26:c.681+56C>T::		600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]	126192 [benign DISEASE=Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,not specified];			rs2126042	0.1859	0.2051	3378,.		-0.2650			7.64				COSV66457755	0.0773	0.3394	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32331082	32331082	-	T	het	off-target	QUAL=119;DP=106;AF=0.17;MQM=60;SAP=3;ABP=103	BRCA2	intron	BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron9/26:c.793+64dup::,BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron9/26:c.793+64dup::	BRCA2:NM_000059.4:intron_variant:MODIFIER:intron9/26:c.793+64dup::		600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]			AluSx (SINE/Alu)	rs751977993		0.1177	3,.	0.1093,0.1427,0.1201,0.1052,0.1424				0.19					0.2185	0.1287	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32337751	32337751	A	G	het		QUAL=835;DP=75;AF=0.49;MQM=60;SAP=8;ABP=3	BRCA2	synonymous	BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:	BRCA2:NM_000059.4:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:		600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]	126010 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs1801406	0.2668	0.2946	6331,.	0.2282,0.2127,0.3820,0.3086,0.2989	0.2330			6.39				COSV66448451	0.0033	0.158	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32338918	32338918	A	G	hom		QUAL=32017;DP=989;AF=1.00;MQM=60;SAP=9;ABP=0	BRCA2	synonymous	BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat],BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat]	BRCA2:NM_000059.4:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:		600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]	132779 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs206075		0.9944	72964,.	0.9257,0.9957,0.9999,0.9996,0.9999	0.0760			4.48				COSV101203861	0.0008	0.1579	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32340868	32340868	G	C	hom		QUAL=857;DP=26;AF=1.00;MQM=60;SAP=15;ABP=0	BRCA2	synonymous	BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:	BRCA2:NM_000059.4:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:		600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]	132780 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs206076		0.9942	72963,.	0.9253,0.9956,0.9999,0.9996,0.9999	-0.8640			0.07				COSV66458663	-0.001	0.1579	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32355095	32355095	A	G	het		QUAL=437;DP=38;AF=0.50;MQM=60;SAP=4;ABP=3	BRCA2	synonymous	BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:	BRCA2:NM_000059.4:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:		600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]	126133 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];			rs1799955	0.2326	0.2254	3840,.	0.2155,0.1799,0.3820,0.2162,0.2199	0.0960			6.91				COSV66447569	0.0672	0.5269	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32355250	32355250	T	C	hom		QUAL=19385;DP=598;AF=1.00;MQM=60;SAP=5;ABP=0	BRCA2	missense	BRCA2:ENST00000380152.8:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000544455.6:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:	BRCA2:NM_000059.4:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:		600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]	133738 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 2,Ductal breast carcinoma,not specified,none provided];			rs169547	0.9758	0.9949	73240,.	0.9326,0.9960,0.9999,0.9997,0.9999	2.4910	T(1.00),T(1.00)	B(0.00),B(0.00)	8.75	0.09			COSV66451785	0.1306	0.5302	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32362509	32362509	T	C	hom	off-target	QUAL=2098;DP=63;AF=1.00;MQM=60;SAP=9;ABP=0	BRCA2	intron	BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron16/26:c.7806-14T>C::,BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron16/26:c.7806-14T>C::	BRCA2:NM_000059.4:intron_variant:MODIFIER:intron16/26:c.7806-14T>C::	regulatory_region_variant:promoter_flanking_region	600185_[GENE=BRCA2_PHENOS={Pancreatic cancer 2}, 613347 (3); {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Glioblastoma 3}, 613029 (3), Autosomal recessive; Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant; Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Somatic mutation, Autosomal recessive, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant]	126158 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Fanconi anemia, complementation group D1,Breast-ovarian cancer, familial 2,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided];	CS147979 [CLASS=FP MUT=ALT PHEN="Alternative splicing" GENE=BRCA2];		rs9534262		0.5370	22016,.	0.5695,0.5137,0.5581,0.5175,0.4892	-1.4060			6.79		8.33>7.94		COSV66447577	-0.3065	0.1207	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	79192053	79192053	A	G	het		QUAL=10963;DP=825;AF=0.52;MQM=60;SAP=4;ABP=5		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs2988039	0.5066	0.4059	15626,.	0.7074,0.4284,0.7053,0.2530,0.3501	-0.9400			5.13								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr14	45137184	45137184	A	G	het		QUAL=593;DP=53;AF=0.47;MQM=60;SAP=5;ABP=3	FANCM	missense	FANCM:ENST00000267430.10:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit],FANCM:ENST00000542564.6:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000556036.5:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:PF04851 [Type III restriction enzyme res subunit]	FANCM:NM_001308133.2:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:,FANCM:NM_001308134.2:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:,FANCM:NM_020937.4:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:,FANCM:XM_011537034.2:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:,FANCM:XM_011537035.3:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:,FANCM:XM_017021523.1:missense_variant:MODERATE:exon2/21:c.624A>G:p.Ile208Met:,FANCM:XM_017021524.2:intron_variant:MODIFIER:intron1/20:c.-205+645A>G::,FANCM:XM_017021525.2:5_prime_UTR_variant:MODIFIER:exon2/21:c.-351A>G::,FANCM:XM_017021527.1:5_prime_UTR_variant:MODIFIER:exon2/22:c.-429A>G::,FANCM:XR_001750470.1:non_coding_transcript_exon_variant:MODIFIER:exon2/22:n.716A>G::,FANCM:XR_001750471.2:non_coding_transcript_exon_variant:MODIFIER:exon2/22:n.716A>G::,FANCM:XR_001750472.1:non_coding_transcript_exon_variant:MODIFIER:exon2/21:n.716A>G::	regulatory_region_variant:promoter	609644_[GENE=FANCM_PHENOS=Spermatogenic failure 28, 618086 (3), Autosomal recessive; ?Premature ovarian failure 15, 618096 (3), Autosomal recessive]	241326 [benign DISEASE=Fanconi anemia,not specified];			rs45547534	0.0054	0.0105	11,.	0.0026,0.0066,0.0000,0.0156,0.0102	0.0190	D(0.00),D(0.00),D(0.00)	D(0.94),D(0.97),P(0.78)	24.10	0.12			COSV53531926	0.2945	0.954	0.13	1	29	0 / 1					FKBP3 (inh=n/a oe_syn=1.05 oe_mis=1.00 oe_lof=0.54), FANCM (inh=AR oe_syn=1.00 oe_mis=1.01 oe_lof=0.46)
chr14	67823655	67823655	T	G	het	off-target	QUAL=6800;DP=523;AF=0.50;MQM=60;SAP=4;ABP=3	RAD51B	intron	RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron2/6:c.84+28T>G::,RAD51B:ENST00000471583.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+28T>G::	RAD51B:NM_001321809.2:intron_variant:MODIFIER:intron2/11:c.84+28T>G::,RAD51B:NM_001321810.2:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron1/9:c.84+28T>G::,RAD51B:NM_001321814.2:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron1/9:c.-31+28T>G::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron2/11:c.-372+28T>G::,RAD51B:NM_001321818.2:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_001321819.1:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_001321821.2:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_133509.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron2/10:c.84+28T>G::						rs17783124	0.2504	0.3236	8298,.	0.3469,0.1965,0.0743,0.3535,0.2331	0.1820			5.16					-0.128	0.3976	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67835050	67835050	-	A	het	off-target	QUAL=2995;DP=252;AF=0.49;MQM=60;SAP=3;ABP=3	RAD51B	intron	RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron3/6:c.199-22dup::,RAD51B:ENST00000471583.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron3/11:c.199-22dup::	RAD51B:NM_001321809.2:intron_variant:MODIFIER:intron3/11:c.199-22dup::,RAD51B:NM_001321810.2:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron2/9:c.199-22dup::,RAD51B:NM_001321814.2:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron2/9:c.85-22dup::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron3/11:c.-257-22dup::,RAD51B:NM_001321818.2:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_001321819.1:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_001321821.2:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_133509.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron3/10:c.199-22dup::						rs34564590		0.3725	11256,.	0.4928,0.2060,0.1445,0.3497,0.2297				7.56					0.0584	0.8709	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67864958	67864958	A	T	hom	off-target	QUAL=39;DP=8;AF=0.25;MQM=60;SAP=3;ABP=0	RAD51B	intron	RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron4/6:c.316-45A>T::,RAD51B:ENST00000471583.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron4/11:c.316-45A>T::	RAD51B:NM_001321809.2:intron_variant:MODIFIER:intron4/11:c.316-45A>T::,RAD51B:NM_001321810.2:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron3/9:c.316-45A>T::,RAD51B:NM_001321814.2:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron3/9:c.202-45A>T::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron5/11:c.-42-45A>T::,RAD51B:NM_001321818.2:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_001321819.1:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_001321821.2:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_133509.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron4/10:c.316-45A>T::	regulatory_region_variant:CTCF_binding_site					rs1474939		0.9748	45517,.	0.9538,0.9450,0.9280,0.9804,0.9786	-0.7160			0.54					0.0883	0.8469	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67864962	67864963	TT	-	hom	off-target	QUAL=39;DP=8;AF=0.25;MQM=60;SAP=3;ABP=0	RAD51B	intron	RAD51B:ENST00000390683.7:intron_variant:MODIFIER:intron4/6:c.316-4_316-3del::,RAD51B:ENST00000471583.5:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron4/11:c.316-4_316-3del::	RAD51B:NM_001321809.2:intron_variant:MODIFIER:intron4/11:c.316-4_316-3del::,RAD51B:NM_001321810.2:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron3/9:c.316-4_316-3del::,RAD51B:NM_001321814.2:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron3/9:c.202-4_202-3del::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron5/11:c.-42-4_-42-3del::,RAD51B:NM_001321818.2:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:NM_001321819.1:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:NM_001321821.2:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:NM_133509.5:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron4/10:c.316-4_316-3del::	regulatory_region_variant:CTCF_binding_site				(T)n (Simple_repeat)	rs745505141		0.0597	1255,.		0.0000			0.49					0.0866	0.7098	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68477627	68477627	T	-	het	off-target	QUAL=780;DP=387;AF=0.18;MQM=60;SAP=103;ABP=357	RAD51B	intron	RAD51B:ENST00000471583.5:intron_variant:MODIFIER:intron10/10:c.1037-8del::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron10/11:c.1036+9390del::	RAD51B:NM_001321809.2:intron_variant:MODIFIER:intron10/11:c.1036+9390del::,RAD51B:NM_001321810.2:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_001321812.1:intron_variant:MODIFIER:intron9/9:c.1036+9390del::,RAD51B:NM_001321814.2:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_001321815.1:intron_variant:MODIFIER:intron9/9:c.922+9390del::,RAD51B:NM_001321817.2:intron_variant:MODIFIER:intron11/11:c.680-8del::,RAD51B:NM_001321818.2:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_001321821.2:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_002877.6:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_133509.5:intron_variant:MODIFIER:intron10/10:c.1036+9390del::,RAD51B:NM_133510.4:intron_variant:MODIFIER:intron10/10:c.1037-8del::					(T)n (Simple_repeat)	rs528099287		0.3362	19,.	0.3351,0.3246,0.3069,0.3405,0.3435	-0.6900			0.04					0.0191	0.7785	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	103699416	103699416	G	A	het		QUAL=12821;DP=959;AF=0.52;MQM=60;SAP=3;ABP=5	KLC1,XRCC3	intron,missense	KLC1:ENST00000334553.10:intron_variant:MODIFIER:intron15/16:c.1849-1239G>A::,KLC1:ENST00000348520.10:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::,XRCC3:ENST00000352127.11:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000452929.6:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,XRCC3:ENST00000553264.5:missense_variant:MODERATE:exon6/8:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000554280.5:intron_variant:MODIFIER:intron14/15:c.1755-1239G>A::,XRCC3:ENST00000554913.5:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000554974.5:missense_variant:MODERATE:exon2/4:c.107C>T:p.Thr36Met:PF08423 [Rad51],XRCC3:ENST00000555055.6:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],KLC1:ENST00000555836.5:intron_variant:MODIFIER:intron15/16:c.1822-1239G>A::,KLC1:ENST00000557450.5:intron_variant:MODIFIER:intron13/14:c.1624-1239G>A::	XRCC3:NM_001100118.2:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:,XRCC3:NM_001100119.2:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,KLC1:NM_001130107.2:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,XRCC3:NM_001371229.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_001371231.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_001371232.1:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,XRCC3:NM_005432.4:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:,KLC1:NM_182923.4:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::,XRCC3:XM_005268046.2:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:	regulatory_region_variant:promoter_flanking_region	600675_[GENE=XRCC3_PHENOS={Melanoma, cutaneous malignant, 6}, 613972 (3); {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	8944 [risk factor DISEASE=Cutaneous malignant melanoma 6];	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3];		rs861539	0.2169	0.2978	7375,.	0.2066,0.1733,0.0546,0.3767,0.2435	0.7970	 , ,T(0.17), ,T(0.17), ,T(0.17),T(0.13),T(0.17), , 	 , ,B(0.19), ,B(0.19), ,B(0.19),B(0.19),B(0.19), , 	7.75	0.03			COSV57974380	-0.0104	0.0958	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLC1 (inh=n/a oe_syn=1.01 oe_mis=0.52 oe_lof=0.23), XRCC3 (inh=AD oe_syn=1.06 oe_mis=0.92 oe_lof=1.13)
chr14	104776629	104776629	T	C	het	off-target	QUAL=1967;DP=130;AF=0.61;MQM=60;SAP=13;ABP=16	AKT1	intron	AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron3/12:c.287+30A>G::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron4/13:c.287+30A>G::	AKT1:NM_001014431.2:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:NM_001014432.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:NM_001382430.1:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:NM_001382431.1:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:NM_001382432.1:intron_variant:MODIFIER:intron6/15:c.287+30A>G::,AKT1:NM_001382433.1:intron_variant:MODIFIER:intron6/15:c.287+30A>G::,AKT1:NM_005163.2:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:XR_002957536.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/13:n.487+30A>G::		164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3)]				rs2494735		0.4886	20042,.	0.7094,0.5849,0.6464,0.3558,0.5358	-3.6570			0.14				COSV62573175	-0.0881	0.1969	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104792555	104792555	C	T	hom	off-target	QUAL=3635;DP=111;AF=1.00;MQM=60;SAP=15;ABP=0	AKT1	intron	AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron1/12:c.46+43G>A::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron2/13:c.46+43G>A::	AKT1:NM_001014431.2:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:NM_001014432.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:NM_001382430.1:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:NM_001382431.1:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:NM_001382432.1:intron_variant:MODIFIER:intron4/15:c.46+43G>A::,AKT1:NM_001382433.1:intron_variant:MODIFIER:intron4/15:c.46+43G>A::,AKT1:NM_005163.2:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:XR_002957536.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/13:n.246+43G>A::	regulatory_region_variant:promoter	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3)]				rs2494748	0.3562	0.5131	19603,.	0.2491,0.4609,0.1970,0.6140,0.4223	-0.8470			1.14				COSV62573228	-0.0527	0.1668	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104792556	104792556	A	G	hom	off-target	QUAL=3635;DP=111;AF=1.00;MQM=60;SAP=15;ABP=0	AKT1	intron	AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron1/12:c.46+42T>C::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron2/13:c.46+42T>C::	AKT1:NM_001014431.2:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:NM_001014432.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:NM_001382430.1:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:NM_001382431.1:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:NM_001382432.1:intron_variant:MODIFIER:intron4/15:c.46+42T>C::,AKT1:NM_001382433.1:intron_variant:MODIFIER:intron4/15:c.46+42T>C::,AKT1:NM_005163.2:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:XR_002957536.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/13:n.246+42T>C::	regulatory_region_variant:promoter	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3)]				rs2494749		0.8716	58789,.	0.8879,0.7063,0.3346,0.9247,0.6897	-1.6150			0.28				COSV62573234	-0.1092	0.1671	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr15	40706144	40706144	T	G	het	off-target	QUAL=1309;DP=99;AF=0.56;MQM=60;SAP=28;ABP=6	RAD51	intron	RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron3/8:c.226-33T>G::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron3/7:c.225+4943T>G::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::	RAD51:NM_001164269.2:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:NM_001164270.2:intron_variant:MODIFIER:intron3/8:c.226-33T>G::,RAD51:NM_002875.5:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:NM_133487.4:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:XM_006720626.3:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:XM_011521857.2:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:XM_011521858.2:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:XM_011521859.2:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:XM_011521860.2:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:XM_011521861.2:intron_variant:MODIFIER:intron3/8:c.226-33T>G::,RAD51:XM_011521862.3:intron_variant:MODIFIER:intron3/8:c.-29-2881T>G::	regulatory_region_variant:open_chromatin_region	179617_[GENE=RAD51_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; Mirror movements 2, 614508 (3), Autosomal dominant; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]				rs45457497	0.3542	0.2722	4765,.	0.2457,0.5169,0.6746,0.1655,0.2748	1.4560			10.92				COSV51111815	-0.2525	0.616	0.11	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	43409749	43409749	A	-	het		QUAL=548;DP=58;AF=0.43;MQM=60;SAP=5;ABP=5	TP53BP1,TUBGCP4	splice_region&intron,3'UTR	TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron23/26:c.5156-8del::,TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::,TUBGCP4:ENST00000564079.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::	TP53BP1:NM_001141979.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::,TP53BP1:NM_001141980.3:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TUBGCP4:NM_001286414.3:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TP53BP1:NM_001355001.2:splice_region_variant&intron_variant:LOW:intron25/28:c.2426-8del::,TP53BP1:NM_005657.4:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TUBGCP4:NM_014444.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TUBGCP4:XM_011521455.2:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TP53BP1:XM_011521985.2:splice_region_variant&intron_variant:LOW:intron23/26:c.5156-8del::,TUBGCP4:XM_017022078.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*4545del::,TP53BP1:XR_001751382.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron25/28:n.5587-8del::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]				rs56813954		0.3535	4177,.	0.1846,0.3650,0.4202,0.3555,0.3896	0.7380			0.86					-0.0467	0.0936	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43415610	43415610	A	T	het		QUAL=1611;DP=136;AF=0.46;MQM=60;SAP=15;ABP=5	TP53BP1	synonymous	TP53BP1:ENST00000263801.7:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:,TP53BP1:ENST00000382039.7:synonymous_variant:LOW:exon22/27:c.4923T>A:p.Ser1641=:,TP53BP1:ENST00000382044.9:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:ENST00000450115.6:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:	TP53BP1:NM_001141979.3:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:NM_001141980.3:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:NM_001355001.2:synonymous_variant:LOW:exon24/29:c.2193T>A:p.Ser731=:,TP53BP1:NM_005657.4:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:,TP53BP1:XM_011521985.2:synonymous_variant:LOW:exon22/27:c.4923T>A:p.Ser1641=:,TP53BP1:XM_011521986.3:synonymous_variant:LOW:exon23/24:c.5073T>A:p.Ser1691=:,TP53BP1:XR_001751382.2:non_coding_transcript_exon_variant:MODIFIER:exon23/29:n.5186T>A::						rs2230451	0.1286	0.1684	2343,.	0.1698,0.1011,0.0024,0.1892,0.2102	0.1790			9.38				COSV55501344	-0.0314	0.8666	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43427958	43427958	A	-	het	off-target	QUAL=1011;DP=306;AF=0.17;MQM=60;SAP=3;ABP=293	TP53BP1	intron	TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron18/27:c.3813+58del::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron18/26:c.3828+58del::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron18/27:c.3828+58del::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron18/27:c.3828+58del::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron18/27:c.3828+58del::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron18/27:c.3828+58del::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron19/28:c.948+58del::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron18/27:c.3813+58del::,TP53BP1:XM_011521985.2:intron_variant:MODIFIER:intron18/26:c.3828+58del::,TP53BP1:XM_011521986.3:intron_variant:MODIFIER:intron18/23:c.3828+58del::,TP53BP1:XR_001751382.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/28:n.3941+58del::,TP53BP1:XR_931899.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/18:n.3457+58del::					AluJb (SINE/Alu)	rs35437737		0.0034	0,.		0.3850			1.04					-0.0108	0.4009	0	3	380	0 / 2					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43427999	43427999	C	T	het	off-target	QUAL=4219;DP=347;AF=0.55;MQM=60;SAP=12;ABP=12	TP53BP1	intron	TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron18/27:c.3813+17G>A::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron18/26:c.3828+17G>A::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron18/27:c.3828+17G>A::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron18/27:c.3828+17G>A::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron18/27:c.3828+17G>A::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron18/27:c.3828+17G>A::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron19/28:c.948+17G>A::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron18/27:c.3813+17G>A::,TP53BP1:XM_011521985.2:intron_variant:MODIFIER:intron18/26:c.3828+17G>A::,TP53BP1:XM_011521986.3:intron_variant:MODIFIER:intron18/23:c.3828+17G>A::,TP53BP1:XR_001751382.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/28:n.3941+17G>A::,TP53BP1:XR_931899.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/18:n.3457+17G>A::						rs550239	0.3804	0.2812	10161,.	0.6560,0.2112,0.4095,0.1105,0.2170	0.2330			13.83				COSV55496522	0.024	0.4006	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43432448	43432448	T	G	hom		QUAL=20035;DP=634;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	missense	TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:NM_001355001.2:missense_variant:MODERATE:exon18/29:c.541A>C:p.Lys181Gln:,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:,TP53BP1:XM_011521985.2:missense_variant:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln:,TP53BP1:XM_011521986.3:missense_variant:MODERATE:exon17/24:c.3421A>C:p.Lys1141Gln:,TP53BP1:XR_001751382.2:non_coding_transcript_exon_variant:MODIFIER:exon17/29:n.3534A>C::,TP53BP1:XR_931899.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/18:n.3305-4280A>C::				CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs2602141		0.4596	20795,.	0.8589,0.3182,0.4142,0.3018,0.4497	3.6770	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	17.49	0.08			COSV55496532	0.0253	0.2685	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43438288	43438288	A	G	het	off-target	QUAL=11474;DP=893;AF=0.50;MQM=60;SAP=4;ABP=3	TP53BP1	intron	TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron16/27:c.3176+36T>C::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron16/26:c.3191+36T>C::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron17/28:c.311+36T>C::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron16/27:c.3176+36T>C::,TP53BP1:XM_011521985.2:intron_variant:MODIFIER:intron16/26:c.3191+36T>C::,TP53BP1:XM_011521986.3:intron_variant:MODIFIER:intron16/23:c.3191+36T>C::,TP53BP1:XR_001751382.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/28:n.3304+36T>C::,TP53BP1:XR_931899.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/18:n.3304+36T>C::						rs16957730	0.1368	0.1749	2510,.	0.1956,0.1017,0.0025,0.1893,0.2105	1.4740			6.59					-0.15	0.131	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43447488	43447488	-	A	het		QUAL=27;DP=16;AF=0.31;MQM=60;SAP=7;ABP=8	TP53BP1	splice_region&intron	TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron12/27:c.2702-4dup::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron12/26:c.2717-4dup::,TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::	TP53BP1:NM_001141979.3:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::,TP53BP1:NM_001141980.3:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4dup::,TP53BP1:NM_001355001.2:splice_region_variant&intron_variant:LOW:intron12/28:c.-313-4dup::,TP53BP1:NM_005657.4:splice_region_variant&intron_variant:LOW:intron12/27:c.2702-4dup::,TP53BP1:XM_011521985.2:splice_region_variant&intron_variant:LOW:intron12/26:c.2717-4dup::,TP53BP1:XM_011521986.3:splice_region_variant&intron_variant:LOW:intron12/23:c.2717-4dup::,TP53BP1:XR_001751382.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron12/28:n.2830-4dup::,TP53BP1:XR_931899.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron12/18:n.2830-4dup::						rs749575788		0.0707	109,.					8.34					0.1608	0.7491	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43456106	43456106	A	G	hom		QUAL=30192;DP=958;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	synonymous	TP53BP1:ENST00000263801.7:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:,TP53BP1:ENST00000382039.7:synonymous_variant:LOW:exon12/27:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000382044.9:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000450115.6:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:	TP53BP1:NM_001141979.3:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:NM_001141980.3:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon12/29:c.-528T>C::,TP53BP1:NM_005657.4:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:,TP53BP1:XM_011521985.2:synonymous_variant:LOW:exon12/27:c.2502T>C:p.Asp834=:,TP53BP1:XM_011521986.3:synonymous_variant:LOW:exon12/24:c.2502T>C:p.Asp834=:,TP53BP1:XR_001751382.2:non_coding_transcript_exon_variant:MODIFIER:exon12/29:n.2615T>C::,TP53BP1:XR_931899.2:non_coding_transcript_exon_variant:MODIFIER:exon12/19:n.2615T>C::						rs690367		0.4635	21348,.	0.8732,0.3186,0.4142,0.3016,0.4349	1.4440			5.25				COSV55496541,COSV55506600	0.0129	0.3074	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43469998	43469998	C	T	het		QUAL=3267;DP=207;AF=0.57;MQM=60;SAP=7;ABP=13	TP53BP1	missense	TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon11/29:c.-1781G>A::,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:,TP53BP1:XM_011521985.2:missense_variant:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser:,TP53BP1:XM_011521986.3:missense_variant:MODERATE:exon11/24:c.1249G>A:p.Gly417Ser:,TP53BP1:XR_001751382.2:non_coding_transcript_exon_variant:MODIFIER:exon11/29:n.1362G>A::,TP53BP1:XR_931899.2:non_coding_transcript_exon_variant:MODIFIER:exon11/19:n.1362G>A::	regulatory_region_variant:TF_binding_site,TF_binding_site_variant			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1];		rs689647	0.3824	0.2816	10211,.	0.6566,0.2149,0.4114,0.1121,0.2250	1.3850	T(0.09),T(0.09),T(0.09),T(0.09)	B(0.00),B(0.00),B(0.00),B(0.00)	10.29	0.07			COSV55496549,COSV55506613	-0.2152	0.2971	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43475576	43475576	G	C	hom		QUAL=3605;DP=116;AF=1.00;MQM=60;SAP=3;ABP=0	TP53BP1	missense	TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:	TP53BP1:NM_001141979.3:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:NM_001141980.3:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:NM_001355001.2:5_prime_UTR_variant:MODIFIER:exon9/29:c.-1956C>G::,TP53BP1:NM_005657.4:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:,TP53BP1:XM_011521985.2:missense_variant:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu:,TP53BP1:XM_011521986.3:missense_variant:MODERATE:exon9/24:c.1074C>G:p.Asp358Glu:,TP53BP1:XR_001751382.2:non_coding_transcript_exon_variant:MODIFIER:exon9/29:n.1187C>G::,TP53BP1:XR_931899.2:non_coding_transcript_exon_variant:MODIFIER:exon9/19:n.1187C>G::				CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs560191		0.4631	21315,.	0.8730,0.3178,0.4140,0.3015,0.4352	0.1670	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	10.29	0.24			COSV55496034	0.1848	0.2374	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43480838	43480838	A	C	het	off-target	QUAL=10489;DP=864;AF=0.48;MQM=60;SAP=3;ABP=6	TP53BP1	intron	TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron5/27:c.484+57T>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron5/26:c.499+57T>G::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron5/27:c.499+57T>G::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron5/28:c.-2531+57T>G::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron5/27:c.484+57T>G::,TP53BP1:XM_011521985.2:intron_variant:MODIFIER:intron5/26:c.499+57T>G::,TP53BP1:XM_011521986.3:intron_variant:MODIFIER:intron5/23:c.499+57T>G::,TP53BP1:XR_001751382.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/28:n.612+57T>G::,TP53BP1:XR_931899.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/18:n.612+57T>G::						rs7173383	0.1368	0.1748	2501,.		-0.0460			1.75					-0.0814	0.5585	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43491802	43491802	C	T	hom	off-target	QUAL=26789;DP=851;AF=1.00;MQM=60;SAP=5;ABP=0	TP53BP1	intron	TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron3/27:c.272-49G>A::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron3/26:c.287-49G>A::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron3/27:c.287-49G>A::	TP53BP1:NM_001141979.3:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:NM_001141980.3:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:NM_001355001.2:intron_variant:MODIFIER:intron3/28:c.-2743-49G>A::,TP53BP1:NM_005657.4:intron_variant:MODIFIER:intron3/27:c.272-49G>A::,TP53BP1:XM_011521985.2:intron_variant:MODIFIER:intron3/26:c.287-49G>A::,TP53BP1:XM_011521986.3:intron_variant:MODIFIER:intron3/23:c.287-49G>A::,TP53BP1:XR_001751382.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/28:n.400-49G>A::,TP53BP1:XR_931899.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/18:n.400-49G>A::	regulatory_region_variant:promoter					rs555252		0.9870	71066,.	0.8771,0.9942,0.9993,0.9995,0.9683	0.0420			6.87					0.0182	0.1987	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=n/a oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	75351274	75351274	-	T	het	off-target	QUAL=571;DP=98;AF=0.12;MQM=60;SAP=55;ABP=58	NEIL1	intron	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-818dup::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-818dup::	NEIL1:NM_001256552.1:intron_variant:MODIFIER:intron2/9:c.693-818dup::,NEIL1:NM_001352519.2:intron_variant:MODIFIER:intron2/5:c.100-8dup::,NEIL1:NM_001352520.2:intron_variant:MODIFIER:intron3/10:c.129-818dup::,NEIL1:NM_024608.4:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:NR_046311.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/10:n.848-818dup::,NEIL1:XM_005254659.5:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:XM_006720677.4:intron_variant:MODIFIER:intron2/9:c.666-818dup::,NEIL1:XM_006720678.4:intron_variant:MODIFIER:intron2/8:c.693-1031dup::,NEIL1:XM_006720679.4:intron_variant:MODIFIER:intron2/9:c.564-818dup::,NEIL1:XM_006720680.2:intron_variant:MODIFIER:intron3/10:c.435-818dup::,NEIL1:XM_011522001.3:intron_variant:MODIFIER:intron2/9:c.624-818dup::,NEIL1:XM_011522002.2:intron_variant:MODIFIER:intron3/10:c.435-818dup::,NEIL1:XM_011522003.3:intron_variant:MODIFIER:intron4/11:c.435-818dup::,NEIL1:XM_011522004.3:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:XM_011522005.2:intron_variant:MODIFIER:intron2/10:c.100-8dup::,NEIL1:XM_011522006.2:intron_variant:MODIFIER:intron2/9:c.149-739dup::,NEIL1:XM_011522007.2:intron_variant:MODIFIER:intron3/10:c.149-739dup::,NEIL1:XM_011522008.2:intron_variant:MODIFIER:intron3/10:c.149-739dup::,NEIL1:XM_017022566.2:intron_variant:MODIFIER:intron2/8:c.666-1031dup::,NEIL1:XM_017022567.2:intron_variant:MODIFIER:intron2/9:c.149-739dup::,NEIL1:XM_017022568.1:intron_variant:MODIFIER:intron2/2:c.693-818dup::,NEIL1:XR_001751384.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/6:n.891-1031dup::,NEIL1:XR_001751385.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/6:n.823-8dup::,NEIL1:XR_002957677.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.790-818dup::,NEIL1:XR_002957679.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/8:n.956-8dup::,NEIL1:XR_002957680.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.624-8dup::,NEIL1:XR_002957681.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.597-8dup::,NEIL1:XR_002957682.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.620-8dup::,NEIL1:XR_243127.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.817-818dup::,NEIL1:XR_429472.4:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/6:n.821-1031dup::						rs11422837		0.3972	10965,.					0.87								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=n/a oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	75351275	75351275	T	-	het	off-target	QUAL=571;DP=98;AF=0.24;MQM=58;SAP=21;ABP=124	NEIL1	intron	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-818del::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-818del::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-818del::	NEIL1:NM_001256552.1:intron_variant:MODIFIER:intron2/9:c.693-818del::,NEIL1:NM_001352519.2:intron_variant:MODIFIER:intron2/5:c.100-8del::,NEIL1:NM_001352520.2:intron_variant:MODIFIER:intron3/10:c.129-818del::,NEIL1:NM_024608.4:intron_variant:MODIFIER:intron2/9:c.435-818del::,NEIL1:NR_046311.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/10:n.848-818del::,NEIL1:XM_005254659.5:intron_variant:MODIFIER:intron2/9:c.435-818del::,NEIL1:XM_006720677.4:intron_variant:MODIFIER:intron2/9:c.666-818del::,NEIL1:XM_006720678.4:intron_variant:MODIFIER:intron2/8:c.693-1031del::,NEIL1:XM_006720679.4:intron_variant:MODIFIER:intron2/9:c.564-818del::,NEIL1:XM_006720680.2:intron_variant:MODIFIER:intron3/10:c.435-818del::,NEIL1:XM_011522001.3:intron_variant:MODIFIER:intron2/9:c.624-818del::,NEIL1:XM_011522002.2:intron_variant:MODIFIER:intron3/10:c.435-818del::,NEIL1:XM_011522003.3:intron_variant:MODIFIER:intron4/11:c.435-818del::,NEIL1:XM_011522004.3:intron_variant:MODIFIER:intron2/9:c.435-818del::,NEIL1:XM_011522005.2:intron_variant:MODIFIER:intron2/10:c.100-8del::,NEIL1:XM_011522006.2:intron_variant:MODIFIER:intron2/9:c.149-739del::,NEIL1:XM_011522007.2:intron_variant:MODIFIER:intron3/10:c.149-739del::,NEIL1:XM_011522008.2:intron_variant:MODIFIER:intron3/10:c.149-739del::,NEIL1:XM_017022566.2:intron_variant:MODIFIER:intron2/8:c.666-1031del::,NEIL1:XM_017022567.2:intron_variant:MODIFIER:intron2/9:c.149-739del::,NEIL1:XM_017022568.1:intron_variant:MODIFIER:intron2/2:c.693-818del::,NEIL1:XR_001751384.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/6:n.891-1031del::,NEIL1:XR_001751385.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/6:n.823-8del::,NEIL1:XR_002957677.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.790-818del::,NEIL1:XR_002957679.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/8:n.956-8del::,NEIL1:XR_002957680.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.624-8del::,NEIL1:XR_002957681.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.597-8del::,NEIL1:XR_002957682.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.620-8del::,NEIL1:XR_243127.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.817-818del::,NEIL1:XR_429472.4:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/6:n.821-1031del::					AluJr (SINE/Alu)	rs11422837		0.0156	8,.		-0.0650			0.66					-0.1367	0.6314	0.01	1	248	0 / 2					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=n/a oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr16	3589138	3589138	A	G	het		QUAL=1353;DP=101;AF=0.52;MQM=60;SAP=5;ABP=4	SLX4	synonymous	SLX4:ENST00000294008.4:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:	SLX4:NM_032444.4:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:,SLX4:XM_011522715.3:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:,SLX4:XM_017023775.2:synonymous_variant:LOW:exon9/12:c.3678T>C:p.Asn1226=:,SLX4:XM_024450471.1:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:		613278_[GENE=SLX4_PHENOS=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive]	262053 [benign DISEASE=Fanconi anemia, complementation group P,Fanconi anemia,not specified];			rs3810812		0.6383	32978,.	0.8780,0.6691,0.7202,0.5133,0.7614	0.7530			2.17				COSV53564459	0.0145	0.0938	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	3589229	3589229	G	A	het		QUAL=1429;DP=111;AF=0.50;MQM=60;SAP=3;ABP=3	SLX4	missense	SLX4:ENST00000294008.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:	SLX4:NM_032444.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:,SLX4:XM_011522715.3:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:,SLX4:XM_017023775.2:missense_variant:MODERATE:exon9/12:c.3587C>T:p.Pro1196Leu:,SLX4:XM_024450471.1:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:		613278_[GENE=SLX4_PHENOS=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive]	885261 [uncertain significance DISEASE=Fanconi anemia, complementation group P,Fanconi anemia];	CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4];		rs72778139	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0002,0.0000	0.6280	T(0.16)	B(0.06)	16.19	0.11			COSV53560456	0.0011	0.0935	0	0	1	0 / 1					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	23603722	23603722	A	-	het	off-target	QUAL=275;DP=187;AF=0.17;MQM=60;SAP=23;ABP=184	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron12/12:c.3351-53del::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron12/12:c.2466-53del::	PALB2:NM_024675.4:intron_variant:MODIFIER:intron12/12:c.3351-53del::,PALB2:XM_011545946.2:intron_variant:MODIFIER:intron12/12:c.3357-53del::,PALB2:XM_011545947.2:intron_variant:MODIFIER:intron11/11:c.3208-53del::,PALB2:XM_011545948.2:intron_variant:MODIFIER:intron13/13:c.2466-53del::,PALB2:XM_017023671.1:intron_variant:MODIFIER:intron10/10:c.3120-53del::,PALB2:XM_017023672.2:intron_variant:MODIFIER:intron10/10:c.3114-53del::,PALB2:XM_017023673.2:intron_variant:MODIFIER:intron11/11:c.3202-53del::		610355_[GENE=PALB2_PHENOS={Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3); {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]			(A)n (Simple_repeat)	rs35294437		0.4302	589,.	0.4243,0.4254,0.4533,0.4244,0.4502	-1.7020			0.18				COSV55163224	0.0051	0.9466	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23629146	23629146	G	A	het	off-target	QUAL=255;DP=23;AF=0.48;MQM=60;SAP=13;ABP=3	PALB2	intron	PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron6/12:c.2586+58C>T::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::	PALB2:NM_024675.4:intron_variant:MODIFIER:intron6/12:c.2586+58C>T::,PALB2:XM_011545946.2:intron_variant:MODIFIER:intron6/12:c.2592+58C>T::,PALB2:XM_011545947.2:intron_variant:MODIFIER:intron6/11:c.2592+58C>T::,PALB2:XM_011545948.2:intron_variant:MODIFIER:intron7/13:c.1701+58C>T::,PALB2:XM_017023671.1:intron_variant:MODIFIER:intron6/10:c.2592+58C>T::,PALB2:XM_017023672.2:intron_variant:MODIFIER:intron6/10:c.2586+58C>T::,PALB2:XM_017023673.2:intron_variant:MODIFIER:intron6/11:c.2586+58C>T::		610355_[GENE=PALB2_PHENOS={Pancreatic cancer, susceptibility to, 3}, 613348 (3); Fanconi anemia, complementation group N, 610832 (3); {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	126663 [benign DISEASE=Familial cancer of breast];			rs249954	0.3500	0.3102	7832,.		0.3290			2.34				COSV55164558	0.1089	0.387	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	68737438	68737440	TCT	-	het		QUAL=577;DP=134;AF=0.33;MQM=60;SAP=99;ABP=37	CDH1	inframe_deletion	CDH1:ENST00000261769.10:inframe_deletion:MODERATE:exon1/16:c.23_25del:p.Leu8_Ser9delinsPro:,CDH1:ENST00000422392.6:inframe_deletion:MODERATE:exon1/15:c.23_25del:p.Leu8_Ser9delinsPro:	CDH1:NM_001317184.2:inframe_deletion:MODERATE:exon1/15:c.23_25del:p.Leu8_Ser9delinsPro:,CDH1:NM_001317185.2:5_prime_UTR_variant:MODIFIER:exon1/16:c.-1593_-1591del::,CDH1:NM_001317186.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-1797_-1795del::,CDH1:NM_004360.5:inframe_deletion:MODERATE:exon1/16:c.23_25del:p.Leu8_Ser9delinsPro:	regulatory_region_variant:promoter	192090_[GENE=CDH1_PHENOS=Endometrial carcinoma, somatic, 608089 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant; Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; {Breast cancer, lobular}, 114480 (3), Somatic mutation, Autosomal dominant; Ovarian cancer, somatic, 167000 (3)]									0.2190								-0.0347	0.2606	0	0	0	0 / 0					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68737469	68737469	C	T	hom		QUAL=4018;DP=128;AF=0.99;MQM=60;SAP=3;ABP=0	CDH1	splice_region&intron	CDH1:ENST00000261769.10:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::,CDH1:ENST00000422392.6:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::	CDH1:NM_001317184.2:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::,CDH1:NM_001317185.2:splice_region_variant&intron_variant:LOW:intron1/15:c.-1568+6C>T::,CDH1:NM_001317186.2:splice_region_variant&intron_variant:LOW:intron1/14:c.-1772+6C>T::,CDH1:NM_004360.5:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::	regulatory_region_variant:promoter	192090_[GENE=CDH1_PHENOS=Endometrial carcinoma, somatic, 608089 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant; Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; {Breast cancer, lobular}, 114480 (3), Somatic mutation, Autosomal dominant; Ovarian cancer, somatic, 167000 (3)]	136692 [benign DISEASE=Hereditary diffuse gastric cancer,Hereditary cancer-predisposing syndrome,not specified,none provided,not provided];			rs3743674	0.7634	0.8161	50031,.	0.6465,0.7409,0.7648,0.8784,0.7780	-0.1320			6.86		8.63>8.16	0.000/0.032	COSV55733220	-0.132	0.3636	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68737515	68737515	-	GCCCCAGCCCCGT	hom	off-target	QUAL=2378;DP=85;AF=0.99;MQM=60;SAP=3;ABP=0	CDH1	intron	CDH1:ENST00000261769.10:intron_variant:MODIFIER:intron1/15:c.48+62_48+63insCGTGCCCCAGCCC::,CDH1:ENST00000422392.6:intron_variant:MODIFIER:intron1/14:c.48+62_48+63insCGTGCCCCAGCCC::	CDH1:NM_001317184.2:intron_variant:MODIFIER:intron1/14:c.48+62_48+63insCGTGCCCCAGCCC::,CDH1:NM_001317185.2:intron_variant:MODIFIER:intron1/15:c.-1568+62_-1568+63insCGTGCCCCAGCCC::,CDH1:NM_001317186.2:intron_variant:MODIFIER:intron1/14:c.-1772+62_-1772+63insCGTGCCCCAGCCC::,CDH1:NM_004360.5:intron_variant:MODIFIER:intron1/15:c.48+62_48+63insCGTGCCCCAGCCC::	regulatory_region_variant:promoter,TF_binding_site_variant	192090_[GENE=CDH1_PHENOS=Endometrial carcinoma, somatic, 608089 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant; Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; {Breast cancer, lobular}, 114480 (3), Somatic mutation, Autosomal dominant; Ovarian cancer, somatic, 167000 (3)]				rs45625236		0.8107	47776,.	0.6400,0.7363,0.7605,0.8698,0.7752				8.71				COSV55741627	0.1373	0.2609	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), RNA5SP429 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	68823538	68823538	T	C	het		QUAL=14799;DP=1140;AF=0.52;MQM=60;SAP=3;ABP=9	CDH1	synonymous	CDH1:ENST00000261769.10:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:,CDH1:ENST00000422392.6:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:	CDH1:NM_001317184.2:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:,CDH1:NM_001317185.2:synonymous_variant:LOW:exon13/16:c.528T>C:p.Ala176=:,CDH1:NM_001317186.2:synonymous_variant:LOW:exon12/15:c.111T>C:p.Ala37=:,CDH1:NM_004360.5:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	192090_[GENE=CDH1_PHENOS=Endometrial carcinoma, somatic, 608089 (3); {Prostate cancer, susceptibility to}, 176807 (3), Somatic mutation, Autosomal dominant; Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Gastric cancer, hereditary diffuse, with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; {Breast cancer, lobular}, 114480 (3), Somatic mutation, Autosomal dominant; Ovarian cancer, somatic, 167000 (3)]	142770 [benign DISEASE=Hereditary diffuse gastric cancer,Hereditary cancer-predisposing syndrome,not specified,none provided];	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1];		rs1801552		0.6983	38020,.	0.8906,0.6658,0.6503,0.6253,0.6535	0.0880			8.26				COSV55728161	0.0748	0.3653	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), FTLP14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	81783128	81783128	C	T	het		QUAL=4998;DP=430;AF=0.51;MQM=60;SAP=291;ABP=3	PLCG2	intron	PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::	PLCG2:NM_002661.5:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::		600220_[GENE=PLCG2_PHENOS=Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant; Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant]				rs8045964	0.4241	0.4282	13632,.	0.3924,0.3658,0.2790,0.4221,0.6311	-0.4400			1.02				COSV63869127			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783182	81783182	T	A	hom	off-target	QUAL=24059;DP=746;AF=1.00;MQM=60;SAP=3;ABP=0	PLCG2	intron	PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::	PLCG2:NM_002661.5:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::		600220_[GENE=PLCG2_PHENOS=Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant; Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant]				rs4476171		0.9994	76019,.		-1.8100			0.13							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	89738853	89738853	A	G	hom	off-target	QUAL=17997;DP=573;AF=1.00;MQM=60;SAP=3;ABP=0	ZNF276,FANCA	3'UTR,intron	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron42/42:c.4260+29T>C::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron42/42:c.4264+29T>C::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron42/42:c.4260+29T>C::,ZNF276:NM_001113525.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron42/42:c.4264+29T>C::,ZNF276:NM_152287.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,ZNF276:NR_110122.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2607A>G::,ZNF276:NR_110126.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2490A>G::,ZNF276:NR_110128.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2430A>G::,ZNF276:NR_110129.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2524A>G::,ZNF276:XM_017023890.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*607A>G::,ZNF276:XR_933484.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.2618A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255266 [benign DISEASE=not specified];			rs1800359		0.7228	41663,.	0.9362,0.7857,0.9868,0.5909,0.8015	-6.7440			0.04				COSV57066846	0.109	0.8889	0.13	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=n/a oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89739569	89739569	G	A	het	off-target	QUAL=2213;DP=181;AF=0.48;MQM=60;SAP=10;ABP=4	ZNF276,FANCA	3'UTR,intron	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron39/42:c.3935-16C>T::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron39/42:c.3935-16C>T::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron39/42:c.3935-16C>T::,ZNF276:NM_001113525.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron39/42:c.3935-16C>T::,ZNF276:NM_152287.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,ZNF276:NR_110122.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3323G>A::,ZNF276:NR_110126.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3206G>A::,ZNF276:NR_110128.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3146G>A::,ZNF276:NR_110129.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3240G>A::,ZNF276:XM_017023890.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1323G>A::,ZNF276:XR_933484.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3334G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255264 [benign DISEASE=not specified];			rs1061646		0.4245	14112,.	0.5457,0.6134,0.7247,0.2933,0.4714	0.3980			4.77		8.17>8.42		COSV57068489	0.3468	0.9433	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=n/a oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89739939	89739939	A	T	het	off-target	QUAL=879;DP=48;AF=0.71;MQM=60;SAP=3;ABP=21	ZNF276,FANCA	3'UTR,intron	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,ZNF276:NM_001113525.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,ZNF276:NM_152287.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,ZNF276:NR_110122.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3693A>T::,ZNF276:NR_110126.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3576A>T::,ZNF276:NR_110128.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3516A>T::,ZNF276:NR_110129.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.3610A>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	135541 [not provided DISEASE=not specified];			rs7195906		0.5421	24964,.	0.7747,0.6672,0.9831,0.3801,0.5897	-0.7080			2.22				COSV57065786	-0.0109	0.9438	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=n/a oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89748809	89748809	C	T	het	off-target	QUAL=1916;DP=156;AF=0.51;MQM=60;SAP=3;ABP=3	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255254 [benign DISEASE=not specified];	CS137887 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs1800345	0.5449	0.4279	14350,.	0.5555,0.6309,0.7528,0.2993,0.4786	-0.7150			0.63					-0.2069	0.9081	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89752083	89752083	T	C	het	off-target	QUAL=9384;DP=751;AF=0.49;MQM=60;SAP=3;ABP=3	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::	regulatory_region_variant:CTCF_binding_site	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]				rs3743860	0.5865	0.4730	17820,.		-0.1620			4.09				COSV59795426	-0.0235	0.1227	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89765102	89765102	C	A	het	off-target	QUAL=11999;DP=972;AF=0.48;MQM=60;SAP=4;ABP=6	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255248 [benign DISEASE=not specified];			rs2159116	0.0933	0.1454	1477,.	0.0354,0.0997,0.0033,0.1836,0.1863	-2.7020			0.46				COSV59796461	0.0569	0.2314	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89769915	89769915	C	T	het		QUAL=829;DP=95;AF=0.40;MQM=60;SAP=14;ABP=11	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000568369.5:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:	FANCA:NM_000135.4:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134254 [benign DISEASE=Fanconi anemia, complementation group A,Fanconi anemia,not specified];	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia A" GENE=FANCA];		rs7195066		0.4727	19532,.	0.6757,0.6527,0.9854,0.3093,0.5889	0.0770	T(0.31),T(0.31)	B(0.00),B(0.00)	12.81	0.20			COSV59796193	-0.8381	0.9724	0.41	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89771670	89771670	A	G	het		QUAL=12928;DP=1057;AF=0.49;MQM=60;SAP=3;ABP=5	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000568369.5:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::	FANCA:NM_000135.4:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:NM_001286167.3:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255245 [benign DISEASE=Fanconi anemia, complementation group A,Fanconi anemia,not specified];			rs1800340	0.5599	0.4376	14233,.	0.5199,0.6353,0.7430,0.3035,0.5709	-1.3870			0.04			0.000/0.000	COSV66881670	0.5986	0.017	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89778786	89778786	A	G	het	off-target	QUAL=6231;DP=616;AF=0.53;MQM=60;SAP=696;ABP=8	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron20/42:c.1826+15T>C::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron20/42:c.1826+15T>C::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron20/42:c.1826+15T>C::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron20/42:c.1826+15T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255241 [benign DISEASE=Fanconi anemia, complementation group A,not specified];			rs1800337		0.5177	22344,.	0.6912,0.6621,0.9843,0.3806,0.5917	-1.3620			0.76					-0.2189	0.323	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783072	89783072	C	T	hom		QUAL=6739;DP=202;AF=1.00;MQM=60;SAP=83;ABP=0	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000568369.5:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus]	FANCA:NM_000135.4:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134244 [benign DISEASE=Fanconi anemia, complementation group A,Fanconi anemia,not specified];	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs2239359		0.5134	21654,.	0.6922,0.6207,0.8561,0.3908,0.4927	-0.9650	T(1.00),T(1.00)	B(0.00),B(0.00)	0.34	0.26			COSV66881058	-0.0985	0.1132	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791556	89791556	T	C	het	off-target;low_conf_region	QUAL=14549;DP=1042;AF=0.53;MQM=60;SAP=4;ABP=11	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron13/42:c.1226-20A>G::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron13/42:c.1226-20A>G::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron13/42:c.1226-20A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron13/42:c.1226-20A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255232 [benign DISEASE=not specified];			rs1800330	0.5719	0.4408	15190,.	0.5601,0.6379,0.7532,0.3041,0.5673	-5.4410			0.01		4.71>4.86		COSV66881251	-0.0147	0.8821	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792097	89792097	T	C	het	off-target	QUAL=4331;DP=304;AF=0.51;MQM=60;SAP=3;ABP=3	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255229 [benign DISEASE=not specified];			rs6500452	0.5317	0.4185	13540,.	0.5151,0.6311,0.7490,0.2939,0.4777	-2.0850			0.09				COSV66880734	0.0339	0.8272	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792117	89792117	C	G	het	off-target	QUAL=4358;DP=307;AF=0.51;MQM=60;SAP=3;ABP=3	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255230 [benign DISEASE=not specified];			rs1800287		0.5383	24598,.	0.7636,0.6651,0.9842,0.3815,0.5884	-0.1090			1.07				COSV66881254	-0.0698	0.9211	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792600	89792600	G	A	het	off-target	QUAL=948;DP=102;AF=0.41;MQM=60;SAP=24;ABP=10	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]				rs3856	0.5302	0.4045	13293,.		-0.0020			2.88					0.0947	0.2816	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792608	89792608	T	-	het	off-target	QUAL=876;DP=104;AF=0.39;MQM=60;SAP=22;ABP=13	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron11/42:c.1007-61del::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron11/42:c.1007-61del::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]				rs35617323	0.3570	0.4847	19147,.		0.0480			0.75					-0.0313	0.2811	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799635	89799635	T	C	het		QUAL=9341;DP=729;AF=0.49;MQM=60;SAP=3;ABP=3	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000389302.7:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000534992.5:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000543736.5:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000563673.5:missense_variant:MODERATE:exon9/10:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000568369.5:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus]	FANCA:NM_000135.4:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:,FANCA:NM_001018112.3:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:,FANCA:NM_001286167.3:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:,FANCA:NM_001351830.2:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134294 [benign DISEASE=Malignant tumor of breast,Fanconi anemia, complementation group A,Fanconi anemia,not specified];	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs7190823	0.6905	0.5309	23636,.	0.7249,0.6678,0.9844,0.3847,0.5899	0.6710	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	2.79	0.08				0.2453	0.3475	0.25	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89803353	89803353	T	C	hom	off-target	QUAL=3848;DP=114;AF=1.00;MQM=60;SAP=3;ABP=0	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron7/42:c.710-12A>G::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron7/10:c.710-12A>G::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron7/10:c.710-12A>G::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron6/9:c.614-12A>G::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron7/9:c.710-12A>G::,FANCA:ENST00000568369.5:intron_variant:MODIFIER:intron7/42:c.710-12A>G::	FANCA:NM_000135.4:intron_variant:MODIFIER:intron7/42:c.710-12A>G::,FANCA:NM_001018112.3:intron_variant:MODIFIER:intron7/10:c.710-12A>G::,FANCA:NM_001286167.3:intron_variant:MODIFIER:intron7/42:c.710-12A>G::,FANCA:NM_001351830.2:intron_variant:MODIFIER:intron6/9:c.614-12A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255269 [benign DISEASE=Fanconi anemia, complementation group A,not specified];			rs1800286		0.7172	40949,.	0.9231,0.7825,0.9887,0.5904,0.7959	-1.9470			1.75		9.13>9.77	0.000/0.040		-0.1221	0.0527	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr17	7669662	7669662	T	G	het		QUAL=154;DP=216;AF=0.35;MQM=60;SAP=168;ABP=44	TP53	missense,intron,3'UTR	TP53:ENST00000269305.9:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron8/8:c.994-3418A>C::,TP53:ENST00000413465.6:intron_variant:MODIFIER:intron6/6:c.782+4519A>C::,TP53:ENST00000420246.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::,TP53:ENST00000445888.6:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:ENST00000455263.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::,TP53:ENST00000504290.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*148A>C::,TP53:ENST00000504937.5:missense_variant:MODERATE:exon7/7:c.733A>C:p.Thr245Pro:,TP53:ENST00000510385.5:3_prime_UTR_variant:MODIFIER:exon8/8:c.*236A>C::,TP53:ENST00000610292.4:missense_variant:MODERATE:exon10/10:c.1012A>C:p.Thr338Pro:,TP53:ENST00000610538.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::,TP53:ENST00000610623.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*148A>C::,TP53:ENST00000618944.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*236A>C::,TP53:ENST00000619186.4:missense_variant:MODERATE:exon7/7:c.652A>C:p.Thr218Pro:,TP53:ENST00000619485.4:missense_variant:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro:,TP53:ENST00000620739.4:missense_variant:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro:,TP53:ENST00000622645.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::	TP53:NM_000546.6:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:NM_001126112.3:missense_variant:MODERATE:exon11/11:c.1129A>C:p.Thr377Pro:,TP53:NM_001126113.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::,TP53:NM_001126114.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::,TP53:NM_001126115.2:missense_variant:MODERATE:exon7/7:c.733A>C:p.Thr245Pro:,TP53:NM_001126116.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*236A>C::,TP53:NM_001126117.2:3_prime_UTR_variant:MODIFIER:exon8/8:c.*148A>C::,TP53:NM_001126118.2:missense_variant:MODERATE:exon10/10:c.1012A>C:p.Thr338Pro:,TP53:NM_001276695.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*148A>C::,TP53:NM_001276696.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*236A>C::,TP53:NM_001276697.3:missense_variant:MODERATE:exon7/7:c.652A>C:p.Thr218Pro:,TP53:NM_001276698.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*236A>C::,TP53:NM_001276699.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*148A>C::,TP53:NM_001276760.3:missense_variant:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro:,TP53:NM_001276761.3:missense_variant:MODERATE:exon11/11:c.1012A>C:p.Thr338Pro:		191170_[GENE=TP53_PHENOS={Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; {Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; Nasopharyngeal carcinoma, somatic, 607107 (3); Breast cancer, somatic, 114480 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Pancreatic cancer, somatic, 260350 (3)]	975959 [uncertain significance DISEASE=Li-Fraumeni syndrome 1];			rs774269719		0.0003	0,.	0.0005,0.0000,0.0001,0.0004,0.0002	0.4640	T(0.29), , , ,T(0.29), , ,T(0.28), ,T(0.28), , , ,T(0.29),T(0.28),T(0.28), 	B(0.01), , , ,B(0.01), , ,B(0.01), ,B(0.01), , , ,B(0.01),B(0.01),B(0.01), 	19.38	0.35			COSV52716766	-0.1083	0.9312	0.06	0	0	0 / 0					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7673159	7673159	G	A	het	off-target	QUAL=21;DP=4;AF=0.75;MQM=60;SAP=10;ABP=5	TP53	intron	TP53:ENST00000269305.9:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron8/8:c.993+376C>T::,TP53:ENST00000413465.6:intron_variant:MODIFIER:intron6/6:c.782+1022C>T::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::,TP53:ENST00000504290.5:intron_variant:MODIFIER:intron6/7:c.*12+48C>T::,TP53:ENST00000504937.5:intron_variant:MODIFIER:intron5/6:c.597+376C>T::,TP53:ENST00000510385.5:intron_variant:MODIFIER:intron6/7:c.*100+48C>T::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron8/9:c.876+376C>T::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::,TP53:ENST00000610623.4:intron_variant:MODIFIER:intron6/7:c.*12+48C>T::,TP53:ENST00000618944.4:intron_variant:MODIFIER:intron6/7:c.*100+48C>T::,TP53:ENST00000619186.4:intron_variant:MODIFIER:intron5/6:c.516+376C>T::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron9/10:c.876+376C>T::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron9/10:c.876+376C>T::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::	TP53:NM_000546.6:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:NM_001126112.3:intron_variant:MODIFIER:intron9/10:c.993+376C>T::,TP53:NM_001126113.3:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::,TP53:NM_001126114.3:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::,TP53:NM_001126115.2:intron_variant:MODIFIER:intron5/6:c.597+376C>T::,TP53:NM_001126116.2:intron_variant:MODIFIER:intron6/7:c.*100+48C>T::,TP53:NM_001126117.2:intron_variant:MODIFIER:intron6/7:c.*12+48C>T::,TP53:NM_001126118.2:intron_variant:MODIFIER:intron8/9:c.876+376C>T::,TP53:NM_001276695.3:intron_variant:MODIFIER:intron10/11:c.*12+48C>T::,TP53:NM_001276696.3:intron_variant:MODIFIER:intron10/11:c.*100+48C>T::,TP53:NM_001276697.3:intron_variant:MODIFIER:intron5/6:c.516+376C>T::,TP53:NM_001276698.3:intron_variant:MODIFIER:intron6/7:c.*100+48C>T::,TP53:NM_001276699.3:intron_variant:MODIFIER:intron6/7:c.*12+48C>T::,TP53:NM_001276760.3:intron_variant:MODIFIER:intron9/10:c.876+376C>T::,TP53:NM_001276761.3:intron_variant:MODIFIER:intron9/10:c.876+376C>T::		191170_[GENE=TP53_PHENOS={Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; {Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; Nasopharyngeal carcinoma, somatic, 607107 (3); Breast cancer, somatic, 114480 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Pancreatic cancer, somatic, 260350 (3)]			Tigger5b (DNA/TcMar-Tigger)						0.0110			2.96					0.0532	0.5803	0	0	0	0 / 0					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7676154	7676154	G	C	het		QUAL=7653;DP=570;AF=0.54;MQM=60;SAP=4;ABP=10	TP53	missense	TP53:ENST00000269305.9:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000359597.8:missense_variant:MODERATE:exon3/9:c.215C>G:p.Pro72Arg:,TP53:ENST00000413465.6:missense_variant:MODERATE:exon3/7:c.215C>G:p.Pro72Arg:,TP53:ENST00000420246.6:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000445888.6:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000455263.6:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000610292.4:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg:,TP53:ENST00000610538.4:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:ENST00000619485.4:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:ENST00000620739.4:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:ENST00000622645.4:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:	TP53:NM_000546.6:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:NM_001126112.3:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:NM_001126113.3:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:NM_001126114.3:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:NM_001126118.2:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg:,TP53:NM_001276695.3:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:NM_001276696.3:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:NM_001276760.3:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:NM_001276761.3:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:		191170_[GENE=TP53_PHENOS={Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; {Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; Nasopharyngeal carcinoma, somatic, 607107 (3); Breast cancer, somatic, 114480 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Pancreatic cancer, somatic, 260350 (3)]	12351 [drug response DISEASE=CODON 72 POLYMORPHISM,Li-Fraumeni syndrome 1,Hereditary cancer-predisposing syndrome,Li-Fraumeni syndrome,Lip and oral cavity carcinoma,not specified,none provided,antineoplastic agents response - Efficacy, Toxicity/ADR,cisplatin response - Efficacy, Toxicity/ADR,cyclophosphamide response - Efficacy, Toxicity/ADR,fluorouracil response - Efficacy, Toxicity/ADR,paclitaxel response - Efficacy, Toxicity/ADR,not provided];			rs1042522		0.6682	31786,.	0.3799,0.7145,0.5700,0.7378,0.5002	1.4380	T(0.57),T(0.36),T(0.24),T(0.26),T(0.57),T(0.37),T(0.26),T(0.31),T(0.26),T(0.26),T(0.32)	B(0.05),B(0.35),B(0.37),B(0.13),B(0.05),B(0.15),B(0.05),B(0.15),B(0.05),B(0.05),B(0.13)	5.09	0.37			COSV52666208,COSV53098660	0.0506	0.2351	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7676326	7676341	CCCCAGCCCTCCAGGT	-	het	off-target	QUAL=134;DP=20;AF=0.50;MQM=60;SAP=17;ABP=3	TP53	intron	TP53:ENST00000269305.9:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron2/8:c.96+41_97-54del::,TP53:ENST00000413465.6:intron_variant:MODIFIER:intron2/6:c.96+41_97-54del::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron2/9:c.-22+41_-21-54del::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::	TP53:NM_000546.6:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:NM_001126112.3:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:NM_001126113.3:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:NM_001126114.3:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:NM_001126118.2:intron_variant:MODIFIER:intron2/9:c.-22+41_-21-54del::,TP53:NM_001276695.3:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:NM_001276696.3:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:NM_001276760.3:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:NM_001276761.3:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::		191170_[GENE=TP53_PHENOS={Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; {Glioma susceptibility 1}, 137800 (3), Somatic mutation, Autosomal dominant; {Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Somatic mutation, Autosomal dominant; Nasopharyngeal carcinoma, somatic, 607107 (3); Breast cancer, somatic, 114480 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Pancreatic cancer, somatic, 260350 (3)]	440349 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified];			rs59758982		0.8270	51911,.		1.0620			2.80					0.2762	0.2084	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	31226467	31226467	G	A	hom		QUAL=2514;DP=83;AF=1.00;MQM=60;SAP=25;ABP=0	NF1	synonymous	NF1:ENST00000356175.7:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:ENST00000358273.9:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:	NF1:NM_000267.3:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:NM_001042492.3:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:		613113_[GENE=NF1_PHENOS=Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Watson syndrome, 193520 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant]	183826 [benign DISEASE=Neurofibromatosis, familial spinal,Cafe-au-lait macules with pulmonary stenosis,Neurofibromatosis-Noonan syndrome,Hereditary cancer-predisposing syndrome,Neurofibromatosis, type 1,not specified,none provided,not provided];			rs2285892	0.4968	0.4252	15853,.	0.6830,0.4940,0.5192,0.3012,0.3700	-1.2810			1.98				COSV62191601	-0.0802	0.2782	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232069	31232069	-	T	het	off-target	QUAL=512;DP=117;AF=0.22;MQM=60;SAP=15;ABP=81	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron24/56:c.3198-4dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron24/57:c.3198-4dup::	NF1:NM_000267.3:intron_variant:MODIFIER:intron24/56:c.3198-4dup::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron24/57:c.3198-4dup::		613113_[GENE=NF1_PHENOS=Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Watson syndrome, 193520 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant]	803349 [benign DISEASE=Neurofibromatosis, type 1];			rs371047262		0.2195	4358,.	0.1409,0.2117,0.2402,0.0924,0.0980				3.43								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232914	31232914	C	A	hom	off-target	QUAL=1030;DP=35;AF=1.00;MQM=60;SAP=71;ABP=0	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron26/56:c.3496+33C>A::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron26/57:c.3496+33C>A::	NF1:NM_000267.3:intron_variant:MODIFIER:intron26/56:c.3496+33C>A::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron26/57:c.3496+33C>A::		613113_[GENE=NF1_PHENOS=Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Watson syndrome, 193520 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant]	257285 [benign DISEASE=not specified];			rs2066736	0.4581	0.4036	13847,.	0.6156,0.4861,0.4375,0.2999,0.3653	0.2040			1.36				COSV62196981	0.0482	0.4187	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31236055	31236055	-	TG	hom	off-target	QUAL=9290;DP=402;AF=0.91;MQM=60;SAP=505;ABP=0	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron29/56:c.3974+36_3974+37dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron29/57:c.3974+36_3974+37dup::	NF1:NM_000267.3:intron_variant:MODIFIER:intron29/56:c.3974+36_3974+37dup::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron29/57:c.3974+36_3974+37dup::		613113_[GENE=NF1_PHENOS=Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Watson syndrome, 193520 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant]			(T)n (Simple_repeat)	rs1555615581		0.0012	0,.	0.0048,0.0016,0.0008,0.0003,0.0011				1.26					-0.1072	0.4329	0	23	464	0 / 4					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31236067	31236067	T	G	hom	off-target	QUAL=10229;DP=371;AF=0.99;MQM=60;SAP=508;ABP=0	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron29/56:c.3974+46T>G::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron29/57:c.3974+46T>G::	NF1:NM_000267.3:intron_variant:MODIFIER:intron29/56:c.3974+46T>G::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron29/57:c.3974+46T>G::		613113_[GENE=NF1_PHENOS=Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Watson syndrome, 193520 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant]			(T)n (Simple_repeat)	rs72813695		0.0120	1,.	0.0289,0.0160,0.0175,0.0083,0.0099	-1.2570			0.72				COSV62193060	-0.0532	0.4323	0.01	19	472	0 / 4					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31336607	31336607	-	A	hom	off-target	QUAL=833;DP=40;AF=0.78;MQM=60;SAP=47;ABP=0	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron40/56:c.6085-17dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron41/57:c.6148-17dup::	NF1:NM_000267.3:intron_variant:MODIFIER:intron40/56:c.6085-17dup::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron41/57:c.6148-17dup::		613113_[GENE=NF1_PHENOS=Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Watson syndrome, 193520 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant]	495785 [benign DISEASE=not provided];			rs33925668		0.3420	9270,.	0.3519,0.3449,0.3132,0.2280,0.2049				0.15					-0.1696	0.9023	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31343172	31343172	C	G	hom	off-target	QUAL=5223;DP=163;AF=1.00;MQM=60;SAP=3;ABP=0	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron47/56:c.7126+37C>G::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron48/57:c.7189+37C>G::	NF1:NM_000267.3:intron_variant:MODIFIER:intron47/56:c.7126+37C>G::,NF1:NM_001042492.3:intron_variant:MODIFIER:intron48/57:c.7189+37C>G::		613113_[GENE=NF1_PHENOS=Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Somatic mutation, Autosomal dominant; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Watson syndrome, 193520 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant]	257300 [benign DISEASE=not specified,not provided];			rs7405740	0.8738	0.9074	59658,.	0.7987,0.8870,0.8808,0.9149,0.9485	-1.4250			1.00					0.0359	0.3352	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22), AK4P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	35106468	35106468	C	T	hom		QUAL=2531;DP=85;AF=1.00;MQM=60;SAP=46;ABP=0	RAD51D,	missense,5'UTR	RAD51D:ENST00000335858.11:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:PF08423 [Rad51],RAD51D:ENST00000345365.11:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000394589.8:missense_variant:MODERATE:exon7/11:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000460118.6:5_prime_UTR_variant:MODIFIER:exon5/9:c.-38G>A::,RAD51D:ENST00000590016.5:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:PF08423 [Rad51],:ENST00000593039.5:missense_variant:MODERATE:exon2/7:c.17G>A:p.Arg6Gln:PF08423 [Rad51]	RAD51D:NM_001142571.2:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:,RAD51D:NM_002878.4:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:,RAD51D:NM_133629.3:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:,RAD51D:NR_037711.2:non_coding_transcript_exon_variant:MODIFIER:exon5/9:n.520G>A::,RAD51D:NR_037712.2:non_coding_transcript_exon_variant:MODIFIER:exon4/8:n.385G>A::,RAD51L3-RFFL:NR_037714.1:non_coding_transcript_exon_variant:MODIFIER:exon2/7:n.246G>A::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	142159 [benign DISEASE=Breast-ovarian cancer, familial 4,Hereditary cancer-predisposing syndrome,not specified];	CM172631 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=RAD51D];		rs4796033	0.0951	0.1555	1452,.	0.0296,0.2950,0.0455,0.1414,0.1630	1.1790	T(1.00),T(1.00),T(1.00), ,T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00), ,B(0.01),B(0.00)	14.87	0.13			COSV104653496	-0.3303	0.9421	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=n/a oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35118530	35118530	G	A	het		QUAL=1656;DP=131;AF=0.55;MQM=60;SAP=7;ABP=6	RAD51D,	intron,synonymous	RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:ENST00000345365.11:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000394589.8:synonymous_variant:LOW:exon4/11:c.234C>T:p.Ser78=:PF08423 [Rad51],RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron2/8:c.-208+581C>T::,RAD51D:ENST00000590016.5:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,:ENST00000593039.5:intron_variant:MODIFIER:intron1/6:c.3+2761C>T::	RAD51D:NM_001142571.2:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51D:NM_002878.4:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:,RAD51D:NM_133629.3:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:NR_037711.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/8:n.289+581C>T::,RAD51D:NR_037712.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/7:n.289+581C>T::,RAD51L3-RFFL:NR_037714.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.232+2761C>T::	regulatory_region_variant:CTCF_binding_site	602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	183785 [benign DISEASE=Breast-ovarian cancer, familial 4,Hereditary cancer-predisposing syndrome,not specified];			rs9901455	0.1875	0.1558	2577,.	0.3055,0.1043,0.2299,0.0821,0.0860	1.6750			17.75				COSV99338663	-0.0467	0.6691	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=n/a oe_syn=1.01 oe_mis=1.02 oe_lof=0.80), FNDC8 (inh=n/a oe_syn=0.99 oe_mis=0.91 oe_lof=0.69)
chr17	43071077	43071077	T	C	het		QUAL=4362;DP=432;AF=0.47;MQM=60;SAP=269;ABP=6	BRCA1	missense,intron	BRCA1:ENST00000352993.7:missense_variant:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly:,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000468300.5:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:ENST00000491747.6:missense_variant:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-7126A>G::,BRCA1:ENST00000591534.5:missense_variant:MODERATE:exon3/11:c.310A>G:p.Ser104Gly:,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-20887A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:NM_007298.3:missense_variant:MODERATE:exon14/22:c.1525A>G:p.Ser509Gly:,BRCA1:NM_007299.4:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:NM_007300.4:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon15/23:n.5014A>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	41827 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799966	0.3558	0.3539	8001,.	0.2404,0.3171,0.3801,0.3259,0.5041	-0.1940	T(0.11),T(0.11),T(0.12),T(0.12),T(0.10),T(0.11), ,T(0.20), 	B(0.01),B(0.04),B(0.00),B(0.07),B(0.02),B(0.04), ,B(0.04), 	8.64	0.25			COSV58783381	-0.0744	0.319	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43082453	43082453	A	G	het		QUAL=343;DP=34;AF=0.50;MQM=60;SAP=25;ABP=3	BRCA1	synonymous,intron	BRCA1:ENST00000352993.7:synonymous_variant:LOW:exon11/22:c.882T>C:p.Ser294=:,BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000468300.5:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000491747.6:synonymous_variant:LOW:exon12/23:c.999T>C:p.Ser333=:,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-18502T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-7932T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-32263T>C::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:NM_007298.3:synonymous_variant:LOW:exon11/22:c.999T>C:p.Ser333=:,BRCA1:NM_007299.4:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:NM_007300.4:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon12/23:n.4485T>C::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	125703 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM1719086 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1060915	0.3363	0.3485	7437,.	0.1820,0.3116,0.3787,0.3255,0.5038	0.1030			3.88				COSV58783806	-0.001	0.3454	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43091983	43091983	T	C	het		QUAL=4694;DP=350;AF=0.49;MQM=60;SAP=4;ABP=3	BRCA1	intron,missense	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-951A>G::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-951A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28032A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17462A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+33288A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.788-951A>G::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.3725A>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	41818 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1];		rs16942	0.3526	0.3527	7887,.	0.2365,0.3164,0.3795,0.3242,0.5039	-0.3190	 ,T(1.00),T(1.00), ,T(1.00), ,T(1.00), , , 	 ,B(0.00),B(0.00), ,B(0.00), ,B(0.00), , , 	1.10	0.07			COSV58784397	0.0032	0.8933	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092418	43092418	T	C	het		QUAL=10833;DP=980;AF=0.49;MQM=60;SAP=4;ABP=5	BRCA1	intron,missense	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1386A>G::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-1386A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28467A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17897A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32853A>G::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.3113A>G:p.Glu1038Gly:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.2972A>G:p.Glu991Gly:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.788-1386A>G::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.788-1386A>G::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.3113A>G:p.Glu1038Gly:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.3290A>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	41815 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Malignant tumor of breast,Breast-ovarian cancer, familial 1,Pancreatic cancer 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,none provided,not provided];	CM032861 [CLASS=DP MUT=ALT PHEN="Endometriosis association with" GENE=BRCA1];		rs16941	0.3357	0.3483	7401,.	0.1818,0.3112,0.3789,0.3252,0.5035	-0.1490	 ,T(0.06),T(0.16), ,T(0.17), ,T(0.15), , , 	 ,B(0.12),P(0.61), ,B(0.00), ,P(0.61), , , 	14.07	0.23			COSV58786412	0.0013	0.8933	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092919	43092919	G	A	het		QUAL=2121;DP=130;AF=0.58;MQM=60;SAP=9;ABP=11	BRCA1	intron,missense	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1887C>T::,BRCA1:ENST00000354071.7:missense_variant:MODERATE:exon10/10:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1825C>T::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28968C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18398C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32352C>T::	BRCA1:NM_007294.4:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:NM_007297.4:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1825C>T::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:NM_007300.4:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2789C>T::	regulatory_region_variant:open_chromatin_region	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	41812 [benign DISEASE=Breast carcinoma,Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1];		rs799917		0.4871	21221,.	0.8253,0.3484,0.3789,0.3338,0.5316	4.2470	 ,T(1.00),T(1.00), ,T(1.00), ,T(1.00), , , 	 ,B(0.00),B(0.00), ,B(0.00), ,B(0.00), , , 	17.66	0.14			COSV58784386	-0.0116	0.893	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43093220	43093220	A	G	het		QUAL=1538;DP=127;AF=0.46;MQM=60;SAP=3;ABP=5	BRCA1	intron,synonymous	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-2188T>C::,BRCA1:ENST00000354071.7:synonymous_variant:LOW:exon10/10:c.2311T>C:p.Leu771=:,BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1524T>C::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-29269T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18699T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32051T>C::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1524T>C::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:NM_007300.4:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2488T>C::	regulatory_region_variant:open_chromatin_region	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	125554 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Pancreatic cancer 4,Hereditary cancer-predisposing syndrome,Familial cancer of breast,Fanconi anemia, complementation group S,not specified,none provided,not provided];	CM1719261 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs16940	0.3353	0.3474	7352,.	0.1815,0.3108,0.3790,0.3237,0.5033	-0.4420			3.67				COSV58786443	0.0045	0.8933	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43093449	43093449	G	A	het		QUAL=464;DP=62;AF=0.44;MQM=60;SAP=62;ABP=5	BRCA1	intron,synonymous	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.670+2397C>T::,BRCA1:ENST00000354071.7:synonymous_variant:LOW:exon10/10:c.2082C>T:p.Ser694=:,BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1295C>T::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-29498C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18928C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+31822C>T::	BRCA1:NM_007294.4:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:NM_007297.4:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron9/21:c.787+1295C>T::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:NM_007300.4:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:,BRCA1:NR_027676.2:non_coding_transcript_exon_variant:MODIFIER:exon10/23:n.2259C>T::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	125536 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided,not provided];	CM1719085 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799949	0.3365	0.3526	7893,.	0.2372,0.3165,0.3788,0.3242,0.5041	-0.0010			2.62				COSV58784419	-0.0079	0.8931	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43097350	43097350	A	-	het	off-target	QUAL=543;DP=70;AF=0.39;MQM=60;SAP=13;ABP=11	BRCA1	intron	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron7/9:c.548-58del::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron7/23:c.548-58del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron6/21:c.407-58del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+27835del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-22826del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+27924del::	BRCA1:NM_007294.4:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:NM_007297.4:intron_variant:MODIFIER:intron6/21:c.407-58del::,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron6/21:c.548-58del::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:NM_007300.4:intron_variant:MODIFIER:intron7/23:c.548-58del::,BRCA1:NR_027676.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/22:n.725-58del::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	125889 [benign DISEASE=Breast-ovarian cancer, familial 1,Hereditary cancer-predisposing syndrome,not specified,not provided];			rs8176144		0.2998	7387,.		0.8980			12.13					0.0146	0.268	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43104073	43104086	AAAAAAAAGAAAAG	-	het	off-target	QUAL=10;DP=11;AF=0.27;MQM=60;SAP=10;ABP=8	BRCA1	intron	BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:ENST00000354071.7:intron_variant:MODIFIER:intron6/9:c.441+36_441+49del::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron6/23:c.441+36_441+49del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron5/21:c.300+36_300+49del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+21096_4+21109del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-44+21185_-44+21198del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+21185_-99+21198del::	BRCA1:NM_007294.4:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:NM_007297.4:intron_variant:MODIFIER:intron5/21:c.300+36_300+49del::,BRCA1:NM_007298.3:intron_variant:MODIFIER:intron5/21:c.441+36_441+49del::,BRCA1:NM_007299.4:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:NM_007300.4:intron_variant:MODIFIER:intron6/23:c.441+36_441+49del::,BRCA1:NR_027676.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/22:n.621+36_621+49del::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Pancreatic cancer, susceptibility to, 4}, 614320 (3); {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant]	225705 [benign DISEASE=Breast-ovarian cancer, familial 1,not specified];		Alu (SINE/Alu), (AAG)n (Simple_repeat)	rs373413425		0.3071	7273,.	0.1507,0.2211,0.2941,0.2367,0.4414	1.8490			1.40					-0.779	0.4179	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	58692618	58692618	C	T	het	off-target	QUAL=11283;DP=974;AF=0.47;MQM=60;SAP=5;ABP=12	RAD51C	5'UTR	RAD51C:ENST00000337432.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-26C>T::,RAD51C:ENST00000583539.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-26C>T::	RAD51C:NM_002876.4:5_prime_UTR_variant:MODIFIER:exon1/2:c.-26C>T::,RAD51C:NM_058216.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-26C>T::,RAD51C:NR_103872.2:non_coding_transcript_exon_variant:MODIFIER:exon1/8:n.17C>T::,RAD51C:NR_103873.1:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.46C>T::,RAD51C:XM_006722001.4:5_prime_UTR_variant:MODIFIER:exon1/9:c.-26C>T::,RAD51C:XM_006722002.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-26C>T::,RAD51C:XM_006722004.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-274C>T::,RAD51C:XM_006722005.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-221C>T::,RAD51C:XM_017024914.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-274C>T::,RAD51C:XM_017024916.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-574C>T::,RAD51C:XM_017024917.1:5_prime_UTR_variant:MODIFIER:exon1/9:c.-221C>T::,RAD51C:XR_934513.3:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.479C>T::,RAD51C:XR_934514.3:non_coding_transcript_exon_variant:MODIFIER:exon1/10:n.479C>T::	regulatory_region_variant:promoter,TF_binding_site_variant	605792_[GENE=TEX14_PHENOS=Spermatogenic failure 23, 617707 (3), Autosomal recessive]&602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	324173 [likely benign DISEASE=Fanconi anemia,not specified,Breast and Ovarian Cancer Susceptibility];			rs12946397	0.1583	0.1846	2765,.	0.1375,0.1328,0.1701,0.2064,0.1381	-3.2430			1.61				COSV53625930	-0.315	0.6703	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TEX14 (inh=AR oe_syn=0.96 oe_mis=1.04 oe_lof=0.78), IGBP1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAD51C (inh=AR oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	58720846	58720846	T	C	het	off-target	QUAL=203;DP=27;AF=0.44;MQM=60;SAP=29;ABP=4	RAD51C	intron	RAD51C:ENST00000337432.9:intron_variant:MODIFIER:intron6/8:c.904+34T>C::,RAD51C:ENST00000583539.5:intron_variant:MODIFIER:intron6/7:c.904+34T>C::	RAD51C:NM_058216.3:intron_variant:MODIFIER:intron6/8:c.904+34T>C::,RAD51C:NR_103872.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/7:n.779+34T>C::,RAD51C:XM_006722001.4:intron_variant:MODIFIER:intron6/8:c.904+34T>C::,RAD51C:XM_006722002.4:intron_variant:MODIFIER:intron6/7:c.904+34T>C::,RAD51C:XM_006722004.3:intron_variant:MODIFIER:intron6/8:c.553+34T>C::,RAD51C:XM_006722005.3:intron_variant:MODIFIER:intron6/8:c.553+34T>C::,RAD51C:XM_011525092.2:intron_variant:MODIFIER:intron7/9:c.553+34T>C::,RAD51C:XM_011525093.2:intron_variant:MODIFIER:intron7/9:c.553+34T>C::,RAD51C:XM_011525094.2:intron_variant:MODIFIER:intron6/8:c.553+34T>C::,RAD51C:XM_017024914.1:intron_variant:MODIFIER:intron6/8:c.553+34T>C::,RAD51C:XM_017024915.1:intron_variant:MODIFIER:intron6/8:c.553+34T>C::,RAD51C:XM_017024916.1:intron_variant:MODIFIER:intron7/9:c.553+34T>C::,RAD51C:XM_017024917.1:intron_variant:MODIFIER:intron6/8:c.553+34T>C::,RAD51C:XM_017024918.2:intron_variant:MODIFIER:intron6/8:c.553+34T>C::,RAD51C:XM_017024919.1:intron_variant:MODIFIER:intron7/8:c.553+34T>C::,RAD51C:XR_934513.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.1553+34T>C::,RAD51C:XR_934514.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/9:n.1553+34T>C::		602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]				rs28363318	0.2053	0.2973	7194,.	0.2680,0.1858,0.0008,0.3468,0.1934	0.2890			5.35					-0.0782	0.4394	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51C (inh=AR oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	61683635	61683635	A	G	hom		QUAL=7636;DP=310;AF=1.00;MQM=60;SAP=676;ABP=0	BRIP1	synonymous,3'UTR	BRIP1:ENST00000259008.7:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000682453.1:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000682755.1:synonymous_variant:LOW:exon18/18:c.3189T>C:p.Tyr1063=:,BRIP1:ENST00000682989.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*502T>C::,BRIP1:ENST00000683039.1:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:	BRIP1:NM_032043.3:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:,BRIP1:XM_011525332.3:synonymous_variant:LOW:exon21/21:c.3471T>C:p.Tyr1157=:,BRIP1:XM_011525333.3:synonymous_variant:LOW:exon21/21:c.3471T>C:p.Tyr1157=:,BRIP1:XM_011525334.2:synonymous_variant:LOW:exon21/21:c.3471T>C:p.Tyr1157=:,BRIP1:XM_011525335.3:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:,BRIP1:XM_011525336.2:synonymous_variant:LOW:exon20/20:c.3351T>C:p.Tyr1117=:,BRIP1:XM_011525337.2:synonymous_variant:LOW:exon19/19:c.3270T>C:p.Tyr1090=:,BRIP1:XM_011525338.2:synonymous_variant:LOW:exon17/17:c.2988T>C:p.Tyr996=:,BRIP1:XM_017025200.1:synonymous_variant:LOW:exon16/16:c.2928T>C:p.Tyr976=:,BRIP1:XM_017025201.1:synonymous_variant:LOW:exon16/16:c.2928T>C:p.Tyr976=:,BRIP1:XM_017025202.1:synonymous_variant:LOW:exon8/8:c.1557T>C:p.Tyr519=:,BRIP1:XM_017025203.1:synonymous_variant:LOW:exon9/9:c.1557T>C:p.Tyr519=:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183702 [benign DISEASE=Neoplasm of ovary,Fanconi anemia, complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided];			rs4986763	0.6208	0.6048	28379,.	0.6543,0.7941,0.7150,0.5867,0.4553	3.2750			8.10				COSV51995377	0.0046	0.9405	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61685986	61685986	A	G	hom		QUAL=373;DP=12;AF=1.00;MQM=60;SAP=6;ABP=0	BRIP1	missense,intron	BRIP1:ENST00000259008.7:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000577598.5:missense_variant:MODERATE:exon18/18:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000682453.1:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000682755.1:missense_variant:MODERATE:exon17/18:c.2533T>C:p.Ser845Pro:,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1846T>C::,BRIP1:ENST00000683039.1:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:	BRIP1:NM_032043.3:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:,BRIP1:XM_011525332.3:missense_variant:MODERATE:exon20/21:c.2815T>C:p.Ser939Pro:,BRIP1:XM_011525333.3:missense_variant:MODERATE:exon20/21:c.2815T>C:p.Ser939Pro:,BRIP1:XM_011525334.2:missense_variant:MODERATE:exon20/21:c.2815T>C:p.Ser939Pro:,BRIP1:XM_011525335.3:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:,BRIP1:XM_011525336.2:missense_variant:MODERATE:exon19/20:c.2695T>C:p.Ser899Pro:,BRIP1:XM_011525337.2:missense_variant:MODERATE:exon18/19:c.2614T>C:p.Ser872Pro:,BRIP1:XM_011525338.2:missense_variant:MODERATE:exon16/17:c.2332T>C:p.Ser778Pro:,BRIP1:XM_017025200.1:missense_variant:MODERATE:exon15/16:c.2272T>C:p.Ser758Pro:,BRIP1:XM_017025201.1:missense_variant:MODERATE:exon15/16:c.2272T>C:p.Ser758Pro:,BRIP1:XM_017025202.1:missense_variant:MODERATE:exon7/8:c.901T>C:p.Ser301Pro:,BRIP1:XM_017025203.1:missense_variant:MODERATE:exon8/9:c.901T>C:p.Ser301Pro:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	133756 [benign DISEASE=Neoplasm of ovary,Fanconi anemia, complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided];			rs4986764		0.6118	29042,.	0.6744,0.7994,0.7151,0.5875,0.4555	0.2010	T(0.94),T(0.43),T(0.94),T(0.35), ,T(0.94)	B(0.00),B(0.00),B(0.00),B(0.01), ,B(0.00)	3.59	0.09			COSV51995396,COSV99369284	-0.0403	0.9052	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61686104	61686104	T	C	hom		QUAL=3671;DP=114;AF=1.00;MQM=60;SAP=107;ABP=0	BRIP1	synonymous,intron	BRIP1:ENST00000259008.7:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:,BRIP1:ENST00000577598.5:synonymous_variant:LOW:exon18/18:c.2637A>G:p.Glu879=:,BRIP1:ENST00000682453.1:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:,BRIP1:ENST00000682755.1:synonymous_variant:LOW:exon17/18:c.2415A>G:p.Glu805=:,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1964A>G::,BRIP1:ENST00000683039.1:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:	BRIP1:NM_032043.3:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:,BRIP1:XM_011525332.3:synonymous_variant:LOW:exon20/21:c.2697A>G:p.Glu899=:,BRIP1:XM_011525333.3:synonymous_variant:LOW:exon20/21:c.2697A>G:p.Glu899=:,BRIP1:XM_011525334.2:synonymous_variant:LOW:exon20/21:c.2697A>G:p.Glu899=:,BRIP1:XM_011525335.3:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:,BRIP1:XM_011525336.2:synonymous_variant:LOW:exon19/20:c.2577A>G:p.Glu859=:,BRIP1:XM_011525337.2:synonymous_variant:LOW:exon18/19:c.2496A>G:p.Glu832=:,BRIP1:XM_011525338.2:synonymous_variant:LOW:exon16/17:c.2214A>G:p.Glu738=:,BRIP1:XM_011525340.3:3_prime_UTR_variant:MODIFIER:exon19/19:c.*52A>G::,BRIP1:XM_017025200.1:synonymous_variant:LOW:exon15/16:c.2154A>G:p.Glu718=:,BRIP1:XM_017025201.1:synonymous_variant:LOW:exon15/16:c.2154A>G:p.Glu718=:,BRIP1:XM_017025202.1:synonymous_variant:LOW:exon7/8:c.783A>G:p.Glu261=:,BRIP1:XM_017025203.1:synonymous_variant:LOW:exon8/9:c.783A>G:p.Glu261=:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	183703 [benign DISEASE=Neoplasm of ovary,Fanconi anemia, complementation group J,Hereditary cancer-predisposing syndrome,Familial cancer of breast,not specified,none provided];			rs4986765		0.7421	43144,.	0.9105,0.8670,0.8908,0.6633,0.6991	-0.1910			6.68					-0.0065	0.9053	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61780239	61780239	A	-	het	off-target	QUAL=16;DP=26;AF=0.23;MQM=60;SAP=3;ABP=19	BRIP1	intron	BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron13/19:c.1935+22del::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron12/17:c.1935+22del::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron13/16:c.1935+22del::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron14/20:c.1935+22del::,BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron11/17:c.1713+22del::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron13/18:c.1935+22del::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron14/20:c.1935+22del::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron13/17:c.1935+22del::	BRIP1:NM_032043.3:intron_variant:MODIFIER:intron13/19:c.1935+22del::,BRIP1:XM_011525332.3:intron_variant:MODIFIER:intron13/20:c.1935+22del::,BRIP1:XM_011525333.3:intron_variant:MODIFIER:intron13/20:c.1935+22del::,BRIP1:XM_011525334.2:intron_variant:MODIFIER:intron13/20:c.1935+22del::,BRIP1:XM_011525335.3:intron_variant:MODIFIER:intron13/20:c.1935+22del::,BRIP1:XM_011525336.2:intron_variant:MODIFIER:intron13/19:c.1935+22del::,BRIP1:XM_011525337.2:intron_variant:MODIFIER:intron12/18:c.1794+601del::,BRIP1:XM_011525338.2:intron_variant:MODIFIER:intron9/16:c.1452+22del::,BRIP1:XM_011525339.3:intron_variant:MODIFIER:intron13/18:c.1935+22del::,BRIP1:XM_011525340.3:intron_variant:MODIFIER:intron13/18:c.1935+22del::,BRIP1:XM_011525341.3:intron_variant:MODIFIER:intron13/13:c.1935+22del::,BRIP1:XM_017025200.1:intron_variant:MODIFIER:intron9/15:c.1452+22del::,BRIP1:XM_017025201.1:intron_variant:MODIFIER:intron8/15:c.1392+22del::,BRIP1:XM_017025203.1:intron_variant:MODIFIER:intron1/8:c.-26+22del::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]				rs74268880		0.0119	0,.	0.0088,0.0130,0.0112,0.0125,0.0124	-0.7990			0.19					0.0537	0.4204	0.05	0	0	0 / 0					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61780448	61780448	C	G	het	off-target	QUAL=183;DP=14;AF=0.64;MQM=60;SAP=23;ABP=5	BRIP1	intron	BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron12/19:c.1795-47G>C::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron11/17:c.1795-47G>C::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron12/16:c.1795-47G>C::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron13/20:c.1795-47G>C::,BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron10/17:c.1573-47G>C::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron12/18:c.1795-47G>C::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron13/20:c.1795-47G>C::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron12/17:c.1795-47G>C::	BRIP1:NM_032043.3:intron_variant:MODIFIER:intron12/19:c.1795-47G>C::,BRIP1:XM_011525332.3:intron_variant:MODIFIER:intron12/20:c.1795-47G>C::,BRIP1:XM_011525333.3:intron_variant:MODIFIER:intron12/20:c.1795-47G>C::,BRIP1:XM_011525334.2:intron_variant:MODIFIER:intron12/20:c.1795-47G>C::,BRIP1:XM_011525335.3:intron_variant:MODIFIER:intron12/20:c.1795-47G>C::,BRIP1:XM_011525336.2:intron_variant:MODIFIER:intron12/19:c.1795-47G>C::,BRIP1:XM_011525337.2:intron_variant:MODIFIER:intron12/18:c.1794+392G>C::,BRIP1:XM_011525338.2:intron_variant:MODIFIER:intron8/16:c.1312-47G>C::,BRIP1:XM_011525339.3:intron_variant:MODIFIER:intron12/18:c.1795-47G>C::,BRIP1:XM_011525340.3:intron_variant:MODIFIER:intron12/18:c.1795-47G>C::,BRIP1:XM_011525341.3:intron_variant:MODIFIER:intron12/13:c.1795-47G>C::,BRIP1:XM_017025200.1:intron_variant:MODIFIER:intron8/15:c.1312-47G>C::,BRIP1:XM_017025201.1:intron_variant:MODIFIER:intron7/15:c.1252-47G>C::	regulatory_region_variant:TF_binding_site	605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant]	262005 [benign DISEASE=not specified];		AluJb (SINE/Alu)	rs4988351		0.7777	46452,.	0.8564,0.4960,0.8292,0.7506,0.7925	0.1520			3.79				COSV51993354	-0.0103	0.1511	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr18	22415790	22415790	T	C	hom		QUAL=464;DP=19;AF=1.00;MQM=60;SAP=44;ABP=0	CTAGE1	synonymous	CTAGE1:ENST00000391403.4:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:	CTAGE1:NM_172241.3:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:						rs9946145		0.8553	47659,.	0.3488,0.8771,0.8271,0.9161,0.7923	-0.4070			0.74				COSV66942792	0.003	0.9421	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a), ATP7BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	22416048	22416048	G	A	het		QUAL=1512;DP=133;AF=0.46;MQM=60;SAP=5;ABP=5	CTAGE1	synonymous	CTAGE1:ENST00000391403.4:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:	CTAGE1:NM_172241.3:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:						rs7227477	0.4942	0.5056	18446,.	0.4654,0.6070,0.6150,0.4834,0.4305	0.4950			0.33				COSV66942794	0.0059	0.9422	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a), ATP7BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	22975256	22975256	T	C	hom	off-target	QUAL=2177;DP=70;AF=1.00;MQM=60;SAP=4;ABP=0	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron6/17:c.428+37T>C::	RBBP8:NM_002894.3:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:NM_203291.2:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:NM_203292.2:intron_variant:MODIFIER:intron6/17:c.428+37T>C::,RBBP8:XM_005258325.3:intron_variant:MODIFIER:intron6/17:c.428+37T>C::,RBBP8:XM_005258326.4:intron_variant:MODIFIER:intron5/17:c.-489+37T>C::,RBBP8:XM_006722519.2:intron_variant:MODIFIER:intron8/20:c.428+37T>C::,RBBP8:XM_006722520.2:intron_variant:MODIFIER:intron7/19:c.428+37T>C::,RBBP8:XM_006722521.2:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:XM_011526132.2:intron_variant:MODIFIER:intron7/19:c.428+37T>C::,RBBP8:XM_017025916.1:intron_variant:MODIFIER:intron7/18:c.-489+37T>C::,RBBP8:XM_024451233.1:intron_variant:MODIFIER:intron7/19:c.134+37T>C::	regulatory_region_variant:promoter_flanking_region	604124_[GENE=RBBP8_PHENOS=Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3), Autosomal recessive]	673936 [benign DISEASE=not provided];			rs2336916		0.9650	68038,.	0.8519,0.9811,0.9169,0.9844,0.9366	-1.1550			0.79					-0.0265	0.2585	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22984844	22984846	TCA	-	het	off-target	QUAL=362;DP=32;AF=0.47;MQM=60;SAP=3;ABP=3	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::	RBBP8:NM_002894.3:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:NM_203291.2:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:NM_203292.2:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::,RBBP8:XM_005258325.3:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::,RBBP8:XM_005258326.4:intron_variant:MODIFIER:intron6/17:c.-312-41_-312-39del::,RBBP8:XM_006722519.2:intron_variant:MODIFIER:intron9/20:c.605-41_605-39del::,RBBP8:XM_006722520.2:intron_variant:MODIFIER:intron8/19:c.605-41_605-39del::,RBBP8:XM_006722521.2:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:XM_011526132.2:intron_variant:MODIFIER:intron8/19:c.605-41_605-39del::,RBBP8:XM_017025916.1:intron_variant:MODIFIER:intron8/18:c.-312-41_-312-39del::,RBBP8:XM_024451233.1:intron_variant:MODIFIER:intron8/19:c.311-41_311-39del::		604124_[GENE=RBBP8_PHENOS=Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3), Autosomal recessive]				rs3052770		0.5689	21813,.	0.2077,0.5114,0.4647,0.6430,0.5451	-0.3020			0.33					0.0608	0.5028	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	51058485	51058485	-	T	het	off-target	QUAL=2140;DP=214;AF=0.16;MQM=60;SAP=3;ABP=219	SMAD4	intron	SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3508dup::	SMAD4:NM_005359.6:intron_variant:MODIFIER:intron7/11:c.904+45dup::		600993_[GENE=SMAD4_PHENOS=Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant; Myhre syndrome, 139210 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3)]	492739 [benign DISEASE=not specified];			rs386387676		0.1673	105,.	0.1574,0.1563,0.1985,0.1708,0.1496				12.61				COSV61689656	0.0414	0.7737	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr18	51058485	51058485	-	TT	het	off-target	QUAL=2140;DP=214;AF=0.38;MQM=60;SAP=11;ABP=30	SMAD4	intron	SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3507_667+3508dup::	SMAD4:NM_005359.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::		600993_[GENE=SMAD4_PHENOS=Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant; Myhre syndrome, 139210 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3)]				rs386387676		0.3348	7119,.	0.1110,0.2014,0.2348,0.1888,0.1415				12.56				COSV61689656	0.0797	0.7734	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr19	17268749	17268749	C	T	het	off-target	QUAL=1316;DP=109;AF=0.48;MQM=60;SAP=6;ABP=4	BABAM1,	splice_region&intron,intron,intron&NMD_transcript	BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron1/5:c.-13-45C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron1/9:c.-13-45C>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::	BABAM1:NM_001033549.3:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:NM_001288756.2:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:NM_001288757.2:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::	regulatory_region_variant:promoter			CS1518199 [CLASS=DFP MUT=ALT PHEN="Breast cancer association with" GENE=BABAM1];		rs10424178	0.1727	0.2250	4469,.	0.3533,0.0925,0.0004,0.1919,0.1115	-0.3220			4.16		1.98>3.28	0.000/0.134		-0.1219	0.8748	0.25	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17271696	17271696	A	T	het	off-target	QUAL=331;DP=49;AF=0.37;MQM=60;SAP=3;ABP=10	BABAM1,	intron,intron&NMD_transcript	BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron2/9:c.286-2208A>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron3/8:c.344+41A>T::	BABAM1:NM_001033549.3:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:NM_001288756.2:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:NM_001288757.2:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron3/8:c.344+41A>T::						rs10420922	0.4631	0.4940	19690,.	0.6918,0.3280,0.3137,0.4338,0.3806	-0.5940			0.97				COSV63921517	0.043	0.1991	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17276445	17276445	G	A	het	off-target	QUAL=1378;DP=101;AF=0.52;MQM=60;SAP=3;ABP=4	BABAM1,	intron,intron&NMD_transcript	BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron5/9:c.*184-50G>A::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron6/8:c.570-50G>A::	BABAM1:NM_001033549.3:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:NM_001288756.2:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:NM_001288757.2:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,BABAM1:NM_014173.4:intron_variant:MODIFIER:intron6/8:c.570-50G>A::						rs61634114	0.0990	0.1596	2114,.	0.1450,0.0815,0.0007,0.1776,0.1166	0.6530			5.51					-0.4092	0.9558	0.23	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17278839	17278839	C	T	het		QUAL=1232;DP=108;AF=0.47;MQM=60;SAP=3;ABP=4	BABAM1,	splice_region&intron,intron&NMD_transcript	BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000447614.6:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron7/9:c.*400+1930C>T::,BABAM1:ENST00000598188.6:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000601043.5:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::	BABAM1:NM_001033549.3:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:NM_001288756.2:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:NM_001288757.2:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:NM_014173.4:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::	regulatory_region_variant:enhancer					rs10406920	0.1118	0.1716	2411,.	0.1828,0.0790,0.0006,0.1783,0.1144	0.7980			1.96		8.04>7.99	0.000/0.002	COSV63921267	-0.5749	0.9948	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr19	17278895	17278895	G	A	het		QUAL=6312;DP=539;AF=0.47;MQM=60;SAP=3;ABP=7	BABAM1,	synonymous,intron&NMD_transcript	BABAM1:ENST00000359435.8:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000447614.6:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:ENST00000595632.5:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,:ENST00000596542.1:intron_variant&NMD_transcript_variant:MODIFIER:intron7/9:c.*400+1986G>A::,BABAM1:ENST00000598188.6:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000601043.5:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:	BABAM1:NM_001033549.3:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:NM_001288756.2:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:NM_001288757.2:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:NM_014173.4:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:	regulatory_region_variant:enhancer			CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1];		rs8170	0.1124	0.1735	2466,.	0.1918,0.0800,0.0006,0.1795,0.1147	3.0590			10.27				COSV63920809	-0.0872	0.9214	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr20	14186637	14186637	A	G	hom		QUAL=905;DP=31;AF=1.00;MQM=60;SAP=4;ABP=0	MACROD2	intron	MACROD2:ENST00000217246.8:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::,MACROD2:ENST00000642719.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:ENST00000684519.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::	MACROD2:NM_001351661.2:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:NM_001351663.2:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:NM_080676.6:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::					L1PA16 (LINE/L1)	rs6074704	0.4792	0.5259	22712,.		-0.5390			9.31							0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=n/a oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	49684609	49684609	G	A	hom		QUAL=39631;DP=1210;AF=1.00;MQM=60;SAP=5;ABP=0	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::	B4GALT5:NM_004776.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::						rs6512586	0.4681	0.5178	18677,.	0.3755,0.4483,0.3696,0.5460,0.6515	-0.9890			0.26				COSV65493865			0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
